Worktype B8 - PATENT DESCRIBED

Worktype Details

CodeB8
NamePATENT DESCRIBED

Experiments (3077 results)

Filters
Worktypes (81)
3077
771
649
459
458
408
391
367
209
200
185
116
97
92
81
53
52
51
48
47
40
34
33
26
25
24
24
24
21
18
17
14
13
12
10
8
8
8
8
8
7
6
6
6
5
5
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Pharmacology (301)
231
220
196
53
47
45
35
30
27
25
23
22
20
17
17
16
16
15
14
13
12
11
11
11
11
10
9
9
9
8
8
8
8
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1277
No match
29 rarer values not listed
Compounds (301)
28
24
14
14
12
10
9
8
8
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
394
No match
2092 rarer values not listed
Organisms (300)
17
10
9
9
9
8
8
7
6
6
6
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
No match
2216 rarer values not listed
3077 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
772650
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Heterotheca inuloides (ASTERACEAE)
CADALIN,3-4-DIHYDRO: 7-HYDROXY:
1036924
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Gardenia jasminoides (RUBIACEAE)
CROCIN
668174
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
CHAPARRINONE
81709
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Unidentified actinomycete (UNDETERMINED)
ACTINOMYCETE ANTIBIOTIC CL-1957-B
822683
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinoplanes missouriensis (ACTINOPLANACEAE)
ACTINOPLANES ANTIBIOTIC A-4696-G
827358
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
FEED EFFICIENCY IMPROVEMENT
Streptomyces virginiae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-41030-FACTOR FSTREPTOMYCES ANTIBIOTIC A-41030-FACTOR ESTREPTOMYCES ANTIBIOTIC A-41030-FACTOR ASTREPTOMYCES ANTIBIOTIC A-41030-FACTOR GSTREPTOMYCES ANTIBIOTIC A-41030-FACTOR DSTREPTOMYCES ANTIBIOTIC A-41030-FACTOR BSTREPTOMYCES ANTIBIOTIC A-41030-FACTOR C
351808
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxus species (TAXACEAE)
TAXOL
56604
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Croton lechleri (EUPHORBIACEAE)
TASPINE
817974
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces caespitosus (STREPTOMYCETACEAE)
MITOMYCIN A
332285
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MICROBIAL TRANSFORMATION OF
Micrococcus species (MICROCOCCACEAE)
PENICILLANIC ACID,6-AMINO:
598489
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTICYTOTOXIC ACTIVITY
Rabdosia japonica (LAMIACEAE)
RABDOSIIN
432105
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
GOSSYPOL
935094
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
CASSIGAROL A
986341
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS LESS THAN 50 MGM
Mycobacterium bovis (MYCOBACTERIACEAE)
MYCOBACTERIUM ANTIBIOTIC T-2-B-1
127909
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces griseochromogenes (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC UK-86956
823568
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Penicillium vermiculatum (HYPHOMYCETES)
VERMISTATIN
1042734
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Morus lhou (MORACEAE)
KUWANON HKUWANON G
187072
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces routienii (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC CP-61405
321635
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACEUTICAL FORMULATION OF
Empty organism
GENTAMICINNEBRAMYCINNEOMYCINERYTHROMYCIN
1270245
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTIOXIDANT ACTIVITY
Myristica fragrans (MYRISTICACEAE)
1099856
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rauvolfia serpentina (APOCYNACEAE)
ALSTONINESERPENTINE
408739
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
OROBOL
1057988
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Spirulina species (OSCILLATORIACEAE)
856798
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHYPERLIPEMIC ACTIVITY
Polygonum cuspidatum (POLYGONACEAE)
666547
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
MULBERROFURAN D
329865
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Bacillus species (BACILLACEAE)
BACILLUS ANTIBIOTIC 26-74
83164
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Flexibacter species (CYTOPHAGACEAE)
FLEXIBACTER ANTIBIOTIC TAN-542
491159
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Empty organism
XANTHOANGELOL
997405
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIBACTERIAL ACTIVITY
Empty organism
CORIOLIN B,5-OXO: 8-DEOXY: 8-C-BETA-METHYL:
893867
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERTENSIVE ACTIVITY
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLINE
976047
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza glabra (FABACEAE)
LICOCHALCONE ALICOCOUMARONEGLABRENE
894016
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Crossopteryx febrifuga (RUBIACEAE)
CROSSOPTINE B
1216574
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INSECTICIDE ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC B-41-D
1045177
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
BLEOMYCIN
996211
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
AZIRIDINE,2-3-DICARBOXY: (5):
274558
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Raspailia species (RASPAILIIDAE)
ASMARINE A
329158
YIELD IS MORE THAN 100 MGMPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bufo vulgaris (BUFONIDAE)
CINOBUFAGIN
1014788
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Mycobacterium bovis (MYCOBACTERIACEAE)
MYCOBACTERIUM BOVIS ANTIBIOTIC NA-A
999150
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Bacillus megaterium (BACILLACEAE)
ANSAMITOCIN P-4,DEMETHYL:
481344
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxus cuspidata (TAXACEAE)
BACCATIN III,10-DEACETYL:
595360
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
TRANQUILIZING EFFECT
Empty organism
ORYZANOL
328954
PATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF COMPOUND - IN HUMANSISOLATION AND IDENTIFICATION OF
ANTIULCER ACTIVITY
Penicillium canadense (HYPHOMYCETES)
CANADENSOLIDE,DIHYDRO:
612646
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
BASIDIOMYCETE ANTIBIOTIC
490626
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Aspalathus linearis (FABACEAE)
618647
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CNS DEPRESSANT ACTIVITY
Patrinia species (VALERIANACEAE)
PATRIN
686547
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus jujuba (RHAMNACEAE)
BETULINIC ACID
682929
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
N-ACETYLTRANSFERASE INHIBITION
Empty organism
MYRICETIN
555161
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza glabra (FABACEAE)
GLABRIDIN
612647
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Basidiomycete species (TO BE DETERMINED)
BASIDIOMYCETE ANTIBIOTIC
1262118
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Echinacea purpurea (ASTERACEAE)
ECHINACEA FACTOR BECHINACEA FACTOR A
998057
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Onnia species (HYMENOCHAETACEAE)
ONNIA SPECIES ANTIBIOTIC
878263
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cirsium japonicum (ASTERACEAE)
PECTOLINARIN
934523
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
ACACETIN
847118
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces albulus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC B-52653
1035606
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC BM-782-ALPHA-1-ANOCARDIA ANTIBIOTIC BM-782-ALPHA-1NOCARDIA ANTIBIOTIC BM-782-ALPHA-2
657351
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIYEAST ACTIVITY
Spirastrella spinispirulifera (SPIRASTRELLIDAE)
SPONGIASTATIN 6
857439
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Xanthomonas campestris (PSEUDOMONADACEAE)
XANTHAN GUM
1148227
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
GASTROINTESTINAL DISORDERS(UNSPECIFIED)
Ribes nigrum (SAXIFRAGACEAE)
92500
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Polyangium brachysporum (POLYANGIACEAE)
POLYANGIUM ANTIBIOTIC PEPTIDE I
810118
PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FORPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Jacaranda caucana (BIGNONIACEAE)
997797
QUANTITATIVE DATAPATENT DESCRIBEDYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Streptomyces lavendulae (STREPTOMYCETACEAE)
SAFRAMYCIN C
490682
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Inula species (ASTERACEAE)
INULIN
84961
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 81-484
955102
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Empty organism
FUCOIDAN
488072
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CARCINOGENESIS INHIBITION
Empty organism
TRITRIACONTANE-16-18-DIONE
667573
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIPROTOZOAN ACTIVITY
Empty organism
BERBERINE
332508
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CNS DEPRESSANT ACTIVITY
Empty organism
ARACHIDONATE,METHYL:
996159
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
FLAVONE,ISO: 3'-5-7-TRIHYDROXY-4'-6-DIMETHOXY:FLAVONE,ISO: 3'-5-7-TRIHYDROXY-4'-8-DIMETHOXY:
598394
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Capsicum annuum (SOLANACEAE)
CAPSORUBIN
1015214
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces violaceoniger (STREPTOMYCETACEAE)
LYSOLIPIN X
320850
PATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPREPARATION OF DERIVATIVES OF
Empty organism
VITAMIN B-1NICOTINAMIDELACTOSEASCORBIC ACID
1023809
PURIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
355784
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN IMPROVEMENT EFFECT
Hamamelis virginiana (HAMAMELIDACEAE)
319094
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
AMPICILLIN*
359299
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stylotella aurantium (SUBERITIDAE)
STYLOGUANIDINE
385976
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Empty organism
NAHOCOL D,ISO:NAHOCOL A
334593
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Phytolacca dodecandra (PHYTOLACCACEAE)
1016924
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC C-15003-PND
1023813
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
SWEETENING EFFECT
Empty organism
STEVIOSIDEREBAUDIOSIDE A
1032407
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces fradiae (STREPTOMYCETACEAE)
TYLOSIN,23-DE-(MYCINOSYL-OXY):
1190344
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Echinacea purpurea (ASTERACEAE)
HETEROXYLANRHAMNOARABINOGALACTANARABINOGALACTAN
347814
PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxus species (TAXACEAE)
TAXOL
884838
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eudistoma glaucus (CLAVELINIDAE)
EUDISTOMIDINE A
565659
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Schisandra chinensis (SCHISANDRACEAE)
SCHISANDRIN
864523
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces virginiae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 301-D
396125
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Camellia sinensis (THEACEAE)
TEA POLYSACCHARIDES
405979
PATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Emilia flammea (ASTERACEAE)
EMILINE
833671
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC P-23924-A
1267008
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTITUMOR ACTIVITY
Zingiber officinale (ZINGIBERACEAE)
321336
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
CAPAURINE,(-):
747177
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
STABILITY STUDY
Empty organism
DICTYOSTATIN 1
610740
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Cryptolepis sanguinolenta (ASCLEPIADACEAE)
CRYPTOLEPINE
960782
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Avena sativa (POACEAE)
AVENA SATIVA GLYCOPROTEIN(MW 38KD)
1184324
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Pfaffia paniculata (AMARANTHACEAE)
PFAFFOSIDE F
740291
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Spachea correae (MALPIGHIACEAE)
SPACHEA TRITERPENE 1-BSPACHEA TRITERPENE 1-DFRIEDELA-1-20(29)-DIEN-3-4-(R)-OLIDE,3-4-SECO: 27-30-BIS-NOR: 6-ALPHA-7-ALPHA-15-BETA-16-BETA-24-PENTACETOXY-22-ALPHA-CARBOMETHOXY-21-BETA-22-BETA-EPOXY-18-BETA-HYDROXY:SPACHEA TRITERPENE 1-C
671619
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIOXIDANT ACTIVITY
Empty organism
MARITIMEIN
972907
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Oenothera biennis (ONAGRACEAE)
942183
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
DOLICHOL
1187509
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Scytonema pseudohofmannii (SCYTONEMATACEAE)
SCYTOPHYCIN A
978215
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cephalodiscus gilchristi (CEPHALODISCIDAE)
CEPHALOSTATIN 4CEPHALOSTATIN 3CEPHALOSTATIN 2
1006782
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomadura verrucosospora (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC 51532
168542
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC 1-12713
361020
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WOUND HEALING ACCELERATION
Lavandula officinalis (LAMIACEAE)
84877
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces rishiriensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC OFR-1056-I
1068481
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rauvolfia serpentina (APOCYNACEAE)
AJMALINE
918590
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Curcuma aromatica (ZINGIBERACEAE)
CURCUMENONE
950303
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSTIMULANT ACTIVITY
Tremella fuciformis (TREMELLALES)
427297
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Karwinskia humboldtiana (RHAMNACEAE)
PEROXISOMICINE A-1
477269
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIVIRAL ACTIVITY
Empty organism
LACTIC ACID
666535
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
ALBANOL A
618460
PATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Lentinus edodes (TRICHOLOMATACEAE)
LENTINAN
470517
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
MELANIN FORMATION INHIBITION
Empty organism
ARBUTIN
155155
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTITUMOR-PROMOTING ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC RK-1409-B
101412
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Agelas coniferin (AGELASIDAE)
AGELIFERIN
418585
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Abrus precatorius (FABACEAE)
ABRUSOSIDE C
13825
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
VERRUCARIN E
3408
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
CONTRACEPTIVE AND/OR INTERCEPTIVE EFFECT
Empty organism
CORONARIDINE
349120
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
REVERSE TRANSCRIPTASE INHIBITION
Dictyota dichotoma (DICTYOTACEAE)
DICTYODIAL
76434
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
MISCELLANEOUS EFFECTS
Aspergillus alliaceus (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC I
1014745
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
FORPHENICOL
323658
PMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Cladosporium cladosporioides (HYPHOMYCETES)
CLADOSPORIN
110257
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
NAGSTATIN
610751
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIFERTILITY
HYALURONIDASE INHIBITION
Empty organism
ROSMARINIC ACID
536707
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tabebuia impetiginosa (BIGNONIACEAE)
986932
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
ANTITUSSIVE ACTIVITY
Empty organism
GLAUCINE,(DL):
1047561
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces griseoincarnatus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AN-7-D
318598
PHARMACOLOGY OF COMPOUND - IN VIVOCOMPLEX FORMATIONPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMICROBIAL ACTIVITY(UNSPECIFIED)
Empty organism
STREPTOMYCES ANTIBIOTIC SF-837
1015206
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CARCINOGENESIS INHIBITION
Mycobacterium bovis (MYCOBACTERIACEAE)
MYCOBACTERIUM BOVIS CELL SUBSTANCE NHS-1
941850
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID T
524763
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Bryophyllum pinnatum (CRASSULACEAE)
QUERCETIN-3-O-ALPHA-L-ARABINOPYRANOSYL(1-2)-ALPHA-L-RHAMNOPYRANOSIDE
1096923
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Euphorbia milii (EUPHORBIACEAE)
CHRYSANTHEMIN
976016
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Panax ginseng (ARALIACEAE)
BENZYL-BETA-PRIMEVEROSIDE
130252
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC BE-12233
408307
SYNTHESIS OF ANALOGSPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Catharanthus roseus (APOCYNACEAE)
LEUROSIDINELEUROCRISTINEVINCALEUKOBLASTINE
555027
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIBACTERIAL ACTIVITY
Polygonum capitatum (POLYGONACEAE)
962227
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
PIPERITENONE,ISO:PIPERITENONECARVONE
1035591
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces lydicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC GT-2558-B
686536
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus jujuba (RHAMNACEAE)
BETULINIC ACID
857462
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Penicillium thomii (HYPHOMYCETES)
OXANTHINECARBOXYLIC ACID
1049866
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bacillus cereus (BACILLACEAE)
TUNICAMYCIN F
1045719
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
MILBEMYCIN B-1
338630
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHEPATOTOXIC ACTIVITY
Empty organism
MALTITOL,ISO:
200532
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TMC-1
713299
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
TOXIC EFFECT(GENERAL)
Cordyceps sinensis (CLAVICIPITACEAE)
823489
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Nocardia blackwellii (NOCARDIACEAE)
INDISOCIN
185568
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptoverticillium baldacii (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC FD-594
378181
PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
INSECT REPELLENT ACTIVITY
Empty organism
CINNAMALDEHYDE
321665
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESSEPARATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDQUANTITATIVE DATA REPORTED
Empty organism
CAMPESTEROLSTIGMASTEROLSITOSTEROL,BETA:
260654
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
ANTINEMATODAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC K-96-0188
1089097
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Cassia singueana (FABACEAE)
SINGUEANOL I
376585
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
DIURETIC ACTIVITY
Streptomyces lavendofoliae (STREPTOMYCETACEAE)
PIPERASTATIN A
417799
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Empty organism
ELLAGIC ACID
755044
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIANGIOGENIC ACTIVITY
Empty organism
CHRYSANTHONE ACHRYSANTHONE BCHRYSANTHONE C
13735
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Myrothecium verrucaria (HYPHOMYCETES)
VERRUCARIN A,HEXAHYDRO:
535208
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
HISTAMINE RELEASE INHIBITION
Allium cepa (LILIACEAE)
536827
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANGIOTENSIN CONVERTING ENZYME STIMULATION
Camellia sinensis (THEACEAE)
996414
QUANTITATIVE DATAPATENT DESCRIBEDYIELD IS 50-100 MGMISOLATION AND IDENTIFICATION OF
Streptomyces griseoflavus (STREPTOMYCETACEAE)
PYRROLO-(3,2-E)-INDOLE-7-CARBOXYLIC ACID,3-(H): 3-ACETYL-1-2-DIHYDRO-4-HYDROXY-5-METHOXY:
443719
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CORONARY BLOOD FLOW INCREASED
Panax pseudoginseng (ARALIACEAE)
GINSENOSIDE RB-1
328052
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Heracleum candicans (APIACEAE)
XANTHOTOXIN
354704
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIDEPRESSANT ACTIVITY
Empty organism
ANDROSTERONE,EPI: DEHYDRO:
997074
UV SPECTRUM GIVEN FORPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
TOXICITY ASSESSMENT(QUANTITATIVE)
Inonotus species (HYMENOCHAETACEAE)
DICAFFEIC ACID,DEHYDRO: DILACTONE (-):DICAFFEIC ACID,DEHYDRO: DILACTONE (+):
406245
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Phellodendron amurense (RUTACEAE)
BERBERINE
555043
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
CATHARANTHINEVINDOLINE
950162
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUSSIVE ACTIVITY
Fritillaria ussuriensis (LILIACEAE)
USSURIENINE
693853
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
128154
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Streptomyces amphibiosporus (STREPTOMYCETACEAE)
LACTIMIDOMYCIN
555041
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Schizonepeta tenuifolia (LAMIACEAE)
ROSMARINIC ACID
1006834
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Agaricus heterosistes (AGARICACEAE)
AGARICUS HETEROSISTES ANTIBIOTIC B
568620
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
ECDYSONE,BETA:
979213
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Daedalea dickinsii (POLYPORACEAE)
DAEDALEA DICKINSII ANTIBIOTIC KS-2-A
355780
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Luffa operculata (CUCURBITACEAE)
444446
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-9(11)-CIS-24-DIEN-26-OIC ACID,12(S)-ACETOXY-3-OXO:
1091388
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Empty organism
BICYCLO-(3.2.1)-OCTANE-1-ACETIC ACID,3-8-DIOXA: 4-(4-8-DIMETHYL)-5-HYDROXY-7-NONEN-1-YL-4-METHYL: (1-RS-4-SR-5-RS):
1182340
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLAQUE FORMATION SUPPRESSANT
Empty organism
QUERCETINMYRICETIN
875984
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Empty organism
TETRANDRINE,(+):
125877
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Acanthaster planci (ACANTHASTERIDAE)
ACANTHASTER SPHINGOGLYCOLIPID
818787
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora species (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC M-9026-2MICROMONOSPORA ANTIBIOTIC M-9026-1
982442
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS LESS THAN 50 MGM
Saccharopolyspora hirsuta (SCHIZOMYCETACEAE)
SACCHAROPOLYSPORA ANTIBIOTIC KA-6606-I
1275114
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Dipsacus asperoides (DIPSACACEAE)
HEDERAGENIN
75592
GEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC 1316-B-1
985212
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces lavendulae (STREPTOMYCETACEAE)
CHLOROCARCIN C
686574
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
LIPASE INHIBITION
Garcinia indica (CLUSIACEAE)
GARCINOL
824677
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
MANILOSPORIN A
1006819
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora olivoasterospora (MICROMONOSPORACEAE)
FORTIMICIN AO
991785
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Alkanna tinctoria (BORAGINACEAE)
ALKANNIN ISO-VALERATE
693893
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
LUPEOL
512056
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
TOBACCO SUBSTITUTE
Empty organism
COTININE,(-):
1130726
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
1269892
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Marsdenia cundurango (ASCLEPIADACEAE)
CONDURANGOGLYCOSIDE D-0,20-ISO-O-METHYL:
1020864
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
CYCLOHEXA-1-3-DIENE-1-CARBOXALDEHYDE,6-AMINO-5-HYDROXY
764914
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Cimicifuga racemosa (RANUNCULACEAE)
359301
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Asparagus officinalis (LILIACEAE)
325586
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACEUTICAL FORMULATION OFPREPARATION OF DERIVATIVES OF
Empty organism
ERYTHROMYCIN
1007938
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOPLASMAL ACTIVITY
Actinomadura species (THERMOMONOSPORACEAE)
HUGAMYCIN
950173
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERTENSIVE ACTIVITY
Fritillaria ussuriensis (LILIACEAE)
VERTICINONE
477622
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
CAMPTOTHECIN
1259111
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
NARCOTIC ANTAGONIST ACTIVITY
Panax ginseng (ARALIACEAE)
997409
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CORIOLIN B,5-OXO: 8-C-ALPHA-METHYL:
1141019
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Patinopecten yessoensis (PECTINIDAE)
610296
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Schumanniophyton magnificum (RUBIACEAE)
SCHUMANNIOPHYTINE,ISO:
339506
PATENT DESCRIBEDSEPARATION OF (EXCEPT OILS, VENOM, PROTEINS, FATS)
Humulus lupulus (CANNABACEAE)
LUPULIN
757659
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Paeonia species (PAEONIACEAE)
GLUCOPYRANOSE,BETA-D: 1-2-3-6-TETRAGALLOYL:
990926
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2012
1006829
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Saccharomyces species (SACCHAROMYCETACEAE)
SACCHAROMYCES ANTIBIOTIC
817978
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC BD-01
1075696
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Catharanthus roseus (APOCYNACEAE)
LEUROSINE,DEACETYL:LEUROSINELEUROFORMINE,DEACETYL:LEUROFORMINE
737306
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Fagopyrum cymosum (POLYGONACEAE)
CATECHIN,EPI: (-):
1083002
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CNS DEPRESSANT ACTIVITY
Montanoa tomentosa (ASTERACEAE)
ZOAPATANOL
971176
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBODY FORMATION ENHANCEMENT
Empty organism
TELEOCIDIN A-2TELEOCIDIN A-1
154346
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS
PLANT GROWTH INHIBITOR(UNSPEC)
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC KSB-8200-W
764735
PATENT DESCRIBEDHOMEOPATHIC STUDIES
Empty organism
987310
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Glycyrrhiza glabra (FABACEAE)
GLYCYRRHIZIN
405024
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces tumorcoagulans (STREPTOMYCETACEAE)
STREPTOMYCES TUMORCOAGULANS ANTIBIOTIC
983898
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
TAENIFUGE ACTIVITY
Empty organism
RACEMOMYCIN A
667209
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SUNSCREEN EFFECT
Empty organism
POLYGLUTAMIC ACID
833676
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
COLLAGENASE INHIBITION
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC P-23924-D
1066236
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Ananas comosus (BROMELIACEAE)
1083004
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
UTERINE STIMULANT EFFECT
Montanoa tomentosa (ASTERACEAE)
ZOAPATANOL
22516
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Acronychia baueri (RUTACEAE)
ACRONYCINE
397626
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Glycyrrhiza glabra (FABACEAE)
COUMARONE,2-(2'-4'-DIHYDROXY-PHENYL)-4-METHOXY-5-(3-METHYL-BUTEN-2-YL)-6-HYDROXY:
818782
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora species (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC M-9026
79349
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOGLYCEMIC ACTIVITY
Lithospermum erythrorhizon (BORAGINACEAE)
LITHOSPERMAN C
1019744
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TM-531-C
85637
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 3780
999420
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora olivoasterospora (MICROMONOSPORACEAE)
FORTIMYCIN AE
218984
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Scleroderma texense (SCLERODERMATACEAE)
TEXENOMYCIN B
326280
SEPARATION OF ISOMERSPATENT DESCRIBED
Empty organism
PENICILLAMINE,(DL):
425990
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIBACTERIAL ACTIVITY
Empty organism
BERBERINE
562365
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
ACETOPHENONE,4'-HYDROXY:
1021805
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces baarnensis (STREPTOMYCETACEAE)
ENAMINOMYCIN A
386038
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Cryptolepis sanguinolenta (ASCLEPIADACEAE)
524754
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HAIR STIMULANT EFFECT
Empty organism
FERULIC ACID
819316
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AY-24668
698762
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Polymnia sonchifolia (ASTERACEAE)
ALDARIC ACID,TRICAFFEOYL:
417438
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Empty organism
ALLICIN
979266
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eupatorium sachalinense (ASTERACEAE)
HIYODORILACTONE CHIYODORILACTONE BEUCANNABINOLIDE
425922
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
TOPSENTIN D,NOR:
1012483
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Micromonospora inyoensis (MICROMONOSPORACEAE)
KANAMYCIN A
812185
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION OFPATENT DESCRIBEDQUANTITATIVE DATA REPORTED
Rauvolfia serpentina (APOCYNACEAE)
RESCINNAMINERESERPINE
89701
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC SF-2370
2636
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
NUPHAR LUTEUM ALKALOID(C-30-H-42-N-2-O-5)
874494
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bacillus subtilis (BACILLACEAE)
DIFFICOLDIFFICOL,OXY:
1056249
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cephalotaxus harringtonia (CEPHALOTAXACEAE)
CEPHALOTAXINE
1015859
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Stevia rebaudiana (ASTERACEAE)
974525
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Empty organism
ALLANTOIN
406933
SYNTHESIS OF ANALOGSPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CEPHALOTAXINE,3'-O-(5-METHYL-2-OXO-HEXANOYL):*
1026067
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
MONACOLIN K LACTONE 236-B
657715
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Geum japonicum (ROSACEAE)
TORMENTIC ACID 28-O-BETA-D-GLUCOSIDE
813259
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CHOLINESTERASE INHIBITION
Empty organism
STEPHAGLABRIN
330234
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIFUNGAL ACTIVITY
Empty organism
THYMOLHINOKITIOLUNDECANOIC ACID
1000426
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Micromonospora globosa (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC S-54832/A-IVMICROMONOSPORA ANTIBIOTIC S-54832/A-IMICROMONSPORA ANTIBIOTIC S-54832/A-IIMICROMONOSPORA ANTIBIOTIC S-54832/A-III
678718
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
WEIGHT GAIN INHIBITION
Empty organism
SITOST-5-EN-3-ONESITOST-4-EN-3-ONE,6-HYDROXY:
997100
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC 2-200
448009
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Rehmannia glutinosa (SCROPHULARIACEAE)
AJUGOL,6-O-TRANS-FERULOYL:
99100
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Coriolus consors (POLYPORACEAE)
CORIOLIC ACID,DEOXY:
411719
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Vinca minor (APOCYNACEAE)
VINCAMINE,16-EPI:VINCAMINE
811032
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Micromonospora olivoasterospora (MICROMONOSPORACEAE)
FORITMICIN BFORTIMICIN A
569668
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Coriandrum sativum (APIACEAE)
388599
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CELL PROLIFERATION INHIBITION
Eudistoma species (CLAVELINIDAE)
EILATIN
616933
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXIC EFFECT(GENERAL)
Empty organism
COLEOPHOMA ANTIBIOTIC YO-7396
448795
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS
ANTIFUNGAL ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MH-850-A
666106
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aloe vera (LILIACEAE)
IMMUNO-10
859263
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ardisia crenata (MYRSINACEAE)
ARDISIA CRENATA COMPOUND(C49H75N7015)
410725
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces griseoflavus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-1670-ASTREPTOMYCES ANTIBIOTIC SF-1670-B
329561
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Actinomyces imbricatus (ACTINOMYCETACEAE)
IMBRICIN
425948
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
COTYLENIC ACID
975465
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
DENTIFRICE ACTIVITY
Eclipta alba (ASTERACEAE)
932463
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Panax ginseng (ARALIACEAE)
PANAX GINSENG GLYCOPROTEIN
328976
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Pseudomonas aeruginosa (PSEUDOMONADACEAE)
PSEUDOMONAS ANTIBIOTIC
1011901
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces tenjimariensis (STREPTOMYCETACEAE)
ISTAMYCIN AISTAMYCIN B
998583
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces olivaceus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MM-4550-A
740295
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Spachea correae (MALPIGHIACEAE)
SPACHEA TRITERPENE 1-BSPACHEA TRITERPENE 1-DFRIEDELA-1-20(29)-DIEN-3-4-(R)-OLIDE,3-4-SECO: 27-30-BIS-NOR: 6-ALPHA-7-ALPHA-15-BETA-16-BETA-24-PENTACETOXY-22-ALPHA-CARBOMETHOXY-21-BETA-22-BETA-EPOXY-18-BETA-HYDROXY:SPACHEA TRITERPENE 1-C
1172136
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HYPOGLYCEMIC ACTIVITY
Empty organism
SILYMARIN
989427
PURIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
960753
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tithonia diversifolia (ASTERACEAE)
TAGITININ C
1005125
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Streptomyces pyridochromogenes (STREPTOMYCETACEAE)
CEPHALOSPORIN C
846265
ION EXCHANGE METHODS USEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza glabra (FABACEAE)
GLYCYRRAM
183427
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Scolecobasidium arenarium (HYPHOMYCETES)
SCOLECOBASIDIUM ANTIBIOTIC WF-2015-B
393251
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
COLLAGENASE INHIBITION
Empty organism
GALLIC ACID ETHYL ESTER
1065296
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDPREPARATION OF DERIVATIVES OFISOLATION AND IDENTIFICATION OF
Croton sublyratus (EUPHORBIACEAE)
PLAUNOL MONOACETATE
600566
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinoplanes species (ACTINOPLANACEAE)
ACTINOPLANES ANTIBIOTIC BE-40665-A
924086
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Morus bombycis (MORACEAE)
NOJIRIMYCIN,1-DEOXY:
595089
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Empty organism
LOLIOLIDE
1053036
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Morus bombycis (MORACEAE)
SANGGENON D
1065856
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Teucrium marum (LAMIACEAE)
852772
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycine max (FABACEAE)
SOYASAPONIN A-1
352460
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
MISCELLANEOUS EFFECTS
Empty organism
PIPERINE
1010726
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS
HERBICIDAL ACTIVITY
Streptomyces griseus (STREPTOMYCETACEAE)
PIPERIDINE-2-6-DIONE,1-(R)-3-(S)-5-(S)-ALPHA-(R)-3-(2-(3-5-DIMETHYL-2-OXO-CYCLOHEXYL)-2-HYDROXY-ETHYL):
554312
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIACNE ACTIVITY
Empty organism
HESPERETIN
764636
PATENT DESCRIBED
Empty organism
MANZAMINE
555273
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
OLEANOLIC ACID
469811
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Trewia nudiflora (EUPHORBIACEAE)
TREWIASINE
560729
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Micromonospora species (MICROMONOSPORACEAE)
GLYPHOMICIN A
154335
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TAN-1434
451464
PATENT DESCRIBED
Empty organism
SILYBIN
1028567
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Veillonella alcalescens (VEILLONELLACEAE)
VEILLONELLA ANTIBIOTIC TV-1301
385898
PATENT DESCRIBED
Gloiopeltis species (ENDOCLADIACEAE)
152814
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIPARASITIC ACTIVITY
Chrysosporium meridarium (HYPHOMYCETES)
CHRYSOSPORIUM ANTIBIOTIC
565112
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
TYROSINASE INHIBITION
Syzygium aromaticum (MYRTACEAE)
458791
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN MOISTURIZING EFFECT
Melissa officinalis (LAMIACEAE)
693882
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
330363
PATENT DESCRIBEDPHARMACEUTICAL FORMULATION OF
Empty organism
ASCORBIC ACID
1212754
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIULCER ACTIVITY
Tussilago farfara (ASTERACEAE)
614106
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
185180
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces tolurosus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AG-55-2
1004047
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora sagamiensis nonreducans (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC XK-62-7
598482
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Artemisia capillaris (ASTERACEAE)
228112
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Rozites caperata (CORTINARIACEAE)
882622
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
AVAROL
386036
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
PHYTIC ACID
1035422
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
KOJIC ACID DIBUTYRATEKOJIC ACID DIPALMITATEKOJIC ACID DISTEARATEKOJIC ACID DIOLEATE
978410
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
CERCOSPORIN
1005728
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALPHA-AMYLASE INHIBITION
Streptomyces diastaticus-amylostaticus (STREPTOMYCETACEAE)
AMYLOSTATIN B
817449
PATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces species (STREPTOMYCETACEAE)
REBAUDIOSIDE A
647404
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIAMEBIC ACTIVITY
Empty organism
QUASSINOID TERPENE II
419168
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
PERILLYL ALCOHOL
32789
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDPREPARATION OF DERIVATIVES OFISOLATION AND IDENTIFICATION OF
Cassia senna (FABACEAE)
SENNOSIDE ASENNOSIDE B
963787
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RNA SYNTHESIS STIMULATION
Garcinia kola (CLUSIACEAE)
GARCINIKOLIN
941846
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODOSTERONE
1020741
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces vinaceus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2012-L
1007058
PATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Gibberella fujikuroi (HYPOCREACEAE)
GIBBERELLIN A-18
1005335
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania species (MENISPERMACEAE)
GINDARINE
652742
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Garcinia mangostana (CLUSIACEAE)
MANGOSTIN,ALPHA:
577454
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TYROSINASE INHIBITION
Sapindus mukorossi (SAPINDACEAE)
HEDERAGENIN
194437
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
RUBYMCIN
504483
PATENT DESCRIBEDMEDICINAL FOLKLORE REPORTED FOR
BEVERAGE USE
Eucommia ulmoides (EUCOMMIACEAE)
388597
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CELL DIFFERENTIATION INDUCTION
Eudistoma species (CLAVELINIDAE)
SHERMILAMINE A,DEBROMO:SEGOLINE,NOR:SEGOLINE A,ISO:SEGOLINE ASEGOLINE B
395553
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Salacia prinoides (HIPPOCRATEACEAE)
LUP-20(29)-EN-2-ONE,3-BETA-30-DIHYDROXY:
693878
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
909446
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eleutherococcus senticosus (ARALIACEAE)
ELEUTHEROSIDE D
1021122
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces nojiriensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AN-2
597931
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Camellia sinensis (THEACEAE)
CATECHIN,(+):CATECHIN-3-O-GALLATE,EPI: (-):CATECHIN,EPI: (-):GALLOCATECHIN-3-O-GALLATE,EPI: (-):
330476
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Claviceps purpurea (CLAVICIPITACEAE)
SECALONIC ACID
1006583
UV SPECTRUM GIVEN FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces staurosporeus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AM-2282
407051
PHARMACOLOGY OF EXTRACT - IN VITROPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
CYTOTOXIC ACTIVITY
Brucea antidysenterica (SIMAROUBACEAE)
BRUCEANTIN
959060
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
PHAGOCYTOSIS RATE INCREASED
Echinacea purpurea (ASTERACEAE)
991312
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
HYPOTENSIVE ACTIVITY
Geranium nepalense (GERANIACEAE)
GERANIIN
90267
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Zofiela marina (TO BE DETERMINED)
ZOFIMARIN
566504
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
ALOENIN
1002341
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinoplanes species (ACTINOPLANACEAE)
ACTINOPLANES ANTIBITOIC A-7413-C
513805
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
BEQUINOSTATIN A
676030
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
GENE EXPRESSION INDUCTION
Belamcanda chinensis (IRIDACEAE)
449390
PATENT DESCRIBEDTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANS
TOXIC EFFECT(GENERAL)
Empty organism
GYMNEMIC ACID
686237
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Lonicera japonica (CAPRIFOLIACEAE)
OCHNAFLAVONE
657341
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIYEAST ACTIVITY
Spirastrella spinispirulifera (SPIRASTRELLIDAE)
SPONGIASTATIN 5
667572
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIPROTOZOAN ACTIVITY
Empty organism
BERBERINE
1070916
PHARMACOLOGY OF EXTRACT - IN VIVOIDENTIFICATION OFPATENT DESCRIBED
DIURETIC ACTIVITY
Trapa japonica (TRAPACEAE)
861998
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
STEVIOSIDEREBAUDIOSIDE AMALTITOL
390587
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Agrobacterium aurantiacum (RHIZOBIACEAE)
ADONIXANTHIN GLUCOSIDEASTAXANTHIN GLUCOSIDE
76598
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Penicillium rugulosum (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC BP-3-II
980871
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CORIOLUS VERSICOLOR POLYSACCHARIDE
321340
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
PENICILLAMINE,(DL):
741570
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ilex kudincha (AQUIFOLIACEAE)
ILEKUDINOL B
1006568
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinomyces species (ACTINOMYCETACEAE)
ACTINOMYCES ANTIBIOTIC BBM-928-EACTINOMYCES ANTIBIOTIC BBM-928-F
470132
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIPSORIATIC ACTIVITY
Empty organism
ANTHRONE,1-8-DIHYDROXY:
183229
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-1415-B-3
336028
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
NITIDINE
555020
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Zingiber officinale (ZINGIBERACEAE)
ZERUMBODIENONEHUMULENE EPOXIDE 2HUMULENE EPOXIDE 1
693892
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
LUPEOL
997792
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
SAFRAMYCIN BSAFRAMYCIN CSAFRAMYCIN DSAFRAMYCIN ASAFRAMYCIN E
946768
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Picrasma javanica (SIMAROUBACEAE)
PICRASMA SESQUITERPENE LACTONE II
605259
PATENT DESCRIBED
Empty organism
STILLOPSIN
994065
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Staphylococcus species (MICROCOCCACEAE)
STAPHYLOKINASE
111941
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2547
1087444
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIULCER ACTIVITY
Aloe arborescens (LILIACEAE)
ALOCTIN A
495186
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
TAXOL
836503
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN BACLACINOMYCIN A
994029
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
CUMENE
678180
PATENT DESCRIBED
Allium sativum (LILIACEAE)
905048
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Arthrobacter species (CORYNEFORM ACTINOMYCETE)
MENAQUINONE 4
1004981
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Actinomyces melleochryseus (ACTINOMYCETACEAE)
ACTINOMYCIN D
678848
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Chonemorpha fragrans (APOCYNACEAE)
CHONEMORPHA LIGNAN I
426260
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HAIR STIMULANT EFFECT
Empty organism
FORSKOLIN
319093
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
CEPHALOSPORIN*
1048685
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Bos bovis (BOVIDAE)
MUELLERIAN INHIBITING SUBSTANCE
126177
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces matensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC PI-083
1006710
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces lavendofoliae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AM-630
983348
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Echinacea angustifolia (ASTERACEAE)
928016
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
GENISTEIN
321632
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Peganum harmala (ZYGOPHYLLACEAE)
VASICINE
1032849
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Volvariella volvacea (PLUTEACEAE)
SANITANIN S-DSANITANIN 2-C
934377
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Nocardia orientalis (NOCARDIACEAE)
AMYCOLATOPSIS ANTIBIOTIC MM-47767AMYCOLATOPSIS ANTIBIOTIC MM-55256AMYCOLATOPSIS ANTIBIOTIC MM-55260AMYCOLATOPSIS ANTIBIOTIC MM-47766
359305
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Ficus awkeotsang (MORACEAE)
981268
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATEMAYTANSINOL BUTYRATE
662697
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIYEAST ACTIVITY
Swartzia madagascariensis (FABACEAE)
SWARTZIADIONE
1045704
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Onosma zerizaminum (BORAGINACEAE)
SHIKONIN
1008521
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
HEX-2-EN-1-AL
417203
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
DEODORIZING EFFECT
Empty organism
GLYCYRRHETINIC ACID
841366
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
FEEDING DETERRENT(ANIMAL)
Empty organism
ALOIN
418030
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Swietenia mahagoni (MELIACEAE)
SWIETENOLIDE DIACETATE
560520
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ABSORPTION EFFECTS(CUTANEOUS)
Empty organism
TOCOPHEROL,ALPHA:
420942
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Foeniculum vulgare (APIACEAE)
ANOLANETHOLE
110735
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Merremia mammosa (CONVOLVULACEAE)
MERREMOSIDE C
822501
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Rabdosia rubescens (LAMIACEAE)
RUBESCENSIN D
76117
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces ambofaciens (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC PTL-448-A
762282
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Dictyophora indusiata (PHALLACEAE)
DICTYOPHORINE A
185167
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Achromobacter stenohalis (ACHROMOBACTERIACEAE)
ACHMOBACTER LIPOPOLYSACCHARIDE
1113577
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
PSORIASIS TREATMENT
Salvia officinalis (LAMIACEAE)
552306
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Desmos cochinchinensis (ANNONACEAE)
FLAVANONE,8-FORMYL-2-5-7-TRIHYDROXY-6-METHYL:
602855
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
VASODILATOR ACTIVITY
Cnidium officinale (APIACEAE)
CONIFERYL FERULATEDILIGUSTILIDE#SENKYUNOLIDE PLEVISTOLIDE ATOKINOLIDE B
329150
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIARRHYTHMIC ACTIVITY
Cadia ellisiana (FABACEAE)
CADIA ELLISIANA SUBSTANCE(C-20-H-27-N-3-O-3)
666568
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
MULBERROFURAN C
490687
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ancistrocladus korupensis (ANCISTROCLADACEAE)
MICHELLAMINE AMICHELLAMINE B
626054
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
HYPOGLYCEMIC ACTIVITY
Harungana madagascariensis (CLUSIACEAE)
978662
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Sandoricum indicum (MELIACEAE)
BRYONOLIC ACID
206200
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Exophiala pisciphila (HYPHOMYCETES)
EXOPHILIN A
976026
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Vancouveria hexandra (BERBERIDACEAE)
ICARIIN
1055564
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
CADEGUOMYCIN
854331
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Myrothecium verrucaria (HYPHOMYCETES)
RORIDIN E-2
183423
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Scolecobasidium arenarium (HYPHOMYCETES)
SCOLECOBASIDIUM ANTIBIOTIC WF-2015-A
837065
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Selinum monnieri (APIACEAE)
COUMARIN,6-HYDROXY-8-(3-METHYL-BUT-2-ENYL):
933805
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Plectranthus forskholii (LAMIACEAE)
FORSKOLIN,1-9-DIDEOXY:
626531
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
LYMPHOCYTE SUPPRESSION
Tripterygium wilfordii (CELASTRACEAE)
1021809
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Streptomyces sakayensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DO-65-I
810808
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSISOLATION AND IDENTIFICATION OF
SWEETENING EFFECT
Stevia rebaudiana (ASTERACEAE)
STEVIA REBAUDIANA GLYCOSIDE
490630
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALDOSE REDUCTASE INHIBITION
Polygala tenuifolia (POLYGALACEAE)
XANTHONE,1-3-6-TRIHYDROXY-2-7-DIMETHOXY:
365376
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
CINNAMALDEHYDECINNAMALDEHYDE,METHOXY:
826182
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
GUM ARABIC
523321
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Agave americana (AGAVACEAE)
39383
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ESTROGENIC EFFECT
Butea monosperma (FABACEAE)
827011
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Chaetomella cinnamomea (COELOMYCETES)
CHAETOMELLA ANTIBIOTIC PF-1057-A
200715
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC NA-14742
854133
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Panax quinquefolius (ARALIACEAE)
PANAXAN APANAXAN EPANAXAN DPANAXAN BPANAXAN C
1050643
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aspergillus repens (HYPHOMYCETES)
FLAVOGLAUCIN
1002709
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC M-368-A
1027134
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora species (MICROMONOSPORACEAE)
ANTLERMICIN D
694210
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Momordica cochinchinensis (CUCURBITACEAE)
MOMORDIN I-C
15403
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
CHOLERETIC ACTIVITY
Cynara scolymus (ASTERACEAE)
607102
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Olea europaea (OLEACEAE)
TYROSOL,HYDROXY:
821176
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTICOAGULANT ACTIVITY
Streptoverticillium cinnamoneum (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC SAC-IIISTREPTOVERTICILLIUM ANTIBIOTIC SAC-IISTREPTOVERTICILLIUM ANTIBIOTIC SAC-I
440028
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Silybum marianum (ASTERACEAE)
SILYMARIN
535058
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sophora flavescens (FABACEAE)
SOPHORA GLYCOPROTEIN
342157
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIBACTERIAL ACTIVITY
Streptomyces griseusm (STREPTOMYCETACEAE)
LEUKEMOMYCIN C,DIHYDRO:
319170
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
RIFAMPICIN
397428
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxus species (TAXACEAE)
BACCATIN III,10-DEACETYL:TAXOL
565657
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
DIURETIC ACTIVITY
Zea mays (POACEAE)
722189
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ALPHA-GLUCOSIDASE INHIBITION
Matricaria chamomilla (ASTERACEAE)
606211
PATENT DESCRIBED
Quercus pedunculata (FAGACEAE)
610065
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIDANDRUFF EFFECT
Empty organism
ZINCPOLYANEMINE
68354
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
REDUCTASE,5-ALPHA: INHIBITION
Empty organism
ASTAXANTHIN
1005731
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces diastaticus-amylostaticus (STREPTOMYCETACEAE)
AMYLOSTATIN D
426259
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Camellia sinensis (THEACEAE)
218059
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ecteinascidia turbinata (PEROPHORIDAE)
ECTEINASCIDIN 729,N-12-FORMYL:
361025
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
GASTRIN RELEASING PEPTIDE RECEPTOR BINDING INHIBITION
Empty organism
KUWANON G
998643
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
BESTATIN
218067
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ecteinascidia turbinata (PEROPHORIDAE)
ECTEINASCIDIN 722
1030470
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces antibioticus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC P-15150STREPTOMYCES ANTIBIOTIC P-15149-NSTREPTOMYCES ANTIBIOTIC P-15148STREPTOMYCES ANTIBIOTIC P-15153
319495
GEL PERMEATION CHROMATOGRAPHY USEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Catharanthus longifolius (APOCYNACEAE)
CALONGINE
318673
PURIFICATION OFPATENT DESCRIBED
Empty organism
LINOLEIC ACIDOLEIC ACID
347369
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Alpinia urarensis (ZINGIBERACEAE)
QUERCETIN
996162
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALKALINE PHOSPHATASE INHIBITION
Streptomyces species (STREPTOMYCETACEAE)
FORPHENICINE
257325
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Pseudallescheria species (MICROASCACEAE)
PSEUDALLESCHERIA ANTIBIOTIC AM-6898-E
672832
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Euphorbia peplus (EUPHORBIACEAE)
992390
PMR SPECTRUM REPORTEDQUANTITATIVE DATAPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Streptomyces roseoviolaceus (STREPTOMYCETACEAE)
ROSEORUBICIN B
422546
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Camellia sinensis (THEACEAE)
CAMELLIA GALACTOGLUCAN
469804
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Trewia nudiflora (EUPHORBIACEAE)
TRENUDINE
555046
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Hansenula polymorpha (SACCHAROMYCETACEAE)
PINENE,ALPHA:
325605
STABILITY STUDIES OFPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OF
Empty organism
DIGOXIN,BETA-ACETYL:*
992469
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIYEAST ACTIVITY
Streptomyces incarnatus (STREPTOMYCETACEAE)
82935
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Xanthomonas albilineans (PSEUDOMONADACEAE)
ALBICIDIN
1005834
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Actinomadura fulva (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC AB-85
327016
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aesculus hippocastanum (HIPPOCASTANACEAE)
AESCIN
489821
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Pittosporum species (PITTOSPORACEAE)
843295
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
VIRIDOGRISEIN CL-C,NEO:
969133
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ambrosia chamissonis (ASTERACEAE)
THIARUBRINE HTHIARUBRINE ETHIARUBRINE FTHIARUBRINE DTHIARUBRINE G
416862
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTIMUTAGENIC ACTIVITY
Hydrangea serrata (SAXIFRAGACEAE)
906864
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Humulus lupulus (CANNABACEAE)
890280
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Empty organism
GLYCYRRHIZIN
385894
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WOUND HEALING ACCELERATION
Tournefortia sarmentosa (BORAGINACEAE)
991352
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Saccharomyces species (SACCHAROMYCETACEAE)
SACCHAROMYCES POLYSACCHARIDE ANTIBIOTIC
708509
PATENT DESCRIBED
Rhodiola crenulata (CRASSULACEAE)
998879
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Pseudomonas acidophila (PSEUDOMONADACEAE)
PSEUDOMONAS ANTIBIOTIC G-6302
1058109
ION EXCHANGE METHODS USEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 875-A
565648
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Spirastrella spinispirulifera (SPIRASTRELLIDAE)
SPONGISTATIN 6SPONGISTATIN 4
322452
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDPREPARATIVE METHODS EMPLOYEDABSORPTION/DISTRIBUTION STUDYTLC DATA REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Cephalotaxus harringtonia (CEPHALOTAXACEAE)
HARRINGTONINE
321082
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Bacillus subtilis (BACILLACEAE)
657333
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Spirastrella spinispirulifera (SPIRASTRELLIDAE)
SPONGIASTATIN 4
970702
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cephalodiscus gilchristi (CEPHALODISCIDAE)
CEPHALOSTATIN 5
952083
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
PHAGOCYTOSIS RATE DECREASED
Polystictus versicolor (HYMENOCHAETACEAE)
614034
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces candidus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC OS-3256-B
1081611
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Papaver setigerum (PAPAVERACEAE)
CODEINE
566565
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
WOUND HEALING ACCELERATION
Empty organism
BRYONOLIC ACID
552716
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Swertia japonica (GENTIANACEAE)
BELLIDIFOLIN
831150
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Coleus blumei (LAMIACEAE)
ROSMARINIC ACID
739185
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Anacardium occidentale (ANACARDIACEAE)
RESORCINOL,5-(PENTADECA-8-11-DIENYL):
1050632
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CHOLESTEROL INHIBITION
Absidia coerulea (MUCORACEAE)
MEVINOLIN
491817
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Verticillium balanoides (HYPHOMYCETES)
BALANOL
1284018
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIALZHEIMER'S ACTIVITY
Empty organism
GALANTHAMINE
249890
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomadura species (THERMOMONOSPORACEAE)
DECATROMICIN ADECATROMICIN B
329545
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
HESPERETIN-DIHYDROCHALCONE-4'-O-BETA-D-XYLOSIDE
489473
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
DNA POLYMERASE BETA INHIBITION
Xestospongia sapra (PETROSIIDAE)
HALENAQUINOL SULFATE
409307
PATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
XYLITOL
976037
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Menispermum dauricum (MENISPERMACEAE)
DAURICINE
823358
UV SPECTRUM GIVEN FORISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces bottopensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-45-A-2
544921
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LEUKOTRIENE C-4 INHIBITION
Dalbergia odorifera (FABACEAE)
MEDICARPIN,ISO:
950180
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Fritillaria ussuriensis (LILIACEAE)
SOLANIDINE
489899
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
AJMALICINE
1227196
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTHELMINTIC ACTIVITY
Empty organism
SHOGAOL,6:
975895
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
SPASMOLYTIC ACTIVITY
Petasites japonicus (ASTERACEAE)
PETASIN,ISO:
336378
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFPATENT DESCRIBEDQUANTITATIVE DATA REPORTEDINDICATION BY COLOR REACTIONSTLC DATA REPORTED
Empty organism
STEVIOSIDE
7980
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
ZINCPOLYANEMINE
975824
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
KIDNEY STONE DEVELOPMENT INHIBITION
Desmodium styracifolium (FABACEAE)
SCHAFTOSIDE
745314
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Scytalidium species (HYPHOMYCETES)
HALOVIR A
975781
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN PIGMENTATION EFFECT
Humulus lupulus (CANNABACEAE)
1015256
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTITUMOR ACTIVITY
Streptoverticillium griseoverticillatum (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC P-4639
341183
PURIFICATION OFPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
TETRACYCLINE,ALPHA-6-DEOXY:*
598547
X-RAY CHRYSTALLOGRAPHIC STUDIESABSOLUTE CONFIGURATION DETERMINEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stylotella aurantium (SUBERITIDAE)
STYLOSTATIN 2
95697
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Propionibacterium avidum (LACTOBACILLACEAE)
PROPIONIBACTERIUM ANTIBIOTIC N-P-I
994563
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Strychnos nux-vomica (LOGANIACEAE)
BRUCINESTRYCHNINE
1006781
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Arthrobacter species (CORYNEFORM ACTINOMYCETE)
ARTHROBACTER ANTIBIOTIC 02-8
1020845
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTICOCCIDIAL ACTIVITY
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC X-14868-A
170859
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Amycolatopsis species (ACTINOMYCETACEAE)
AMYCOLATOPSIS ANTIBIOTIC TA-0234
660611
PATENT DESCRIBED
Empty organism
CONCHIOLIN
870546
SYNTHESIS OF ANALOGSPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Actinomadura roseoviolacea (THERMOMONOSPORACEAE)
CARMINOMYCIN,13-DEOXO: 10-HYDROXY:CARMINOMYCIN,13-DEOXO:
823779
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Saccharopolyspora hirsuta (SCHIZOMYCETACEAE)
SACCHAROPOLYSPORA ANTIBIOTIC KA-6606-XIII
31927
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Hypericum perforatum (CLUSIACEAE)
1091387
SYNTHESIS OF ANALOGSPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
BICYCLO-(3.2.1)-OCTANE-1-ACETIC ACID,3-8-DIOXA: 4-(4-8-DIMETHYL)-5-HYDROXY-7-NONEN-1-YL-4-METHYL: (1-RS-4-SR-5-RS):
534965
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
INSECT ATTRACTANT ACTIVITY
Guaiacum officinale (ZYGOPHYLLACEAE)
1187553
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nudibranchia species (MOLLUSCA)
KABIRAMIDE C
892087
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Uncaria gambier (RUBIACEAE)
CATECHIN,(+):
136642
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Neosartorya species (TRICHOCOMACEAE)
NEOSARTORYA ANTIBIOTIC PF-1032-B
617448
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
MAYTANSINE
1020439
AMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
INTERFERON INDUCTION STIMULATION
Perilla frutescens (LAMIACEAE)
PERILLA FRUTESCENS VAR.CRISPA INTERFERON INDUCER
469812
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Trewia nudiflora (EUPHORBIACEAE)
TREWIASINE
1049858
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Actinoplanes species (ACTINOPLANACEAE)
NOSIHEPTIDE
1050029
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Lentinus edodes (TRICHOLOMATACEAE)
1006701
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AM-3672
330310
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
TOXICITY ASSESSMENT(QUANTITATIVE)
Penicillium vermiculatum (HYPHOMYCETES)
VERMICULINE
971078
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
CANNABICHROMENE
1034827
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomyces species (ACTINOMYCETACEAE)
ACTINOMYCES ANTIBIOTIC BBM-928-B
814255
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Penicillium stipitatum (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC PS-X-1
819297
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces glaucogriseus (STREPTOMYCETACEAE)
NOSIHEPTIDE
319073
SYNTHESIS OF ANALOGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PREPARATION OF DERIVATIVES OF
Empty organism
PENICILLIN VPENICILLIN G
1036501
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Lactuca virosa (ASTERACEAE)
LACTUCINLACTUPICRIN
931616
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Perilla frutescens (LAMIACEAE)
PERILLA INTERFERON INDUCER
566554
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN MOISTURIZING EFFECT
Empty organism
TREHALOSE
683219
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
LEUCANTHIN BPARTHENOLIDE
594783
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sophora flavescens (FABACEAE)
SOPHORAFLAVONONE G
630350
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
QUERCITRIN,ISO:
1234350
PHARMACOLOGY OF EXTRACT - IN VITROPLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY(PLANT PATHOGENS)
Phytolacca americana (PHYTOLACCACEAE)
13833
PHARMACOLOGY OF COMPOUND - IN VIVOYIELD IS MORE THAN 100 MGMPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Myrothecium roridum (HYPHOMYCETES)
VERRUCARIN A
68318
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
MISCELLANEOUS EFFECTS
Empty organism
ASTAXANTHIN
1169269
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
GLYCYRRHIZIN
883717
ISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTPATENT DESCRIBED
Olea europaea (OLEACEAE)
SQUALENE
598536
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sporormiella minima (PHAEOTRICHACEAE)
SPOROMEILLA ANTIBIOTIC WF-15604-A
334610
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Phytolacca dodecandra (PHYTOLACCACEAE)
OLEAN-12-EN-28-OIC ACID,3-O-(2'-O-(2''-O-(ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSYL)-BETA-D-GLUCOPYRANOSYL):
946748
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Stauntonia chinensis (LARDIZABALACEAE)
YEMUOSIDE YM-11
148040
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Penicillium species (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC MER-AF-1032-BPENICILLIUM ANTIBIOTIC MER-AF-1032-A
653673
SYNTHESIS OF ANALOGSPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Abrus precatorius (FABACEAE)
ABRUQUINONE A
568635
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Empty organism
KOJIC ACID
997613
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
SMOOTH MUSCLE RELAXANT ACTIVITY
Teucrium marum (LAMIACEAE)
491814
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INTERLEUKIN-1 RELEASE INHIBITION
Pongamia pinnata (FABACEAE)
PONGAPINONE A
737370
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Maytenus ilicifolia (CELASTRACEAE)
QUERCITRIN,ISO:
1029027
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC B-41-146-D
420330
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR-PROMOTING ACTIVITY
Empty organism
SQUALENE
969132
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ambrosia chamissonis (ASTERACEAE)
THIARUBRINE HTHIARUBRINE ETHIARUBRINE FTHIARUBRINE DTHIARUBRINE G
318653
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDSEPARATION OF (EXCEPT OILS, VENOM, PROTEINS, FATS)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Inonotus culicularis (HYMENOCHAETACEAE)
INONOTUS CULICULARIS ANTITUMOR SUBSTANCE
1048695
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Anthocidaris crassispina (ECHINOMETRIDAE)
ANTHOCIDARIS CRASSIPINA GLYCOPROTEIN
693885
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULONIC ACID
975773
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN PIGMENTATION EFFECT
Polygonum bistorta (POLYGONACEAE)
741776
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
987637
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CORIOLIN
1148133
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIFERTILITY
ESTROGENIC EFFECT
Empty organism
FLAVONE,ISO: 7-ISO-PROPYL-OXY:
417701
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RADICAL SCAVENGING EFFECT
Empty organism
EMODIN
1036165
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
ANSAMITOCIN P-3,4-5-DEOXY:
996140
PATENT DESCRIBEDYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Streptomyces galilaeus (STREPTOMYCETACEAE)
RHODORUBIN ARHODIRUBIN B
205982
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptoverticillium species (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC N-1999-A-2
982058
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Catharanthus roseus (APOCYNACEAE)
VINCALEUKOBLASTINE
727430
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Urtica dioica (URTICACEAE)
PHYTOSTEROLS
976543
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Achyranthes bidentata (AMARANTHACEAE)
POLYSACCHARIDE
113402
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC RS-10
649483
SYNTHESIS OF ANALOGSPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
NOSCAPINE
325154
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
DODECAN-1-12-DIOIC ACID
159659
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Amycolatopsis species (ACTINOMYCETACEAE)
AMYCOLATOPSIS ANTIBIOTIC SF-2748
713870
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Menispermum dauricum (MENISPERMACEAE)
ALKALOIDS
693702
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CARCINOGENESIS INHIBITION
Empty organism
FLAVONE,4'-BROMO:
630353
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Ribes nigrum (SAXIFRAGACEAE)
PYCNOGENOL
1006714
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Scutellaria baicalensis (LAMIACEAE)
1155526
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIBACTERIAL ACTIVITY
Empty organism
CADINOL,ALPHA: (-):
327294
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
CORONARY VASODILATOR ACTIVITY(AUTONOMIC)
Empty organism
EBURNANE,16-CARBOXY-17-METHOXY:*
447616
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Empty organism
COLOMINIC ACID
999154
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AM-2947-A
332452
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIFERTILITY EFFECT(UNSPECIFIED)
Papaver somniferum (PAPAVERACEAE)
327358
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cnicus benedictus (ASTERACEAE)
521847
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Empty organism
PROTOCATECHUALDEHYDEPROTOCATECHUIC ACID
962863
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sanguinaria canadensis (PAPAVERACEAE)
SANGUINARINE
318684
CHEMICAL CONVERSION OFPATENT DESCRIBED
Pinus species (PINACEAE)
LINOLEIC ACIDOLEIC ACID
98743
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Flexibacter species (CYTOPHAGACEAE)
FLEXIBACTER ANTIBIOTIC B-572-A-1
399674
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN IMPROVEMENT EFFECT
Irvingia gabonensis (SIMAROUBACEAE)
327477
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cnicus benedictus (ASTERACEAE)
KARDOLLIN 85KARDOLLIN 35KARDOLLIN 22KARDOLLIN 75KARDOLLIN 95
607296
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
148311
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECT STERILITY INDUCTION
Phialophora cyclaminis (HYPHOMYCETES)
PHIALOPHORA ANTIBIOTIC WF-3010
441498
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Peucedanum terebinthaceum (APIACEAE)
PTERYXIN,ISO: EPOXY:
822918
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Aspergillus terreus (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC MF-4833
657326
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIYEAST ACTIVITY
Spirastrella spinispirulifera (SPIRASTRELLIDAE)
SPONGIASTATIN 4
346725
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Alternaria alternata (HYPHOMYCETES)
TAXOL
101410
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Agelas coniferin (AGELASIDAE)
AGELIFERIN
1077499
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Empty organism
GOSSYPOL
1029011
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTICOCCIDIAL ACTIVITY
Streptomyces albus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SY-9
428209
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Luffa cylindrica (CUCURBITACEAE)
993673
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOGLYCEMIC ACTIVITY
Streptomyces lavendulae (STREPTOMYCETACEAE)
MORANOLIN
1034810
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces albus (STREPTOMYCETACEAE)
STREPTOMYCES ALBUS ANTITUMOR PROTEIN AN-3
1002584
QUANTITATIVE DATAPATENT DESCRIBEDYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Streptomyces coeruleorubidus (STREPTOMYCETACEAE)
BAUMYCIN A-2
185298
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Myxococcus flavescens (MYXOCOCCACEAE)
MYXOCOCCUS ANTIBIOTIC AJI-12298-2
206049
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC GE-3
141310
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC RK-1441-B
489606
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
AROMATASE INHIBITION
Serenoa repens (ARECACEAE)
68155
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COMMON COLD RELIEF
Echinacea angustifolia (ASTERACEAE)
449396
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Zanthoxylum bungeanum (RUTACEAE)
SANSHOOL,GAMMA: HYDROXY:
993413
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Clostridium species (BACILLACEAE)
CLOSTRIDIUM ANTIBIOTIC C-45
675833
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALDOSE REDUCTASE INHIBITION
Empty organism
SULFURETINMARITIMEIN
854664
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
FOOD USE
Empty organism
PANGAMIC ACID
1056593
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Bacillus pumilus (BACILLACEAE)
BACILLUS PUMILUS ANTIBIOTIC AI-77-I
385980
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Empty organism
COPALOL,TETRAHYDRO: GLUCOSIDE
1271175
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Allium sativum (LILIACEAE)
SCORDONIN A
1021556
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
DOXORUBICIN-CIS-PLATINUM COMPLEX
1002926
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces rosa-notoensis (STREPTOMYCETACEAE)
NANAOMYCIN B,4-(A)-EPI:
334095
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSISOLATION AND IDENTIFICATION OF
BRONCHODILATOR ACTIVITY
Asarum europaeum (ARISTOLOCHIACEAE)
ASARONE,ISO: TRANS:
943183
PATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTITUMOR ACTIVITY
Panax ginseng (ARALIACEAE)
489591
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Atractylodes lancea (ASTERACEAE)
HINESOLEUDESMOL,BETA:ELEMOLTETRADECA-TRANS-4-TRANS-6-TRANS-12-TRIENE-8-10-DIYN-1-3-DIOL DIACETATE
1045196
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN A
327107
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
RUTECARPINE,PSEUDO:
870145
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
FOOD USE
Gynostemma pentaphyllum (CUCURBITACEAE)
1026465
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Coriolus versicolor (POLYPORACEAE)
CORIOLUS ANTIBIOTIC CM-101
876930
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eubacterium limosum (CORYNEFORM ACTINOMYCETE)
VITAMIN B-12
1010268
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
KANAMYCIN B
694395
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
GLUCOSE-6-PHOSPHATE TRANSLOCASE INHIBITION
Streptomyces species (STREPTOMYCETACEAE)
MUMBAISTATIN
1075999
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tagetes erecta (ASTERACEAE)
PYRETHRINS
986342
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Mycobacterium bovis (MYCOBACTERIACEAE)
MYCOBACTERIUM ANTIBIOTIC T-2-B-1
667211
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Linum usitatissimum (LINACEAE)
LINOLENIC ACID,ALPHA:
568653
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CELL GROWTH ENHANCEMENT EFFECT
Empty organism
GINSENOSIDE RB-2
875974
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Xenorhabdus nematophilus (ENTEROBACTERIACEAE)
XENOCOUMACIN 1
1323465
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Prunus persica (ROSACEAE)
PROTEIN,PR-B(PRUNUS)
763430
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
AMYOTROPHIC LATERAL SCLEROSIS DISEASE TREATMENT
Ginkgo biloba (GINKGOACEAE)
700705
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Hypericum perforatum (CLUSIACEAE)
HYPERICIN
834819
ION EXCHANGE METHODS USEDQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nicotiana tabacum (SOLANACEAE)
SOLANASCONE,3-HYDROXY: BETA-SOPHOROSIDE
480575
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIHEMORRHOIDAL ACTIVITY
Empty organism
ARTEMISININ,DIHYDRO:
766246
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Centella asiatica (APIACEAE)
CENTELLASAPONIN ACENTELLASAPOGENOL A
598418
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Empty organism
BETAINE
975528
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces albus (STREPTOMYCETACEAE)
DIFFUSOMYCIN
418071
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COMMON COLD RELIEF
Xanthium sibiricum (ASTERACEAE)
876147
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Rhizopus chinensis (MUCORACEAE)
RHIZOXIN
48985
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Smilax sieboldii (LILIACEAE)
NEOZYGOGENIN
1045715
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
MILBEMYCIN A-1
350270
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MULTIDRUG RESISTANCE INHIBITION
Empty organism
TOLYPORPHIN
1168120
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
GINSENOSIDE RH-1
988134
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIOXIDANT ACTIVITY
Empty organism
GERANIIN
50808
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Prosopis africana (FABACEAE)
PROSOPINE
596535
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HEMOSTATIC ACTIVITY
Agkistrodon halys (CROTALIDAE)
HALYBIN
978377
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERTENSIVE ACTIVITY
Capsicum annuum (SOLANACEAE)
CAPSIANOSIDE H
447319
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Isothecium subdiversiforme (LEMBOPHYLLACEAE)
ANSAMITOCIN P-3,15-METHOXY:
863980
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Podophyllum peltatum (BERBERIDACEAE)
PODOPHYLLOTOXIN
321465
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PREPARATION OF DERIVATIVES OF
Empty organism
AMPICILLIN*
329797
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
VASODILATOR ACTIVITY
Empty organism
VINCAMINE*
720873
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBED
Echinacea purpurea (ASTERACEAE)
473088
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Empty organism
DAMBONITOL
1267357
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HYPOTENSIVE ACTIVITY
Equisetum species (EQUISETACEAE)
321270
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
EUPATORIN
420223
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
DNA POLYMERASE INHIBITION
Empty organism
GERANIIN
832277
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Nocardia aerocolonigenes (NOCARDIACEAE)
REBECCAMYCIN
356312
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Areca catechu (ARECACEAE)
CATECHIN(4-BETA-8)-CATECHIN,EPI: (-):
965308
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTICOAGULANT ACTIVITY
Stichopus japonicus (STICHOPODIDAE)
STICHOPUS SULFATED POLYSACCHARIDE
1021640
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
RAFFINOSEMELIBIOSE
955617
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Trigonella foenum-graecum (FABACEAE)
711450
PATENT DESCRIBED
Empty organism
FERULIC ACID
425921
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
TOPSENTIN D,NOR:
329551
PHARMACOLOGY OF COMPOUND - IN VIVOCHEMICAL CONVERSION OFISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Atractylis gummifera (ASTERACEAE)
ATRACTYLOSIDE,CARBOXY:
790022
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
VALTRATE
836514
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TM-482-B
470479
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aspergillus sulphureus (HYPHOMYCETES)
RADARIN A
331542
PURIFICATION OFPATENT DESCRIBED
Empty organism
INSULIN
993615
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bacillus circulans (BACILLACEAE)
RIBOSTAMYCIN
973777
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
FOOD USE
Empty organism
CHITOSAN
668196
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
NADH OXIDASE INHIBITION
Castela peninsularis (SIMAROUBACEAE)
GLAUCARUBOLONE
948910
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Iris pallasii (IRIDACEAE)
PALLASONE B
356596
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ancistrocladus korupensis (ANCISTROCLADACEAE)
MICHELLAMINE A
321755
PHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Botryotrichum piluliferum (HYPHOMYCETES)
PEARLMYCIN
789996
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANXIOLYTIC EFFECT
Empty organism
VALERAMIDE,ISO:
693870
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
99735
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC DC-92-D
331562
PATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Dactylium dendroides (HYPHOMYCETES)
PROST-5-CIS-ENOIC ACID,9-15-DIOXO:
329963
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Saccharomonospora viridis (THERMOMONOSPORACEAE)
SACCHAROMONOSPORA ANTIBIOTIC AB-65
359294
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cinnamomum cassia (LAURACEAE)
612055
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTITOXIC ACTIVITY
Empty organism
OXYGENASE,CATECHOL-1-2:OXYGENASE,CATECHOL-2-3:
866744
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Penicillium brevi-compactum (HYPHOMYCETES)
MYCOPHENOLIC ACID
127178
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Arthroderma species (GYMNOASCACEAE)
ARTHRODERMA ANTIBIOTIC FR-901308
353006
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
HAIR STIMULANT EFFECT
Empty organism
RETICULINE,NOR:
992481
QUANTITATIVE DATAPATENT DESCRIBEDYIELD IS 50-100 MGMISOLATION AND IDENTIFICATION OF
Tricholoma matsutake (TRICHOLOMATACEAE)
EMITANIN C
234569
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
UV ABSORBENT EFFECT
Vibrio species (VIBRIONACEAE)
ULBACTIN AULBACTIN BULBACTIN C
95505
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Unidentified species (ACTINOMYCETACEAE)
ACTINOMYCES ANTIBIOTIC MF-730-N-6
993242
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
FORMYCIN-3'-5'-CYCLIC PHOSPHATE
565888
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Amphidinium species (GYMNODINIACEAE)
CARIBENOLIDE I
1007669
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2068
182507
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC HQ-24-BACTINOMADURA ANTIBIOTIC HQ-24-A
1043938
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
THAUMATIN
1227527
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,17-HYDROXY:
975784
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ABSORPTION EFFECTS(CUTANEOUS)
Empty organism
GLYCYRRHETINIC ACID
1184320
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Pfaffia paniculata (AMARANTHACEAE)
PFAFFOSIDE A
319260
SEPARATION OF ISOMERSPATENT DESCRIBED
Empty organism
RETICULINE,(DL):
41952
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Medicago sativa (FABACEAE)
PROTEIN
509946
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Euphorbia pulcherrima (EUPHORBIACEAE)
CYCLOART-23-ENE-3-BETA-25-DIOL,9-19:
1082998
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIFERTILITY
UTERINE STIMULANT EFFECT
Montanoa tomentosa (ASTERACEAE)
75420
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Pseudomonas cepacia (PSEUDOMONADACEAE)
CEPACIN B
329960
PMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces lavendulae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC R-4-H
607285
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Alnus jorullensis (BETULACEAE)
566562
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR CONDITIONER
Empty organism
TREHALOSE
878968
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces lavendulae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC CA-146-A
155690
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Phoma species (COELOMYCETES)
PHOMA ANTIBIOTIC PF-1052
218064
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ecteinascidia turbinata (PEROPHORIDAE)
ECTEINASCIDIN 743-N(12)-OXIDE
649486
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
APOPTOSIS INDUCTION
Empty organism
NOSCAPINE
486920
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AC-4437
324067
PATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEMICROBIAL TRANSFORMATION OF
Streptomyces albogriseolus (STREPTOMYCETACEAE)
VINCALEUKOBLASTINE
614049
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Papaver somniferum (PAPAVERACEAE)
CODEINE
653197
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Empty organism
CASTANOSPERMINE
700523
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aloe vera (LILIACEAE)
MALIC ACIDCALCIUMMAGNESIUM
610650
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIHYPERCHOLESTEROLEMIC ACTIVITY
Empty organism
BROMELAIN
431813
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
ARTEMISININ,DIHYDRO:
76506
GEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces carzinostaticus (STREPTOMYCETACEAE)
PINCRAMYCIN
67509
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
928687
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Schisandra chinensis (SCHISANDRACEAE)
SCHISANDRIN
1003403
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptococcus pyogenes (STREPTOCOCCACEAE)
STREPTOLYSIN O
416887
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Camellia sinensis (THEACEAE)
990251
QUANTITATIVE DATAPATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Streptomyces antibioticus (STREPTOMYCETACEAE)
ERYTHRONOLIDE A OXIME
425014
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Empty organism
DEXTRIN-6-SULFATE*DEXTRIN-3-SULFATE*DEXTRIN-2-SULFATE*
332297
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)COMPOUND ISOLATED HAS UNUSUAL NAMEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIFUNGAL ACTIVITY
Streptomyces albus (STREPTOMYCETACEAE)
YEMENIMYCIN
958329
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Empty organism
YEAST MANNAN
443632
CMR SPECTRUM REPORTEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stauntonia chinensis (LARDIZABALACEAE)
YEMUOSIDE YM-2
327478
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Cnicus benedictus (ASTERACEAE)
CNICIN
398969
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Empty organism
HYPOXOSIDE
1020868
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
CYCLOHEXA-1-3-DIENE-1-CARBOXALDEHYDE,6-AMINO-5-HYDROXY
332260
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
TOXICITY ASSESSMENT(QUANTITATIVE)
Streptomyces novoguineensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC T-36496
611606
PATENT DESCRIBEDANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
LABOR INDUCTION EFFECT
Montanoa tomentosa (ASTERACEAE)
398802
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Mortierella elongata (MORTIERELLACEAE)
LINOLENIC ACID
75283
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
RICINUS COMMUNIS AGGLUTININ I
952079
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIHEPATOTOXIC ACTIVITY
Polystictus versicolor (HYMENOCHAETACEAE)
831744
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Cercospora cruenta (HYPHOMYCETES)
MUTASTEIN
1007006
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS LESS THAN 50 MGM
Pseudomonas species (PSEUDOMONADACEAE)
PSEUDOMONAS ANTIBIOTIC BN-227
1022027
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
MOROYAMYCIN
968291
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Clitoria ternatea (FABACEAE)
TERNATIN A-2TERNATIN A-1TERNATIN D-2TERNATIN B-2TERNATIN B-1
678849
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LDL UPTAKE STIMULATION
Chonemorpha fragrans (APOCYNACEAE)
CHONEMORPHA LIGNAN I
982646
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
90060
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptoverticillium ehimense (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC TM-591
393048
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Aspalathus linearis (FABACEAE)
361026
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
GASTRIN RELEASING PEPTIDE RECEPTOR BINDING INHIBITION
Empty organism
KUWANON H
1012361
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Micromonospora sagamiensis (MICROMONOSPORACEAE)
SISOMICIN,3''-N-DIMETHYL:
68111
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Withania somnifera (SOLANACEAE)
892131
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
COFORMYCIN
81676
GEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Unidentified actinomycete (UNDETERMINED)
GUANINE-7-N-OXIDE
1027386
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces antibioticus-antibioticus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TU-1718
730722
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Polygonatum cuspidatum (LILIACEAE)
RESVERATROL,CIS:
82913
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces rubropurpureus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FR-900447
998582
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces olivaceus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MM-4550-A
238138
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Phomopsis species (COELOMYCETES)
PHOMOPSIS ANTIBIOTIC TUF-95-F-47
50576
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Xanthium strumarium (ASTERACEAE)
ATRACTYLOSIDE,CARBOXY:
240235
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Pantoena agglomerans (ENTEROBACTERIACEAE)
OLIGOMYCIN SC-2
79332
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
GROWTH PROMOTER ACTIVITY
Streptomyces majorciensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC LLCO-8078-ALPHA-1
1289516
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aristolochia taliscana (ARISTOLOCHIACEAE)
GERMACRENE D,ENT:
607343
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Coffea arabica (RUBIACEAE)
325897
SEPARATION OF ISOMERSPATENT DESCRIBED
Empty organism
CHRYSANTHEMUM MONOCARBOXYLIC ACID,TRANS: (DL):
657710
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Geum japonicum (ROSACEAE)
EUSCAPHIC ACID
329481
PURIFICATION OFPHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
CYCLOSPORIN A
1263150
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Allium sativum (LILIACEAE)
SCORRDININE A-3
1008934
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces caespitosus (STREPTOMYCETACEAE)
MITOMYCIN B,9-ALPHA-O-METHYL-10-DECARBAMOYL-OXY-9-DEHYDRO:
489573
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Eucalyptus macrocarpa (MYRTACEAE)
MACROCARPAL A
136089
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ACYL-CO-A:CHOLESTEROL ACYLTRANSERASE INHIBITION
Penicillium species (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC FO-608-A
609958
PATENT DESCRIBED
Empty organism
LIQUIRITIGENIN
882580
SYNTHESIS OF ANALOGSPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Andrographis paniculata (ACANTHACEAE)
ANDROGRAPHOLIDE
599542
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Ruscus aculeatus (LILIACEAE)
RUSCOGENIN
1190345
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Echinacea purpurea (ASTERACEAE)
HETEROXYLANRHAMNOARABINOGALACTANARABINOGALACTAN
556422
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces coerulescens (STREPTOMYCETACEAE)
THRAZARINE
974433
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sinomenium diversifolium (MENISPERMACEAE)
AROMOLINE
325795
PURIFICATION OFPATENT DESCRIBED
Empty organism
CHOLESTEROL
118603
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Azadirachta indica (MELIACEAE)
MELIA POLYSACCHARIDE N-9-GI
1001129
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
334601
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIIMPLANTATION EFFECT
Phytolacca dodecandra (PHYTOLACCACEAE)
1324733
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Hazunta species (APOCYNACEAE)
TABERNAEMONTANINE
231112
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SCRC-A-20
330420
IDENTIFICATION OFPATENT DESCRIBEDQUANTITATIVE DATA REPORTED
Pseudomonas aeruginosa (PSEUDOMONADACEAE)
PROSTAGLANDINS
1081120
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
MAYTANSINOL L-LEUCINE ESTER
1020971
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces umbrosus raffinophilus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-62
679741
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIFERTILITY
OOCYTE MATURATION INDUCTION
Panax ginseng (ARALIACEAE)
981763
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
MIRACULIN
1094712
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Polygonum tinctorium (POLYGONACEAE)
TRYPTANTHRIN
637435
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Aralia elata (ARALIACEAE)
826597
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
AWAMYCIN
605179
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Tagetes species (ASTERACEAE)
LUTEIN
330869
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSISOLATION AND IDENTIFICATION OF
APPETITE SUPPRESSANT
Richardella dulcifica (SAPOTACEAE)
MIRACULIN
960730
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
VASODILATOR ACTIVITY
Mansonia altissima (STERCULIACEAE)
MANSONIN
1016373
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
Eucalyptus globulus (MYRTACEAE)
EUCALYPTUS GLOBULUS SUBSTANCE EK
1028463
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
BETA-LACTAMASE INHIBITION
Protaminobacter ruber (PSEUDOMONADACEAE)
PROTAMINOBACTER ANTIBIOTIC 3708
790004
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
VALERAMIDE,ISO:
996223
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
ANTIFUNGAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MC-902-I'STREPTOMYCES ANTIBIOTIC MC-902
855278
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces rochei volubilis (STREPTOMYCETACEAE)
LANKACYCLINOLLANKACIDIN CLANKACIDIN ALANKACIDIN LLANKACIDIN KLANKACIDINOL A
1032417
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-39183 FACTOR B
511271
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Empty organism
RUBIA CYCLIC HEXAPEPTIDE RA-VII
1014798
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Bacillus thuringiensis (BACILLACEAE)
BACILLUS THURINGIENSIS BETA-EXOTOXIN
330309
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIPROTOZOAN ACTIVITY
Penicillium vermiculatum (HYPHOMYCETES)
VERMICULINE
1039958
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
370399
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
GIBBERELLIN A-30GIBBERELLIN A-20
1003391
YIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Daedalea dickinsii (POLYPORACEAE)
DAEDALIA ANTIBIOTIC KS-2-A
737383
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANALGESIC ACTIVITY
Maytenus ilicifolia (CELASTRACEAE)
FRIEDELAN-3-BETA-OL
6341
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Empty organism
ASPERGILLUS ANTIBIOTIC A-22082
1047176
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOTENSIVE ACTIVITY
Babylonia japonica (BUCCINIDAE)
NEOSURUGATOXIN
169908
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
AROMATASE INHIBITION
Bacillus species (BACILLACEAE)
BACILLUS ANTIBIOTIC FR-901537
417199
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPID PEROXIDE FORMATION INHIBITION
Empty organism
ASTAXANTHIN
351019
PATENT DESCRIBED
Empty organism
DOPA,L:METHIONINETOCOPHEROLSALICYLIC ACIDCITRIC ACIDMALIC ACIDCAROTENETYROSINEGUAIAZULENERUTINPAPAINHISTIDINEBENZOIC ACIDHINOKITIOLTRYPTOPHANCYSTEINE
984470
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
SITOSTEROL,BETA: FERULATE
25552
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tylophora indica (ASCLEPIADACEAE)
TYLOPHORA INDICA ALKALOID DTYLOPHORA INDICA ALKALOID E
819285
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces chromofuscus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-58365-A
218045
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ecteinascidia turbinata (PEROPHORIDAE)
ECTEINASCIDIN 729
688183
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Empty organism
SALVIANOLIC ACID A
418719
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMICROBIAL ACTIVITY(UNSPECIFIED)
Empty organism
ORAPOSIDE
147727
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PROTEIN SYNTHESIS INHIBITION
Polyangium brachysporum (POLYANGIACEAE)
GLIDOBACTIN PF-1
1014746
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Empty organism
FORPHENICOL
491277
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Mycale species (MYCALIDAE)
PATEAMINE
1007671
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces tenebrarius (STREPTOMYCETACEAE)
NEBRAMYCIN II
424681
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INSECTICIDE ACTIVITY
Circinella umbellata (MUCORACEAE)
MILBEMYCIN A-4,24-HYDROXY:MILBEMYCIN A-4,30-HYDROXY:MILBEMYCIN A-4,31-HYDROXY:MILBEMYCIN A-4,32-HYDROXY:
942068
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Agaricus bisporus (AGARICACEAE)
AGARICUS LECTIN
552730
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIPRURITIC ACTIVITY
Empty organism
GINSENOSIDE RB-1
358723
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
BETULINIC ACID
427295
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Karwinskia humboldtiana (RHAMNACEAE)
PEROXISOMICINE A-1
917471
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
WEIGHT LOSS
Artemisia capillaris (ASTERACEAE)
CAFFEIC ACIDCHLOROGENIC ACID B,ISO:CHLOROGENIC ACID METHYL ESTERCHLOROGENIC ACID A,ISO:CHLOROGENIC ACIDCHLOROGENIC ACID C,ISO:
84867
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Trichoderma koningii (HYPHOMYCETES)
TRICHODERMA ANTIBIOTIC CAF-0096
960240
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Coriaria japonica (CORIARIACEAE)
CORIARIIN A
114421
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Halichondria okadai (AXINELLIDAE)
HALICHONDRIN B
654657
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAIDENTIFICATION OFPATENT DESCRIBED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
190116
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2582-A
405951
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
CITRONELLOL,(-):
965010
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIFATIGUE ACTIVITY
Panax ginseng (ARALIACEAE)
101534
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ardisia crispa (MYRSINACEAE)
ARDISIA DEPSIPEPTIDE FR-900359
332726
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Corynebacterium hydrocarboclastus (CORYNEFORM ACTINOMYCETE)
CAMPESTEROL
233160
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Metarhizium species (HYPHOMYCETES)
METARRHIZIUM ANTIBIOTIC MER-F-3
560129
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Oroxylum indicum (BIGNONIACEAE)
BAICALEIN
1186597
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC S-42227
612864
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
TOXICITY ASSESSMENT(QUANTITATIVE)
Coriolus versicolor (POLYPORACEAE)
CORIOLUS VERSCIOLOR PROTEOGLUCAN
98197
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces albovinaceus (STREPTOMYCETACEAE)
BORRELIDIN
521438
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Empty organism
TUBEROSIN
1227525
SYNTHESIS OF ANALOGSPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,17-HYDROXY:
1323457
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANALGESIC ACTIVITY
Zingiber officinale (ZINGIBERACEAE)
SHOGAOL,6:GINGEROL,6:
607106
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Lindera umbellata (LAURACEAE)
CHALCONE,2'-6'-DIHYDROXY-4'-METHOXY-3'-(3''-METHYL-6''-METHYL-ETHYL-2''-CYCLOHEXENYL):
657017
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
1227074
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIFERTILITY
ANTIANDROGENIC EFFECT
Empty organism
PAEONIFLORIN
74924
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CELL PROLIFERATION INHIBITION
Penicillium diversum (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC PD-3
992261
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
HEMAGGLUTININ ACTIVITY
Conidiobolus species (ENTOMOPHTHORACEAE)
CONIDIOBOLUS HEMAGGLUTININ MHA-1001
1083003
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ABORTIFACIENT EFFECT
Montanoa tomentosa (ASTERACEAE)
ZOAPATANOL
420642
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIDEMENTIA ACTIVITY
Empty organism
GINSENOSIDE RB-1GINSENOSIDE RG-1
327347
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cnicus benedictus (ASTERACEAE)
983201
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Valsa ceratosperma (VALSACEAE)
COUMARIN,ISO: 8-HYDROXY-5-CARBOXY-3-METHYL:
437429
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Lactobacillus confusus (LACTOBACILLACEAE)
DEXTRAN(LACTOBACILLUS)
1268926
ISOLATION FROM AFTER SAPONIFICATIONQUANTITATIVE DATAPATENT DESCRIBED
Bupleurum falcatum (APIACEAE)
LONGISPINOGENIN
1034078
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Periandra dulcis (FABACEAE)
PERIANDRIC ACID I,3-DEHYDRO:
494850
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIAGING ACTIVITY
Empty organism
ORYZANOL,GAMMA:FERULIC ACID
1007370
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
REVERSE TRANSCRIPTASE INHIBITION
Empty organism
STREPTOVARICIN C DERIVATIVES
1030320
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Rabdosia rubescens (LAMIACEAE)
RUBESCENSIN C
824173
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ALGICIDAL ACTIVITY
Acacia nilotica (FABACEAE)
218051
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ecteinascidia turbinata (PEROPHORIDAE)
ECTEINASCIDIN 743
1199464
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC P-4
183209
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC YL-071O-M
824679
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
MANILOSPORIN B-1
960734
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ATP-ASE(NA+/K+) INHIBITION
Bupleurum falcatum (APIACEAE)
SAIKOSAPONIN A,MALONYL:
1026115
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
THYMIDINE
996413
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PHOSPHODIESTERASE INHIBITION
Streptomyces griseoflavus (STREPTOMYCETACEAE)
PYRROLO-(3,2-E)-INDOLE-7-CARBOXYLIC ACID,3-(H): 3-CARBAMOYL-1-2-DIHYDRO-4-HYDROXY-5-METHOXY:
678719
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
LIPID METABOLISM EFFECTS
Empty organism
SITOST-5-EN-3-ONESITOST-4-EN-3-ONE,6-HYDROXY:
329778
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
SCOPOLAMINE ESTER*
1020804
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
MUCOPEPTIN A
92110
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptococcus pyrogenes (STREPTOCOCCACEAE)
STREPTOCOCCUS ANTIBIOTIC SPF-10
1039157
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
VASODILATOR ACTIVITY
Plectranthus forskholii (LAMIACEAE)
COLEFORSIN
492072
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Euphorbia hirta (EUPHORBIACEAE)
1009058
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC KA-7038-III
879170
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
LEUROCRISTINE
790011
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
ACEVALTRATE
882025
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIVIRAL ACTIVITY
Lentinus edodes (TRICHOLOMATACEAE)
ZEATIN RIBOSIDE
589729
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIARRHYTHMIC ACTIVITY
Panax ginseng (ARALIACEAE)
GINSENOSIDE RE
740294
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Spachea correae (MALPIGHIACEAE)
SPACHEA TRITERPENE 1-BSPACHEA TRITERPENE 1-DFRIEDELA-1-20(29)-DIEN-3-4-(R)-OLIDE,3-4-SECO: 27-30-BIS-NOR: 6-ALPHA-7-ALPHA-15-BETA-16-BETA-24-PENTACETOXY-22-ALPHA-CARBOMETHOXY-21-BETA-22-BETA-EPOXY-18-BETA-HYDROXY:SPACHEA TRITERPENE 1-C
416865
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza glabra (FABACEAE)
GLABRENE
861774
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Papaver bracteatum (PAPAVERACEAE)
THEBAINE
1005832
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinomadura fulva (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC AB-85
332779
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
DEODORIZING EFFECT
Cimicifuga foetida (RANUNCULACEAE)
229948
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus species (BACILLACEAE)
MACROLACTIN M
228105
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Rozites caperata (CORTINARIACEAE)
233358
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Archangium gephyra (MYXOBACTERIA)
TUBULYSIN A
675557
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
1274163
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCPATENT DESCRIBED
Panax pseudoginseng (ARALIACEAE)
GINSENOSIDE RB-1GINSENOSIDE RG-1NOTOGINSENOSIDE R-1
185159
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMES ANTIBIOTIC 31668-P
193405
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Physarum polycephalum (PHYSARALES)
PHYSARUM ANTIBIOTIC MCI-2526
731925
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CHOLESTASE INHIBITION
Cynara scolymus (ASTERACEAE)
NARINGENINLUTEOLINAPIGENIN
731806
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
TYROSINASE INHIBITION
Vitis vinifera (VITACEAE)
659772
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
BETULINIC ACID
469799
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Trewia nudiflora (EUPHORBIACEAE)
TREFLORINE
683119
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CALCIUM CHANNEL BLOCKER
Hypericum perforatum (CLUSIACEAE)
488191
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PROTECTIVE ACTIVITY
Curcuma longa (ZINGIBERACEAE)
CURCUMIN
425915
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
TOPSENTIN B,NOR:
879212
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Argemone mexicana (PAPAVERACEAE)
SANGUINARINE
470918
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Pseudomonas fluorescens (PSEUDOMONADACEAE)
PEPTIFLUORIN,NEO:
955610
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR DYEING EFFECT
Sophora flavescens (FABACEAE)
323245
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Calvatia craniformis (LYCOPERDACEAE)
CALVATIC ACID
995870
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Flavobacterium heparinum (ACHROMOBACTERIACEAE)
CHONDROITINASE C
923941
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Achillea millefolium (ASTERACEAE)
ACHIMILIC ACID A LACTONE
1051702
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces bottropensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-45-A-2
826861
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC SF-2228
38129
QUANTITATIVE DATAIDENTIFICATION OFPATENT DESCRIBED
Chenopodium ambrosioides (CHENOPODIACEAE)
ASCARIDOL
847239
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Lobophytum pauciflorum (ALCYONIIDAE)
LOBOPHYTUM PAUCIFLORUM CEMBRANOLIDE I-BLOBOPHYTUM PAUCIFLORUM CEMBRANOLIDE I-ALOBOPHYTUM PAUCIFLORUM CEMBRANOLIDE I-CLOBOPHYTUM PAUCIFLORUM CEMBRANOLIDE II
978547
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Combretum caffrum (COMBRETACEAE)
COMBRETASTATIN A-4
1166364
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTITOXIC ACTIVITY
Gynostemma pentaphyllum (CUCURBITACEAE)
207429
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Alteromonas rava (ALTEROMONIDACEAE)
ALTEROMONAS ANTIBIOTIC B-4317
329864
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus species (BACILLACEAE)
BACILLUS ANTIBIOTIC 26-74
982314
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Catharanthus roseus (APOCYNACEAE)
VINCALEUKOBLASTINE,3'-4'-DEHYDRO:VINCALEUKOBLASTINE,18-EPI-3'-4'-DEHYDRO:
418080
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
PULLULAN
997406
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIBACTERIAL ACTIVITY
Empty organism
CORIOLIN B,5-OXO: 8-DEOXY: 8-C-BETA-METHYL:
1007411
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora olivoasterospora (MICROMONOSPORACEAE)
FORTIMICIN AH
68159
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COMMON COLD RELIEF
Echinacea sanguinea (ASTERACEAE)
565771
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
LIPOLYTIC EFFECT
Ruscus aculeatus (LILIACEAE)
754832
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
BERBERINE
1056661
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Teucrium polium (LAMIACEAE)
DOLICHODIAL,TRANS:
924233
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Hormothamnion enteromorphoides (MICROCHAETACEAE)
HORMOTHAMNION
74917
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Glycomyces harbinensis (ACTINOMYCETALES)
GLYCOMYCES ANTIBIOTIC LL-D-05139-BETA
584993
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
ABURATSUBOLACTAM AABURATSUBOLACTAM CABURATSUBOLACTAM B
1041346
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Penicillium islandicum (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC 1
978362
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERTENSIVE ACTIVITY
Capsicum annuum (SOLANACEAE)
CAPSIANOSIDE I
330373
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
ALLANTOIN
393383
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Thujopsis dolabrata (CUPRESSACEAE)
HINOKITIOL
693883
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULONIC ACID
171745
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces echinatus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FD-991
525115
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nocardia orientalis (NOCARDIACEAE)
VANCOMYCIN,DEMETHYL:
982369
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
VINCALEUKOBLASTINE
607450
PATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTITUMOR ACTIVITY
Theobroma cacao (STERCULIACEAE)
1084923
SYNTHESIS OF ANALOGSMARKER CODE - FERTILITY REGULATION. NO RETRIEVABLE DATAPARTIAL SYNTHESIS OFPATENT DESCRIBED
Empty organism
ZOAPATANOL,(DL):
124683
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora griseoubida (MICROMONOSPORACEAE)
MYCINAMICIN XVI
1030156
UV SPECTRUM GIVEN FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2080-C
780254
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Artemisia sylvatica (ASTERACEAE)
ARTEMINOLIDE,8-ACETYL:
481341
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Bupleurum falcatum (APIACEAE)
SAIKOSAPONIN ASAIKOSAPONIN B
505319
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
61290
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIMYCOBACTERIAL ACTIVITY
Empty organism
LAURIC ACID
1000825
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Micromonospora species (MICROMONOSPORACEAE)
KANAMYCIN B
319088
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
CEPHALEXIN*
1009893
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOTENSIVE ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
MONENSIN A PHENETHYLURETHANEMONENSIN AMONENSIN B
319284
PATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIOBESITY ACTIVITY
Empty organism
CAFFEINE
407982
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Echinodontium tsugicola (ECHINODONTIACEAE)
ECHINODONTIUM TSUGICOLA POLYSACCHARIDE
1164628
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
ALGINIC ACID
397625
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza glabra (FABACEAE)
COUMARONE,2-(2'-4'-DIHYDROXY-PHENYL)-4-METHOXY-5-(3-METHYL-BUTEN-2-YL)-6-HYDROXY:
975677
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Schisandra chinensis (SCHISANDRACEAE)
GOMISIN A
672851
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Euphorbia peplus (EUPHORBIACEAE)
1000021
YIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Pseudomonas hydrogenovora (PSEUDOMONADACEAE)
PSEUDOMONAS POLYSACCHARIDE ANTIBIOTIC
6345
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Micromonospora floridensis (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC 70591
352913
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Zopfiella curvata (LASIOSPHAERIACEAE)
ZOPFIELLIN
1020946
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Pseudomonas species (PSEUDOMONADACEAE)
BACTOBOLIN,ALANYL:
1020442
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
ELLIPTICINE,9-HYDROXY-2-METHYL:
1076282
TRADITIONAL MEDICINEMARKER CODE - FERTILITY REGULATION. NO RETRIEVABLE DATAPATENT DESCRIBEDANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIFERTILITY EFFECT(UNSPECIFIED)
Piper betle (PIPERACEAE)
694206
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIPRURITIC ACTIVITY
Kochia scoparia (CHENOPODIACEAE)
MOMORDIN I
655052
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Lyophyllum decastes (TRICHOLOMATACEAE)
1156008
PATENT DESCRIBED
Empty organism
NOSCAPINE
492136
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Perilla frutescens (LAMIACEAE)
PHENYL,5-ALLYL-4-METHOXY-1-2-METHYLENEDIOXY-3: BETA-D-GLUCOSIDE
352241
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycine max (FABACEAE)
FLAVONE,ISO: 4'-5-6-TRIHYDROXY: 7-O-BETA-D--PYRANOSIDE
555031
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
VINCALEUKOBLASTINE
408383
PMR SPECTRUM REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDYIELD IS 50-100 MGMINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Montanoa tomentosa (ASTERACEAE)
MONTANOL
994767
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces stimulosus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 34129-RP
385975
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN IMPROVEMENT EFFECT
Empty organism
RUTIN
818468
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Chlorella pyrenoidosa (CHLORELLACEAE)
329991
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Actinomadura carminata (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC
144163
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces espii (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2587-C
607113
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CARCINOGENESIS INHIBITION
Empty organism
BOWMAN-BIRK PROTEASE INHIBITOR
417257
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
CARDOL,METHYL:CARDOLCARDANOLANACARDIC ACID
493876
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aspergillus fumigatus (HYPHOMYCETES)
PSEUROTIN A
976343
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
RENAL FUNCTION IMPROVEMENT
Rehmannia glutinosa (SCROPHULARIACEAE)
VERBASCOSIDE
675957
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TUBULIN POLYMERIZATION ENHANCEMENT
Empty organism
NOSCAPINE
852522
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Streptoverticillium species (STREPTOMYCETACEAE)
TECTORIGENIN
1030149
UV SPECTRUM GIVEN FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces lavendulae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FR-900201
610300
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Schumanniophyton magnificum (RUBIACEAE)
ROHITUKINE
354019
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
TAXOL
125442
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora globosa (MICROMONOSPORACEAE)
ENDYNAMICIN B
1169266
PATENT DESCRIBED
Empty organism
HYALURONIC ACID
1036397
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Fusobacterium nucleatum (BACTERIOIDACEAE)
FUSOBACTERIUM ANTIBIOTIC TF-210
950161
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERTENSIVE ACTIVITY
Fritillaria ussuriensis (LILIACEAE)
USSURIENINE
648015
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Annona squamosa (ANNONACEAE)
MOSIN C
1135858
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
VINCALEUKOBLASTINE
970650
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
WOUND HEALING ACCELERATION
Empty organism
ELLAGIC ACID
488508
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Fusarium moniliforme (HYPHOMYCETES)
GIBBERELLIC ACID
971709
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
INTESTINAL MOTILITY STIMULATION
Panax ginseng (ARALIACEAE)
914627
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
ELLIPTICINE,9-HYDROXY:
407053
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Brucea antidysenterica (SIMAROUBACEAE)
BRUCEANTARIN
920801
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
METASTASIS INHIBITION
Empty organism
PIERICIDIN A,GLUCO:
89561
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Pseudomonas species (PSEUDOMONADACEAE)
PSEUDOMONAS ANTIBIOTIC YM-3229-G-A
1055569
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
APHRODISIAC ACTIVITY
Empty organism
TESTOSTERONE,METHYL:YOHIMBINECAFFEINETOCOPHEROL,ALPHA: ACETATESTRYCHNINE
363926
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Trichosanthes kirilowii (CUCURBITACEAE)
BRYONOLIC ACID
408019
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
TERPINEOL,ALPHA:
441496
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Peucedanum terebinthaceum (APIACEAE)
PTERYXIN,ISO: EPOXY:
1018182
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Dactylosporangium thailandense (ACTINOPLANACEAE)
DACTYLOSPORANGIUM ANTIBIOTIC G-367-2
401111
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Apiosordaria effusa (LASIOSPHAERIACEAE)
APIODIONEN
364959
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WEIGHT LOSS
Cirsium japonicum (ASTERACEAE)
876186
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Pleurotus sajor-caju (POLYPORACEAE)
URSOCHOLIC ACID
523194
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ARACHIDONIC ACID RELEASE INHIBITION
Empty organism
CINEOL,1-8:
985211
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces lavendulae (STREPTOMYCETACEAE)
CHLOROCARCIN B
926926
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Castanospermum australe (FABACEAE)
CASTANOSPERMINE
607095
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Empty organism
RUTIN
1023248
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptosporangium fragilis (STREPTOSPORANGIACEAE)
FRAGILOMYCIN A
963002
PATENT DESCRIBED
Trigonella foenum-graecum (FABACEAE)
TRIGONELLIC ACID
1052865
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC C-19393-S-2
230239
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC BE-51068
393250
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
COLLAGENASE INHIBITION
Empty organism
GALLIC ACID METHYL ESTER
323630
PHARMACOLOGY OF COMPOUND - IN VITROPHEROMONE MARKER CODEPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OF
PHEROMONE(SIGNALLING)
Empty organism
ANISALDEHYDEPHENYLACETIC ACIDCINNAMYL ALCOHOLCINNAMALDEHYDEPHENYLETHYL ALCOHOL,BETA:CINNAMIC ACIDSALICYLIC ACIDBENZYL ALCOHOLPHENOL,SEC-BUTYL:EUGENOLPIPERONALBENZYL ACETONEIONONE,METHYL:SAFROLEACETOPHENONE
1064740
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Montanoa tomentosa (ASTERACEAE)
ZOAPATANOLMONTANOL
830175
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces peuceticus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FCE-22724
155162
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Alcaligenes faecalis (ACHROMOBACTERIACEAE)
ALCALIGENES ANTIBIOTIC B-1015
1001398
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Streptomyces lavendulae (STREPTOMYCETACEAE)
AMICLENOMYCIN
1270246
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Myristica fragrans (MYRISTICACEAE)
PHENONE,OCTYL: 2'-6'-DIHYDROXY-9-(2-5-DIHYDROXY-PHENYL):
1004067
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC KA-7038-II
526061
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Sophora alopecuroides (FABACEAE)
SOPHORIDINE
76596
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Penicillium rugulosum (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC BP-3-I
1031607
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
BUTANE-(2-3-DICARBOXYLIC ACID DILACTONE),BIS-1-4-(3-5-DIMETHOXY-4-HYDROXY-PHENYL):
411812
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Empty organism
PSALLIOTA XANTHODERMA GLYCOPROTEIN
1073961
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
HEMAGGLUTININ ACTIVITY
Aloe species (LILIACEAE)
ALOCUTIN A
1040716
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Protodaedalea species (TULASNELLALES)
PROTODAEDALEA ANTIBIOTIC
669130
PATENT DESCRIBED
Empty organism
AJOENE
996412
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces griseoflavus (STREPTOMYCETACEAE)
PYRROLO-(3,2-E)-INDOLE-7-CARBOXYLIC ACID,3-(H): 3-CARBAMOYL-1-2-DIHYDRO-4-HYDROXY-5-METHOXY:
540516
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Anoectochilus formosanus (ORCHIDACEAE)
BUTYRIC ACID,4-HYDROXY: 3-O-BETA-D-GLUCOSIDEBUTYROLACTONE,GAMMA: 3-O-BETA-D-GLUCOSIDEBUTYRIC ACID,4-HYDROXY: 3-O-BETA-D-GLUCOSIDE METHYL ESTERBUTYRIC ACID,4-ISO-PROPOXY: 3-O-BETA-D-GLUCOSIDE
119659
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces galbus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC IMC-29
358721
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
BETULINIC ACID
568599
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
PERILLYL ALCOHOLPERILLIC ACID METHYL ESTER
657366
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIYEAST ACTIVITY
Spirastrella spinispirulifera (SPIRASTRELLIDAE)
SPONGIASTATIN 7
151373
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC M-871563-ASTREPTOMYCES ANTIBIOTIC M-871563-B
551555
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
CURCUMIN
1042511
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Lasiosiphon kraussianus (THYMELAEACEAE)
LASIOSIPHON KRAUSSIANUS POLYSACCHARIDE
533641
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nicotiana undulata (SOLANACEAE)
AUBERGENONE,4-EPI:
790029
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
DIDROVALTRATE
337816
PHARMACOLOGY OF COMPOUND - IN VIVOPHEROMONE MARKER CODEPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
PHEROMONE(INSECT SEX ATTRACTANT)
Empty organism
DODECA-TRANS-7-TRANS-10-DIEN-1-OL
1081018
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
VINDESINE*
327343
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cnicus benedictus (ASTERACEAE)
618646
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
HYPOTENSIVE ACTIVITY
Patrinia species (VALERIANACEAE)
PATRIN
869327
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Neurospora crassa (SORDARIACEAE)
FORSKOLIN,1-9-DIDEOXY:
955608
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR DYEING EFFECT
Gleditsia officinalis (FABACEAE)
346086
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
OLEANOLIC ACID,3-OXO:PANAXATRIOL,3-OXO:PANAXADIOL,3-OXO:GLYCYRRHETIC ACID,3-OXO:PROTOPANAXADIOL,3-KETO: 20(S):URSOLIC ACID,3-OXO:PROTOPANAXATRIOL,3-OXO: 20(R):
1052862
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC C-19393-H-2
416768
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Panax ginseng (ARALIACEAE)
GYPENOSIDE XVII
218056
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ecteinascidia turbinata (PEROPHORIDAE)
ECTEINASCIDIN 729,N-12-FORMYL:
151293
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-9561
992628
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces fulvoviridis (STREPTOMYCETACEAE)
568733
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
SKIN DEPIGMENTATION EFFECT
Empty organism
KOJIC ACID
566857
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
OCTACOSAN-1-OL
595548
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
PIERICIDIN B-5
329968
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Pseudomonas ovalis (PSEUDOMONADACEAE)
615391
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
HESPERETIN
535206
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
HISTAMINE RELEASE INHIBITION
Allium sativum (LILIACEAE)
218985
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Scleroderma texense (SCLERODERMATACEAE)
TEXENOMYCIN B
356318
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIDANDRUFF EFFECT
Aloe vera (LILIACEAE)
447877
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MBA-028-24-B
991783
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Alkanna tinctoria (BORAGINACEAE)
ALKANNIN ANGELATE
490249
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Annona bullata (ANNONACEAE)
ROLLINIASTATIN 2
323102
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
VINCAMINE,PSEUDO:*VINCAMINE,PSEUDO: 16-EPI:*VINCAMINE,PSEUDO: APO:*
155060
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AB-041
789042
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Erythroxylum pervillei (ERYTHROXYLACEAE)
PERVILLEINE DPERVILLEINE A N-OXIDEPERVILLEINE CPERVILLEINE APERVILLEINE FPERVILLEINE E
1121314
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIBACTERIAL ACTIVITY
Sanguinaria canadensis (PAPAVERACEAE)
811964
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Fusarium nivale (HYPHOMYCETES)
NIVALENOL MONOACETATENIVALENOL
68285
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cnidium monnieri (APIACEAE)
OSTHOL
490681
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Dahlia species (ASTERACEAE)
INULIN
320672
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Scenedesmus species (SCENEDESMACEAE)
1027643
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Hyphomicrobium species (BUDDING BACTERIA)
HYPHOMICROBIUM POLYSACCHARIDE
1184270
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces griseus (STREPTOMYCETACEAE)
DAUNOMYCINONE,7-EPI: 11-DEOXY:
89577
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-79-A
406932
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
HARRINGTONINE,DEOXY:
37468
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ESTROGENIC EFFECT
Butea monosperma (FABACEAE)
187628
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces coeruleorubidus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 14-1-9
413208
SYNTHESIS OF ANALOGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
DAUNORUBICIN
970542
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
LYMPHOCYTE BLASTOGENESIS STIMULANT
Empty organism
CHAMIGRENEGINSENOSIDE BSESQUICARENEOPHIOPOGONIN BOPHIOPOGONIN DGINSENOSIDE G
1036392
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptoverticillium stramineum (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC LLBO-1208-ALPHA:STREPTOVERTICILLIUM ANTIBIOTIC LLBO-1208-BETA
1231387
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANALGESIC ACTIVITY
Eucalyptus species (MYRTACEAE)
607294
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
832053
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Hypomyces aurantius (HYPOMYCETACEAE)
ELYMOCLAVINE
544121
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Empty organism
CYCLOSPORIN A
836524
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces olivoreticuli (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AB-78
896238
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Volvariella volvacea (PLUTEACEAE)
POLYSACCHARIDE(VOLVARIELLA VOLVACEA)
993023
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
MANILOSPORIN A
1055736
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Petriella guttulata (MICROASCACEAE)
PETRIELLA ANTIBIOTIC FR-900261
68103
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
326827
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Corynebacterium simplex (CORYNEFORM ACTINOMYCETE)
DAUNORUBICINOL
828172
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Olea europaea (OLEACEAE)
OLEANOLIC ACID
997414
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
CORIOLIN B,8-OXO:CORIOLIN B,8-C-ALPHA-METHYL:CORIOLIN B,8-DEOXY: C-BETA-METHYL:
965317
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sophora japonica (FABACEAE)
RUTIN
321428
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Chaetomium globosum (CHAETOMIACEAE)
COCHLIODINOL
235916
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Pseudallescheria ellipsoidum (MICROASCACEAE)
PSEUDALLESCHERIA ANTIBIOTIC AM-6898-BPSEUDALLESCHERIA ANTIBIOTIC AM-6898-CPSEUDALLESCHERIA ANTIBIOTIC AM-6898-APSEUDALLESCHERIA ANTIBIOTIC AM-6898-D
970030
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Panax ginseng (ARALIACEAE)
PANAX GLYCOPROTEIN
816351
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bacillus brevis (BACILLACEAE)
EDEINE C
869962
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Myxococcus coralloides (MYXOCOCCACEAE)
CORALLOPYRONIN BCORALLOPYRONIN A
738742
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Hibiscus sabdariffa (MALVACEAE)
HIBISCUS ACID
203449
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Allium chinense (LILIACEAE)
MACROSTEMONOSIDE A
1049875
UV SPECTRUM GIVEN FORQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Penicillium citrinum (HYPHOMYCETES)
CITRININ
810865
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Apis mellifera (APIDAE)
742075
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Solanum lyratum (SOLANACEAE)
SOLAMARGINE
182123
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC NK-170204-BSTRETPOMYCES ANTIBIOTIC NK-170204-A
614896
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Empty organism
NANAOMYCIN A
1020960
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces endus aureus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DO-59-II
193560
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPID PEROXIDE FORMATION INHIBITION
Streptomyces aeriouvifer (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC CL-190-Y-1
686575
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
HYPERFORIN
1027099
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
DAUNORUBICIN,11-AMINO-11-DEOXY:
865033
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Elaeagnus glabra (ELAEAGNACEAE)
CATECHIN,EPI-GALLO: (-):
323248
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces cinnamomeus (STREPTOMYCETACEAE)
ENSANCHOMYCIN
730725
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Polygonatum cuspidatum (LILIACEAE)
RESVERATROL,CIS:
922082
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cinnamomum porrectum (LAURACEAE)
CUBEBIN
41384
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Carthamus tinctorius (ASTERACEAE)
CARTHAMIN
737088
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Prunella vulgaris (LAMIACEAE)
337598
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS 50-100 MGMANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY(PLANT PATHOGEN)
Streptomyces katsunumaensis (STREPTOMYCETACEAE)
CYTRIMYCIN
1025384
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
CYANIDAN-3-OL-3-O-PALMITATE,(+):
154222
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC CC-12
1039552
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Dactylosporangium species (ACTINOPLANACEAE)
DACTYLOSPORANGIUM ANTIBIOTIC SF-2107-C
925141
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Asteropus sarasinosum (THROMBIDAE)
SARASINOSIDE C-2
762818
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTITOXIC ACTIVITY
Vitis vinifera (VITACEAE)
819308
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Talaromyces species (TRICHOCOMACEAE)
FOSFONOCHLORIN
332447
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
INSECTICIDE ACTIVITY
Empty organism
TROPOLONE
1029110
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Silybum marianum (ASTERACEAE)
SILYBIN
200827
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CELL PROLIFERATION INHIBITION
Agaricus bisporus (AGARICACEAE)
AGARICUS GLYCOPROTEIN
989781
YIELD IS MORE THAN 100 MGMWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Microcyclus polymorpha (SPIRILLACEAE)
COENZYME Q-10
626536
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
426256
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Empty organism
HONOKIOL
735340
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxus media (TAXACEAE)
BACCATIN IIICEPHALOMANNINETAXOLBACCATIN III,DEACETYL:
94152
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptococcus pyogenes (STREPTOCOCCACEAE)
STREPTOCOCCUS ANTIBIOTIC SPF-10-12
569946
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eucalyptus species (MYRTACEAE)
EUCALYPTIN
452866
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
APHRODISIAC ACTIVITY
Selinum monnieri (APIACEAE)
CNIDEOSIDE A
1279581
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Aglaia leptantha (MELIACEAE)
SILVESTROLSILVESTROL,EPI:
98751
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Volvariella volvacea (PLUTEACEAE)
VOLVARIELLA ANTIBIOTIC
325898
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
RESORCINOL
1092963
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Citrus reticulata (RUTACEAE)
HESPERIDIN
1033429
UV SPECTRUM GIVEN FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces species (STREPTOMYCETACEAE)
CYSTAMYCIN
816506
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Pseudosaccharomyces species (HYPHOMYCETES)
INSULIN
325136
PURIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Zea mays (POACEAE)
STARCH
187634
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AC-44-37
68199
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Boswellia serrata (BURSERACEAE)
1188178
PATENT DESCRIBED
Foeniculum vulgare (APIACEAE)
491294
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITREPONEMAL ACTIVITY
Streptomyces cacaoi (STREPTOMYCETACEAE)
VIRIDOGRISEIN
151545
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
RAPAMYCIN,29-DEMETHYL:
831219
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
OLIVACINE
2244
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSANTIFERTILITY
HYALURONIDASE INHIBITION
Empty organism
BENZOIC ACID,2-4-6-TRIHYDROXY: CONDENSATION PRODUCTS
126063
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces roseosporus (STREPTOMYCETACEAE)
CONAGENIN
708912
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
318603
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
CHROMENE*CHROMAN*
945255
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ESTROGENIC EFFECT
Rhodococcus equi (NOCARDIACEAE)
ESTRA-1-3-5(10)-TRIEN-3-OL-17-PROPIONIC ACID
823954
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Lyngbya majuscula (OSCILLATORIACEAE)
MAJUSCULAMIDE C#
1039550
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Dactylosporangium species (ACTINOPLANACEAE)
DACTYLOSPORANGIUM ANTIBIOTIC SF-2107-C
686539
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus jujuba (RHAMNACEAE)
BETULINIC ACID
790010
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
ACEVALTRATE
1104376
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTICELLULITE EFFECT
Cola nitida (STERCULIACEAE)
408098
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Amorpha fruticosa (FABACEAE)
FRUTICIN
666559
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
KUWANOL A
515206
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Flavobacterium species (ACHROMOBACTERIACEAE)
AKALONE
830176
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces peuceticus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FCE-22724
417805
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LEUKOTRIENE D-4 INHIBITION
Empty organism
CAR-3-ENE-2-5-DIONE,(DL):
174575
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces griseus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 446-53-1
682930
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIDEPRESSANT ACTIVITY
Empty organism
MYRICETIN
965667
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
488771
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Lansium domesticum (MELIACEAE)
848283
PATENT DESCRIBED
Empty organism
GUAR GUM
1007668
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2068
407057
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Brucea antidysenterica (SIMAROUBACEAE)
1050788
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Bos taurus (BOVIDAE)
SANTACUARATOR A
332449
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXIC EFFECT(GENERAL)
Streptomyces verticillatus (STREPTOMYCETACEAE)
SIASTATIN BSIASTATIN A
325565
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
MYRCENE
318867
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
METHIONINE
811422
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Propionibacterium acnes (LACTOBACILLACEAE)
PROPIONIBACTERIUM ACNES ANTIBIOTIC C-7
396832
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Vismia species (CLUSIACEAE)
VISMIN
817474
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
APHRODISIAC ACTIVITY
Empty organism
SYRINGIN
1031627
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Lathyrus japonicus (FABACEAE)
LATHYRINE,L:LATHYRINE,L: GAMMA-L-GLUTAMYL:
1005067
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Coriolus vernicipes (POLYPORACEAE)
CYTOCHALASIN D
854130
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Panax pseudoginseng (ARALIACEAE)
PANAXAN APANAXAN EPANAXAN DPANAXAN BPANAXAN C
355775
PATENT DESCRIBED
Tripterygium wilfordii (CELASTRACEAE)
566561
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TYROSINASE INHIBITION
Empty organism
RESORCINOL
13823
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
VERRUCARIN D
447624
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
TOPOTECAN*
934738
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Coriolus pubescens (POLYPORACEAE)
CORIOLAN
1063399
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
Matricaria chamomilla (ASTERACEAE)
ESSENTIAL OIL(MATRICARIA CHAMOMILLA)
535410
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Bugula neritina (BUGULIDAE)
BRYOSTATIN 4
68487
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSTIMULANT ACTIVITY
Aloe vera (LILIACEAE)
568643
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Juglans nigra (JUGLANDACEAE)
NAPHTHOQUINONE,1-4: 5-HYDROXY:
1016925
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC C-15003-PND
943184
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Foeniculum vulgare (APIACEAE)
ANETHOLE
1053414
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
ORYZANOL,GAMMA:
325239
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Corydalis incisa (PAPAVERACEAE)
CORYDAMINE
329987
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
IMMUNOSUPPRESSANT ACTIVITY
Eupenicillium brefeldianum (TRICHOCOMACEAE)
BREDININ
976014
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIECZEMA EFFECT
Mimosa tenuiflora (FABACEAE)
842161
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces subflavus (STREPTOMYCETACEAE)
IRUMANOLIDE I
589684
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Panax japonicus (ARALIACEAE)
CHIKUSETSUSAPONIN IV
1006764
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces flavogriseus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 49-A
94141
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Angiococcus disciformis (MYXOCOCCACEAE)
ANGIOLAN A
141308
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIOPHAGE ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC RK-1441-B
1078110
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIFERTILITY
FERTILITY PROMOTION EFFECT
Empty organism
ARGININE,L:
413933
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
GLAZIOVINE,11-12-DIHYDRO: (DL):
968987
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TOPOISOMERASE II INHIBITION
Woodfordia floribunda (LYTHRACEAE)
WOODFORTICOSIN
417814
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LEUKOTRIENE D-4 INHIBITION
Empty organism
CINNAMALDEHYDE,3'-4'-5'-TRIMETHOXY:
327820
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
TERTHIENYL
556455
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Euphorbia kansui (EUPHORBIACEAE)
INGENOL,3-O-(DECA-TRANS-2-CIS-4-DIENOYL):
981498
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
CEREBRAL EDEMA DECREASED
Empty organism
CROCETIN
550820
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Aplysia dactylomela (APLYSIIDAE)
APLYSIA CHAMIGRENE DERIVATIVES
491815
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Verticillium balanoides (HYPHOMYCETES)
BALANOL
981808
CHEMICAL CONVERSION OFPATENT DESCRIBED
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDESTEVIOLBIOSIDE
330003
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
CITRONELLOL,HYDROXY:
362674
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIFUNGAL ACTIVITY
Momordica cochinchinensis (CUCURBITACEAE)
480382
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Empty organism
GALLOCATECHIN-3-O-GALLATE,EPI: (-):
521569
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces platensis (STREPTOMYCETACEAE)
LEUSTRODUSCIN H
89576
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-79-A
686534
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus jujuba (RHAMNACEAE)
BETULINIC ACID
628165
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTIADHESION EFFECT
Vaccinium macrocarpon (ERICACEAE)
409833
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
XANTHOPTERIN,ISO:
823957
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC SF-2140
983080
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC C-14019-5-1
83106
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora species (MICROMONOSPORACEAE)
LEVUREMICIN
1031795
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Scytonema hoffmannii (SCYTONEMATACEAE)
SCYTONEMA ANTIBIOTIC
906865
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Humulus lupulus (CANNABACEAE)
153973
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces gardneri (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-10255-JSTREPTOMYCES ANTIBIOTIC A-10255-G
683220
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
CONFERTIFLORINMELAMPODIN ALEUCANTHIN BENCELINTENULINBURRODINPSILOSTACHYIN AENHYDRINPARTHENOLIDECOSTUNOLIDE
1023197
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
STABILITY STUDY
Panax ginseng (ARALIACEAE)
607440
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Perilla frutescens (LAMIACEAE)
PERILLA ALCOHOL
159661
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Amycolatopsis species (ACTINOMYCETACEAE)
AMYCOLATOPSIS ANTIBIOTIC SF-2748
75553
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinomadura verrucosospora (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC BBM-1675-A-1
1050098
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Diheterospora catemulatum (HYPHOMYCETES)
ANGIOSTATIN
148730
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces graminofaciens (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FD-892
812687
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN SITUANTIFERTILITY
UTERINE STIMULANT EFFECT
Empty organism
ZOAPATANOL
985964
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Amanita onusta (AMANITACEAE)
HEX-4-YNOIC ACID,2-AMINO-6-HYDROXY:
978288
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Betula pubescens (BETULACEAE)
CARYOPHYLLA-4-7-DIEN-6-OL
1017039
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Fusarium roseum (HYPHOMYCETES)
BLEOMYCIN B-2
894123
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOTENSIVE ACTIVITY
Camellia sinensis (THEACEAE)
GALLOCATECHIN GALLATE,(-):
994772
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Protaminobacter luvar (PSEUDOMONADACEAE)
COENZYME Q-10
731926
PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxus species (TAXACEAE)
TAXOL
350051
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Narcissus species (AMARYLLIDACEAE)
GALANTHAMINE
476648
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nicotiana tabacum (SOLANACEAE)
AESCULETINCHLOROGENIC ACIDHYDROQUINONE,2-ISO-PROPYL:BENZENE,1-2-4-TRIHYDROXY:
816352
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bacillus brevis (BACILLACEAE)
EDEINE D
93655
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptococcus pyrogenes (STREPTOCOCCACEAE)
STREPTOCOCCUS ANTIBIOTIC SPF-100-F-II
332945
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces lactamdurans (STREPTOMYCETACEAE)
CEPHAMYCIN C
837612
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Phoma betae (COELOMYCETES)
BETAENONE C
819289
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Streptomyces chromofuscus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-58365-B
127179
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Arthroderma species (GYMNOASCACEAE)
ARTHRODERMA ANTIBIOTIC FR-901308
1049025
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces ishikarinensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC Y-G-665-G-A
1190830
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TESTOSTERONE SYNTHESIS INHIBITION
Empty organism
GLYCYRRHETINIC ACID
595550
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
PIERICIDIN B-5
425923
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Empty organism
TOPSENTIN D,NOR:
1020740
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces vinaceus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2012-L
862404
IDENTIFICATION OFPATENT DESCRIBED
Cnicus benedictus (ASTERACEAE)
CAFFEIC ACIDCATECHIN,(+):RUTIN
408623
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDTOXICITY MARKER CODE
RODENTICIDE ACTIVITY
Empty organism
SYROSINGOPINE
552566
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HAIR STIMULANT EFFECT
Empty organism
MYCOPHENOLIC ACID
1052724
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces canarius (STREPTOMYCETACEAE)
SAPHENAMYCIN
1152242
MARKER CODE - FERTILITY REGULATION. NO RETRIEVABLE DATAPHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TESTOSTERONE SYNTHESIS INHIBITION
Empty organism
OLEANOLIC ACID
154218
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces graminofaciens (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FD-891
1029953
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Phlomis tuberosa (LAMIACEAE)
CAFFEIC ACID
445767
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Annona squamosa (ANNONACEAE)
SQUAMOSTATIN A
134854
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora citrea (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC LL-E-19085-ALPHA
90109
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces griseoincarratus (STREPTOMYCETACEAE)
745317
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
OCULAR PROTECTION ACTIVITY
Empty organism
LUTEIN
1036455
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptococcus lactis (STREPTOCOCCACEAE)
STREPTOCOCCUS LACTIS CELL WALL ANTITUMOR AGENT
332782
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
DEODORIZING EFFECT
Cimicifuga dahurica (RANUNCULACEAE)
457837
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
SILYBIN
154356
AMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Sarcophaga peregrina (SARCOPHAGIDAE)
SARCOPHAGA POLYPEPTIDE SP-6
526517
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN METABOLISM ACCELERATION
Empty organism
OCTACOSAN-1-OL
417531
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
Sarcophyton species (ALCYONIIDAE)
CHATANCIN
207820
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces nobilis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC JCM-4274
127997
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DT-136-B
962893
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HEMOSTATIC ACTIVITY
Typha latifolia (TYPHACEAE)
RHAMNETIN,ISO: 3-RUTINOSIDE-7-RHAMNOSIDE
864522
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces virginiae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 301-C
666108
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TUMOR NECROSING FACTOR SECRETION INHIBITION
Aloe vera (LILIACEAE)
IMMUNO-10
1000199
PATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces pharbovirides (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 17927-A-1
615171
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SWEETENING EFFECT
Stevia rebaudiana (ASTERACEAE)
83173
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Streptoverticillium species (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC 1024-SY-1-A
325899
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
DIGESTANT ACTION
Helix pomatia (HELICIDAE)
327701
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SOBERIZING ACTIVITY
Empty organism
GLUCOSE,D:ASCORBIC ACID
826859
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC SF-2228
872176
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces rimosus (STREPTOMYCETACEAE)
DOXYCYCLINE
978294
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Betula pubescens (BETULACEAE)
CARYOPHYLLA-4-7-DIEN-6-ONE
852489
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rubia cordifolia (RUBIACEAE)
PURPURIN
856067
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOTENSIVE ACTIVITY
Ephedra species (EPHEDRACEAE)
MAHUANNIN C
1000022
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY(PLANT PATHOGENS)
Pseudomonas hydrogenovora (PSEUDOMONADACEAE)
PSEUDOMONAS POLYSACCHARIDE ANTIBIOTIC
1289494
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aristolochia taliscana (ARISTOLOCHIACEAE)
MACHILIN B,(-): 2(S)-3(S):
1028572
UV SPECTRUM GIVEN FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Veillonella alcalescens (VEILLONELLACEAE)
VEILLONELLA ANTIBIOTIC TV-1356
1005730
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALPHA-AMYLASE INHIBITION
Streptomyces diastaticus-amylostaticus (STREPTOMYCETACEAE)
AMYLOSTATIN C
1008900
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces alcalophilus (STREPTOMYCETACEAE)
NOCARDICIN A
1042731
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Morus alba (MORACEAE)
KUWANON HKUWANON G
925030
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CELL PROLIFERATION INHIBITION
Empty organism
TRICHOSANTHIN,ALPHA:
5675
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
VIOMYCIN
81711
GEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Dactylosporangium thailandense (ACTINOPLANACEAE)
DACTYLOSPORANGIUM ANTIBIOTIC G-367-1
331894
PATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Fusarium solani (HYPHOMYCETES)
PHENYLALANINE,L: 3-4-DIHYDROXY: N-PHENYL-ACETYL:
700704
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Hypericum perforatum (CLUSIACEAE)
HYPERICIN
992468
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces incarnatus (STREPTOMYCETACEAE)
102132
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Haliclona species (HALICLONIDAE)
MANZAMINE B
1065749
PMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Montanoa tomentosa (ASTERACEAE)
MONTANOL
150621
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
ECHIGUANINE B
994015
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS 50-100 MGM
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2059
385921
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Citrus aurantium (RUTACEAE)
1092594
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
INTERFERON INDUCTION STIMULATION
Carthamus tinctorius (ASTERACEAE)
329782
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
BENZOQUINONE
1034508
UV SPECTRUM GIVEN FORISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC
565788
PATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTITUMOR ACTIVITY
Mytilus galloprovincialis (MYTILIDAE)
329132
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
TOXICITY ASSESSMENT(QUANTITATIVE)
Streptomyces species (STREPTOMYCETACEAE)
LIBRAMYCIN A
1005833
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinomadura fulva (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC AB-85
879213
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Argemone mexicana (PAPAVERACEAE)
SANGUINARINE,DIHYDRO:
992420
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Pseudomonas yoshitomiensis (PSEUDOMONADACEAE)
PSEUDOMONAS ANTIBIOTIC Y-14556
627161
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIYEAST ACTIVITY
Ircinia species (SPONGILLIDAE)
SULFIRICIN A
893864
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Belamcanda chinensis (IRIDACEAE)
TECTORIGENIN
1050044
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Isodon trichocarpus (LAMIACEAE)
TRICHORABDAL D
1056276
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Lactobacillus bulgaricus (LACTOBACILLACEAE)
568657
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
HEPARINHEPARIN SULFATE
418033
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Swietenia mahagoni (MELIACEAE)
SWIETENOLIDE-3-ACETATE
861106
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Papaver bracteatum (PAPAVERACEAE)
THEBAINE
1053387
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
FORTIMICIN B
56507
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Veratrum album (LILIACEAE)
ZYGADENINE,VERATROYL:
709394
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Salacia prinoides (HIPPOCRATEACEAE)
LUP-20(29)-EN-2-ONE,3-BETA-30-DIHYDROXY:
1025286
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
Aerobacillus colistinus (TO BE DETERMINED)
JOLIPEPTIN
883949
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Olea europaea (OLEACEAE)
SITOSTEROL,BETA:
408820
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
LACTATE DEHYDROGENASE INHIBITION
Aspergillus niger (HYPHOMYCETES)
GENISTEIN,8-HYDROXY:
925134
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Asteropus sarasinosum (THROMBIDAE)
SARASINOSIDE A-1
610307
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORTLC DATA REPORTEDISOLATION AND IDENTIFICATION OF
Schumanniophyton magnificum (RUBIACEAE)
SCHUMANNIFINE,ANHYDRO:
884822
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Primula veris (PRIMULACEAE)
VOLEMITOL,D:
98744
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Flexibacter species (CYTOPHAGACEAE)
FLEXIBACTER ANTIBIOTIC B-572-A-1
1066040
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN SITUANTIFERTILITY
UTERINE STIMULANT EFFECT
Empty organism
ZOAPATANOL
1002338
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinoplanes species (ACTINOPLANACEAE)
ACTINOPLANES ANTIBIOTIC 1-7413-A
67651
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Pueraria thomsonii (FABACEAE)
399730
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Juliania adstringens (JULIANIACEAE)
SHINOL
356086
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aralia elata (ARALIACEAE)
ELATOSIDE FELATOSIDE E
587502
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sorangium cellulosum (SORANGIACEAE)
EPOTHILONE AEPOTHILONE B
979260
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
HIYODORILACTONE B
490697
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CELL PROLIFERATION STIMULATION
Empty organism
SAIKOSAPONIN B-2
1274264
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Mensamaria intercedens (HOLOTHUROIDEA)
513809
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
BEQUINOSTATIN B
174582
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces griseus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 446-53-1
189400
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS
HERBICIDAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC KO-7888-BSTREPTOMYCES ANTIBIOTIC KO-7888-CSTREPTOMYCES ANTIBIOTIC KO-7888-DSTREPTOMYCES ANTIBIOTIC KO-7888
329070
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Hypochnus species (CHIODECTONACEAE)
GLUCAN
373761
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ophiorrhiza mungos (RUBIACEAE)
CAMPTOTHECIN
998050
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Irpex species (POLYPORACEAE)
IRPEX SPECIES ANTIBIOTIC
985207
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CHLOROCARCIN A
319154
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACEUTICAL FORMULATION OF
Empty organism
NEOMYCIN
385965
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
WEIGHT LOSS
Garcinia cambogia (CLUSIACEAE)
1075724
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WOUND HEALING ACCELERATION
Aloe arborescens (LILIACEAE)
1049784
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Pseudomonas species (PSEUDOMONADACEAE)
PSEUDOMONAS ANTIBIOTIC YM-3229-G
1127848
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SMOKING DETERRENT
Nicotiana tabacum (SOLANACEAE)
671651
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Inula viscosa (ASTERACEAE)
TAYUNIN
389721
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIECZEMA EFFECT
Dictamnus dasycarpus (RUTACEAE)
235920
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
IMMUNOGLOBULIN PRODUCTION INHIBITION
Pseudallescheria ellipsoidum (MICROASCACEAE)
PSEUDALLESCHERIA ANTIBIOTIC AM-6898-BPSEUDALLESCHERIA ANTIBIOTIC AM-6898-CPSEUDALLESCHERIA ANTIBIOTIC AM-6898-APSEUDALLESCHERIA ANTIBIOTIC AM-6898-D
878970
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces lavendulae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC CA-146-B
1020833
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AM-2722
1004985
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Streptomyces incarnatus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC RP-32232STREPTOMYCES ANTIBIOTIC RP-35391
330227
PURIFICATION OFPATENT DESCRIBED
Empty organism
TEREPHTHALIC ACID
607096
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Empty organism
RUTIN
777811
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
BENIGN PROSTATIC HYPERPLASIA IMPROVEMENT
Serenoa repens (ARECACEAE)
1021803
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces baarnensis (STREPTOMYCETACEAE)
ENAMINOMYCIN A
1216570
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC B-41-D
1027122
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDPREPARATION OF DERIVATIVES OF
Empty organism
DAUNOMYCINONE,DEMETHOXY-DEOXY:
331923
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Streptomyces tanashiensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 1004
997796
QUANTITATIVE DATAPATENT DESCRIBEDYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Streptomyces lavendulae (STREPTOMYCETACEAE)
SAFRAMYCIN B
596055
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIISCHEMIC EFFECT
Empty organism
PURPUROGALLIN
1081957
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Hedera helix (ARALIACEAE)
HEDERASAPONIN C
68036
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIHYPERTENSIVE ACTIVITY
Allium cepa (LILIACEAE)
882375
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CYTOTOXIC ACTIVITY
Topsentia species (EPIPOLASIDAE)
TOPSENTIN B-2
1020824
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC ME-168
823443
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 662-A
1042865
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTITOXIC ACTIVITY
Polyporus versicolor (POLYPORACEAE)
LACCASE
863632
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Auricularia auricula-judae (AURICULARIACEAE)
1263154
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Allium sativum (LILIACEAE)
SCORDININE A-1
817287
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
CNS STIMULANT ACTIVITY
Empty organism
STRYCHNINE
1034099
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC OA-6129A
81594
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces cosmosus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TMF-518
670665
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CARBONIC ANHYDRASE INHIBITION
Aloe vera (LILIACEAE)
ALOERESIN D
1122755
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Catharanthus roseus (APOCYNACEAE)
VELBANAMINE,ISO: (+):
610228
PATENT DESCRIBED
Empty organism
ARBUTIN
836513
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TM-482-B
329649
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
LYSINE,L:
105310
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Clausena lansium (RUTACEAE)
VALEROLACTAM,EPSILON:
420263
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
AIDS THERAPEUTIC EFFECTS
Empty organism
HYPERICIN,PSEUDO:HYPERICIN,PROTO:HYPERICINFAGOPYRINE
668199
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIPROLIFERATION ACTIVITY
Castela peninsularis (SIMAROUBACEAE)
GLAUCARUBOLONE
818791
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora species (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC M-9026-3
693850
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
666556
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
KUWANOL A
1324726
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Hazunta species (APOCYNACEAE)
997585
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nocardia species (NOCARDIACEAE)
RIFAMYCIN S
960751
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tithonia diversifolia (ASTERACEAE)
TAGITININ C
523854
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Agaricus blazei (AGARICACEAE)
OCTADECA-CIS-9-TRANS-11-DIENOIC ACID,13-HYDROXY:LINOLEIC ACID
614318
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANESTHETIC ACTIVITY(UNSPEC)
Empty organism
TETRODOTOXIN
569997
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Dolabella auricularia (APLYSIIDAE)
DOLASTATIN 10
1036560
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora chalcea (MICROMONOSPORACEAE)
TETROCARCIN F
1004747
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Tremella fuciformis (TREMELLALES)
SANITANIN B
363197
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Fucus vesiculosus (FUCACEAE)
319353
CHEMICAL CONVERSION OFPATENT DESCRIBED
Empty organism
QUINOLINE
610229
PATENT DESCRIBED
Empty organism
LOBELINE
257387
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Diploospora longispora (HYPHOMYCETES)
DIPLOSPORA ANTIBIOTIC WSS-1060DIPLOSPORA ANTIBIOTIC WSS-1061
118599
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Azadirachta indica (MELIACEAE)
MELIA POLYSACCHARIDE N-9-GI
731924
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CHOLESTASE INDUCTION
Cynara scolymus (ASTERACEAE)
NARINGENINLUTEOLINAPIGENIN
417702
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPID PEROXIDE FORMATION INHIBITION
Empty organism
EMODIN
845902
GEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Hypericum erectum (CLUSIACEAE)
WEDELOLACTONE
417662
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Acokanthera spectabilis (APOCYNACEAE)
ACOPIEROSIDE II
329796
PURIFICATION OFPATENT DESCRIBED
Empty organism
ALANINE,BETA:
1021736
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Lentinus edodes (TRICHOLOMATACEAE)
LENTINUS ANTIBIOTIC KS-2-D
848594
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
REBAUDIOSIDE,BETA-GLYCOSYL:
958275
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Scutellaria baicalensis (LAMIACEAE)
BAICALEIN
358182
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITION
Empty organism
BERBERINE
554506
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus paradisi (RUTACEAE)
819092
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Aconitum thunbergii (RANUNCULACEAE)
IGNAVINE
444861
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
METASTASIS INHIBITION
Empty organism
HIRUDIN
1267354
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Viscum album (LORANTHACEAE)
154240
PATENT DESCRIBED
Lycopodium clavatum (LYCOPODIACEAE)
LYCOPODIUM FERREDOXIN
617600
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
VASODILATOR ACTIVITY
Voacanga chalotiana (APOCYNACEAE)
CUANZINE
395568
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces candidus (STREPTOMYCETACEAE)
NAPSAMYCIN CNAPSAMYCIN DNAPSAMYCIN BNAPSAMYCIN A
331925
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces griseoflavus (STREPTOMYCETACEAE)
BICYCLOMYCIN
1029012
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces albus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SY-9
445804
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Empty organism
ROTENONE
1034567
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces diastaticus-amylostaticus (STREPTOMYCETACEAE)
AMYLOSTATIN LAMYLOSTATIN MAMYLOSTATIN KAMYLOSTATIN NAMYLOSTATIN J
955621
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Panax ginseng (ARALIACEAE)
GINSENOSIDE RE
992817
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS 50-100 MGM
Streptomyces platensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-1999
564042
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Houttuynia cordata (SAURURACEAE)
DODECYLALDEHYDE,N:METHYL-NONYL-KETONEDECYLALDEHYDE,N:
843086
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Nocardia species (NOCARDIACEAE)
SPIROCARDIN B
824370
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
NATURAL KILLER CELL ENHANCEMENT
Empty organism
ALANINE,L: L-PYRO-GLUTMYL-L-GLUTAMYL:
1259121
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
NARCOTIC ANTAGONIST ACTIVITY
Hyoscyamus niger (SOLANACEAE)
721263
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ARACHIDONATE-5-LIPOXYGENASE INHIBITION
Empty organism
BOSWELLIC ACID,ACETYL-11-KETO:
353785
SYNTHESIS OF ANALOGSPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
TAXOL
444630
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALDOSE REDUCTASE INHIBITION
Rehmannia glutinosa (SCROPHULARIACEAE)
ETHYL-O-BETA-D-XYLOPRYANOSYL-(1-6)-BETA-D-GLUCOSIDE,2-PHENYL:
1227294
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Empty organism
FLAVONE,ISO: 7-HYDROXY:
678156
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Casearia esculenta (FLACOURTIACEAE)
ESCULENTIN A
490688
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Ancistrocladus korupensis (ANCISTROCLADACEAE)
MICHELLAMINE AMICHELLAMINE B
989323
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOPLASMAL ACTIVITY
Streptomyces violaceus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 1-MET-JA-6844
14482
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
LEUROSINE
445815
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Scirpus fluviatilis (CYPERACEAE)
SCIRPUS FLUVIATILIS TRIMER
675555
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
154219
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces graminofaciens (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FD-891
617620
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Isodon species (LAMIACEAE)
LASIOKAURIN
890639
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Zingiber officinale (ZINGIBERACEAE)
SHOGAOL,6:
156837
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALDOSE REDUCTASE INHIBITION
Chaetomella circinoseta (COELOMYCETES)
CHAETOMELLA ANTIBIOTIC RF-3192-A
257714
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SPA-17-61-BSTREPTOMYCES ANTIBOITIC SPA-17-61-A
332286
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Micrococcus species (MICROCOCCACEAE)
PENICILLIN,PHENOXY-ETHYL:
1270107
IDENTIFICATION OFPATENT DESCRIBED
Larrea tridentata (ZYGOPHYLLACEAE)
GUAIARETIC ACID,NOR-DIHYDRO:
1254687
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTITUSSIVE ACTIVITY
Hedera helix (ARALIACEAE)
8853
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
893950
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
SAIKOSAPONIN C
1275122
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
416070
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aesculus hippocastanum (HIPPOCASTANACEAE)
AESCIN
426794
PRODUCT DEVELOPMENT OF HERBAL EXTRACTPATENT DESCRIBED
Ginkgo biloba (GINKGOACEAE)
325874
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
METHIONINE
90178
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOPLASMAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
ENTEROCIN,5-DEOXY:
483697
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INSECT REPELLENT ACTIVITY
Empty organism
DAMASCONE,ALPHA:
668178
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Empty organism
CHAPARRINONE
950171
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
EXPECTORANT ACTIVITY
Fritillaria ussuriensis (LILIACEAE)
VERTICINE
635620
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Erythrina bidwillii (FABACEAE)
BIDWILLON B
980781
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aristolochia clematitis (ARISTOLOCHIACEAE)
ARISTOLOCHIC ACID IIARISTOLOCHIC ACID I
979263
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Eupatorium sachalinense (ASTERACEAE)
HIYODORILACTONE B
207824
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Streptomyces nobilis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC JCM-4274
378180
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INSECT REPELLENT ACTIVITY
Empty organism
CINNAMALDEHYDE
319875
PURIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBED
Empty organism
ISOPRENE
901982
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
FIGAROIC ACID
84868
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Trichoderma koningii (HYPHOMYCETES)
TRICHODERMA ANTIBIOTIC CAF-0096
327229
PURIFICATION OFPATENT DESCRIBED
Empty organism
ISOPRENE
1192619
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rauvolfia vomitoria (APOCYNACEAE)
RESERPINE
566553
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SUNSCREEN EFFECT
Empty organism
TREHALOSE
536822
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Vanillosmopsis erythropappa (ASTERACEAE)
BISABOLOL,ALPHA:
981981
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
92875
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SS-21020-B
574028
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIMALARIAL ACTIVITY
Ancistrocladus korupensis (ANCISTROCLADACEAE)
KORUPENSAMINE B
1014601
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
STEVIOSIDE
678159
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Casearia esculenta (FLACOURTIACEAE)
ESCULENTIN A
411192
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nicotiana tabacum (SOLANACEAE)
UBIQUINONE 10
1007437
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces ribosideificus (STREPTOMYCETACEAE)
LONOMYCIN
448007
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rehmannia glutinosa (SCROPHULARIACEAE)
AJUGOL,6-O-TRANS-FERULOYL:
1169270
PATENT DESCRIBED
Empty organism
STEVIOSIDE
1287584
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Lepidium meyenii (BRASSICACEAE)
MACAMIDE AMACAMIDE BMACAMIDE CTHIOCYANATE,ISO: BENZYL:
447374
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Picrasma quassioides (SIMAROUBACEAE)
NIGAKINONE
826355
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces rishiriensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC T-23-II
42029
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Marrubium vulgare (LAMIACEAE)
626755
PATENT DESCRIBED
Vaccinium oxycoccos (ERICACEAE)
102653
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Bacillus species (BACILLACEAE)
BACILLUS ANTIBIOTIC KBS-3-P-1003
332450
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Empty organism
QUININE
129362
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces collinus (STREPTOMYCETACEAE)
RESORTHIOMYCIN
84428
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces luridus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-53868-FACTOR A
975777
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SUNSCREEN EFFECT
Rosa multiflora (ROSACEAE)
479820
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPOTHERMIC ACTIVITY
Empty organism
EVODIAMINE
481383
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Phaffia rhodozyma (HYPHOMYCETES)
ECHINENONE
1077496
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Empty organism
GOSSYPOL
683419
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Alpinia officinarum (ZINGIBERACEAE)
GALANGIN
850720
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micropolyspora species (NOCARDIACEAE)
POLYSPORIN,CHLORO:
1289521
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aristolochia taliscana (ARISTOLOCHIACEAE)
GERMACRA-4(15)-5-10(14)-TRIEN-1-BETA-OL,ENT:
1246249
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
SANGUINARINE
909616
PATENT DESCRIBED
Juglans nigra (JUGLANDACEAE)
555364
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Psilocybe cubensis (STROPHARIACEAE)
PSILOCINE
1009139
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC B-41-D
874902
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces cosmosus (STREPTOMYCETACEAE)
COSMOCARCIN B
821611
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces cyaneus (STREPTOMYCETACEAE)
DITRISARUBICIN A
612687
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Papaver bracteatum (PAPAVERACEAE)
THEBAINE
810399
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN HUMANS
BITTER TASTING EFFECT
Stevia rebaudiana (ASTERACEAE)
STEVIA REBAUDIANA COMPOUND A-1
1040760
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Gastrodia elata (ORCHIDACEAE)
BENZYL ALCOHOL,4-HYDROXY:
1183649
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Brucea javanica (SIMAROUBACEAE)
YADANZIOSIDE LYADANZIOSIDE KYADANZIOSIDE I
683223
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
MELAMPODIN A
81880
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTICOCCIDIAL ACTIVITY
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC SF-2324
1015518
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Moncardia species (ACTINOMYCETACEAE)
NOCARDIA ANTIBIOTIC BM-782-ALPHA-1-ANOCARDIA ANTIBIOTIC BM-782-ALPHA-1NOCARDIA ANTIBIOTIC BM-782-ALPHA-2
895606
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Panax ginseng (ARALIACEAE)
SAPONIN III(PANAX GINSENG)SAPONIN IV(PANAX GINSENG)SAPONIN V(PANAX GINSENG)SAPONIN II(PANAX GINSENG)
24030
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIIMPLANTATION EFFECT
Ferula assa-foetida (APIACEAE)
236101
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Streptomyces spectabilis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SNF-4435
330214
STABILITY STUDIES OFPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OF
Empty organism
PROSTAGLANDIN E-3PROSTAGLANDIN E-2
828376
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Olea europaea (OLEACEAE)
ELENOLIDE
155527
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Sarcophaga peregrina (SARCOPHAGIDAE)
SARCOPHAGA POLYPEPTIDE A
952080
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
PHAGOCYTOSIS RATE DECREASED
Polystictus versicolor (HYMENOCHAETACEAE)
993587
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Laburnum anagyroides (FABACEAE)
CYTISINE
869961
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Myxococcus coralloides (MYXOCOCCACEAE)
CORALLOPYRONIN BCORALLOPYRONIN A
724091
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Polygonum multiflorum (POLYGONACEAE)
STILBENE,2-3-4'-5-TETRAHYDROXY: 2-O-BETA-D-GLUCOSIDE
987189
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHEPATOTOXIC ACTIVITY
Symphytum officinale (BORAGINACEAE)
183440
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces carzinostaticus (STREPTOMYCETACEAE)
NEOCARZIRIN C
899606
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cinchona ledgeriana (RUBIACEAE)
QUINIDINE
886023
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUSSIVE ACTIVITY
Luffa aegyptiaca (CUCURBITACEAE)
LUCYOSIDE KLUCYOSIDE ALUCYOSIDE LLUCYOSIDE BLUCYOSIDE GLUCYOSIDE MLUCYOSIDE DLUCYOSIDE JLUCYOSIDE FLUCYOSIDE CLUCYOSIDE HLUCYOSIDE E
763432
IDENTIFICATION IN BY HPLCQUANTITATIVE DATAPATENT DESCRIBED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
555162
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
SKIN DEPIGMENTATION EFFECT
Glycyrrhiza glabra (FABACEAE)
GLABRIDIN
448797
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MH-850-B
853300
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Camellia sinensis (THEACEAE)
GALLOCATECHIN,EPI: (-):
1005565
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bacillus species (BACILLACEAE)
NOJIRIMYCIN,1-DEOXY:
1030152
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces lavendulae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FR-900201
996049
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Chaetomium aureum (CHAETOMIACEAE)
CHAETOMIUM AUREUM PROLINE HYDROYLASE INHIBITOR M-96
487066
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
RESORTHIOMYCIN
333676
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
ANTIMYCIN A
886590
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cassia occidentalis (FABACEAE)
GERMICHRYSONE
327508
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
PELARGONIC ACIDAZELAIC ACID
570735
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Osbeckia chinensis (MELASTOMATACEAE)
OSBECKIC ACID
960784
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Trididemnum solidum (DIDEMNIDAE)
DIDEMNIN YDIDEMNIN X
446851
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
TETRANDRINE,(+):
14472
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
LEUROSINE
562244
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIPRURITIC ACTIVITY
Artemisia capillaris (ASTERACEAE)
637434
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aralia elata (ARALIACEAE)
OLEANOLIC ACID-3-O-ALPHA-L-ARABINOPYRANOSYL(1-2)-ALPHA-L-RHAMNOPYRANOSYL(1-3)-O-BETA-D-GLUCOPYRANOSYL-28-O-BETA-D-GLUCOPYRANOSYL-28-O-BETA-GLUCOPYRANOSYL(1-6)-GLUCOPYRANOSYL:HEDERAGENIN-3-O-ALPHA-L-ARABINOPYRANOSYL(1-2)-ALPHA-L-RHAMNOPYRANOSYL-28-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL(1-4)-ALPHA-L-RHAMNOPYRANOSYL:
856802
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
LIVER EFFECTS(UNSPECIFIED)
Polygonum orientale (POLYGONACEAE)
329831
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
ROSE OXIDE KETONE
493888
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Schizonepeta tenuifolia (LAMIACEAE)
ROSMARINIC ACID MONOMETHYL ESTER
848671
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Penicillium brevi-compactum (HYPHOMYCETES)
MYCOPHENOLIC ACID
826386
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nicotiana rustica (SOLANACEAE)
OXYDOL ISOMER 1
826354
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces rishiriensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC T-23-II
983655
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIBACTERIAL ACTIVITY
Empty organism
SQUALENE
960755
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALDEHYDE REDUCTASE I INHIBITION
Cryptomeria japonica (TAXODIACEAE)
ROYLEANONE,12-DEHYDROXY-7-HYDROXY:
52520
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Larrea tridentata (ZYGOPHYLLACEAE)
GUAIARETIC ACID,NOR-DIHYDRO:
319137
GEL PERMEATION CHROMATOGRAPHY USEDPURIFICATION OFPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
ASPARAGINASE,L:
1005486
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Clausena pentaphylla (RUTACEAE)
CLAUSMARIN B
1027701
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces cirratus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 248-SQ-B
84941
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 165-3
619188
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTPATENT DESCRIBED
Trigonella foenum-graecum (FABACEAE)
DIOSGENIN
417179
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
REDUCTASE,5-ALPHA: INHIBITION
Empty organism
PINOCEMBRIN
923942
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Achillea millefolium (ASTERACEAE)
ACHIMILIC ACID A LACTONE
1183648
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Brucea javanica (SIMAROUBACEAE)
YADANZIOSIDE LYADANZIOSIDE KYADANZIOSIDE I
930345
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Levisticum officinale (APIACEAE)
FERULIC ACID
1030151
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces lavendulae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FR-900201
964968
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Orthosiphon grandiflorus (LAMIACEAE)
569528
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIACNE ACTIVITY
Empty organism
LINOLEIC ACID
1168122
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
GINSENOSIDE RB-1
607419
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TYROSINASE INHIBITION
Pseudostellaria heterophylla (CARYOPHYLLACEAE)
PSEUDOSTELLARIN APSEUDOSTELLARIN BPSEUDOSTELLARIN EPSEUDOSTELLARIN FPSEUDOSTELLARIN DPSEUDOSTELLARIN C
126845
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MH-563-32-F-1
5881
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Streptomyces diastatochromogenes (STREPTOMYCETACEAE)
IKUTAMYCIN
1090885
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIULCER ACTIVITY
Empty organism
ALOCTIN B
534231
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPTOLIDE,15-HYDROXY:
693191
PATENT DESCRIBED
Empty organism
HINOKITIOL
72308
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC K-51-A
607515
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Santalum album (SANTALACEAE)
994610
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTPATENT DESCRIBED
Kallstroemia pubescens (ZYGOPHYLLACEAE)
DIOSGENIN
325603
CHEMICAL CONVERSION OFPATENT DESCRIBED
Empty organism
PROSCILLARIDIN A
1173364
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Eisenia bicyclis (ALARIACEAE)
EISENIN
194494
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Alteromonas species (TO BE DETERMINED)
ALTERAMIDE
333144
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Polyangium cellulosum (POLYANGIACEAE)
POLYANGIUM ANTIBIOTIC FPOLYANGIUM ANTIBIOTIC S
852421
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Pancratium littorale (AMARYLLIDACEAE)
PANCRATISTATIN
959208
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Vinca minor (APOCYNACEAE)
VINCARUBINE
1274078
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Camptotheca acuminata (NYSSACEAE)
CAMPTOTHECINCAMPTOTHECIN,10-HYDROXY:
1034831
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomyces species (ACTINOMYCETACEAE)
ACTINOMYCES ANTIBIOTIC BBM-928-D
856045
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMICROBIAL ACTIVITY(UNSPECIFIED)
Streptomyces comosus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TMF-518
274562
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Raspailia species (RASPAILIIDAE)
ASMARINE B
138644
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CELL DIFFERENTIATION INHIBITION
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC RK-441-S
533256
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIOXIDANT ACTIVITY
Schisandra chinensis (SCHISANDRACEAE)
GOMISIN N
1012233
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinoplanes species (ACTINOPLANACEAE)
PLANOTHIOCIN A
565108
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Pinellia tripartita (ARACEAE)
46096
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Arbutus unedo (ERICACEAE)
13223
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
ANTIAMEBIC ACTIVITY
Simarouba glauca (SIMAROUBACEAE)
GLAUCARUBIN
1231768
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Aspergillus giganteus (HYPHOMYCETES)
ASPERGILLIS POLYPEPTIDE ANTIBIOTIC
592025
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
AIDS THERAPEUTIC EFFECTS
Agathophyllum aromaticum (LAURACEAE)
568737
TRADITIONAL MEDICINEPHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
SKIN DEPIGMENTATION EFFECT
Calendula officinalis (ASTERACEAE)
952188
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Agaricus blazei (AGARICACEAE)
ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-6-BETA-TRIHYDROXY:
561443
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sophora exigua (FABACEAE)
SOPHORAFLAVANONE G
574591
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ircinia species (SPONGILLIDAE)
SULFIRICIN
965009
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIPSORIATIC ACTIVITY
Matricaria chamomilla (ASTERACEAE)
875915
PATENT DESCRIBED
Ipomoea muricata (CONVOLVULACEAE)
IPOMOEA GLYCOSIDE
823830
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Chlorella vulgaris (CHLORELLACEAE)
183230
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-1415-B-1
741567
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ilex kudincha (AQUIFOLIACEAE)
ILEKUDINOL A
154435
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Arthrinium species (HYPHOMYCETES)
ARTHRINIM ANTIBIOTIC BU-4641-V
994565
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Strychnos nux-vomica (LOGANIACEAE)
BRUCINESTRYCHNINE
980889
PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rauvolfia serpentina (APOCYNACEAE)
PERAKINE
989331
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Unidentified fungus (UNDETERMINED)
996488
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS LESS THAN 50 MGM
Streptomyces herbaceus (STREPTOMYCETACEAE)
ADENINE,9-BETA-D-ARABINOFURANOSYL:
98899
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIDIARRHEAL ACTIVITY
Streptomyces noboritoensis amamiensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC WS-1627-A
789037
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MULTIDRUG RESISTANCE INHIBITION
Erythroxylum pervillei (ERYTHROXYLACEAE)
PERVILLEINE DPERVILLEINE A N-OXIDEPERVILLEINE CPERVILLEINE APERVILLEINE FPERVILLEINE E
352242
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
BONE RESORPTION INHIBITION
Glycine max (FABACEAE)
FLAVONE,ISO: 4'-5-6-TRIHYDROXY: 7-O-BETA-D--PYRANOSIDE
1323451
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANALGESIC ACTIVITY
Embelia ribes (MYRSINACEAE)
EMBELIN DIISOBUTYLAMINE
332140
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS LESS THAN 50 MGM
CATECHOL-O-METHYL TRANSFERASE INHIBITION
Corynespora cassiicola (HYPHOMYCETES)
NAPHTHOQUINONE,1-4: 2-3-5-TRIHYDROXY-7-METHOXY:NAHTHOQUINONE,1-4: 2-3-5-TRIHYDROXY-7-METHOXY-6-(3-HYDROXY-BUTANE):
330188
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESYIELD IS MORE THAN 100 MGMWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Digitalis lanata (SCROPHULARIACEAE)
LANATOSIDE ALANATOSIDE CLANATOSIDE B
1183653
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Saussurea lappa (ASTERACEAE)
COSTUNOLIDE
1006830
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Bacteroides fragilis-vulgatus (BACTEROIDACEAE)
BACTEROIDES FRAGILIS-VULGATUS CELL WALL ANTIBIOTIC
817964
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Myrothecium roridum (HYPHOMYCETES)
RORIDIN L-2
362526
PATENT DESCRIBED
Empty organism
FERULIC ACIDRUTIN,ALPHA-GLUCOSYL:
1006778
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinoplanes species (ACTINOPLANACEAE)
RAMOPLANIN
978407
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Paeonia moutan (PAEONIACEAE)
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
713306
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTITUMOR ACTIVITY
Empty organism
TRIPTOLIDE
324065
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Streptomyces albogriseolus (STREPTOMYCETACEAE)
VINDOLINE
882460
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIFUNGAL ACTIVITY
Laurus nobilis (LAURACEAE)
982048
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Catharanthus roseus (APOCYNACEAE)
VINCALEUKOBLASTINE
319814
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
PROPIONIC ACID
1034046
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces oganonensis (STREPTOMYCETACEAE)
ANTHRAIMINE BANTHRAIMINE A
93581
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYSTEINE PROTEASE INHIBITION
Staphylococcus tanabeensis (MICROCOCCACEAE)
STACOPIN P-1
69308
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Hamamelis virginiana (HAMAMELIDACEAE)
409534
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Claviceps purpurea (CLAVICIPITACEAE)
ERGOCRYPTINE,BETA:
894163
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces avermitilis (STREPTOMYCETACEAE)
AVERMECTIN A-2,25-CYCLOPENTYL:
568636
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Empty organism
KOJIC ACID
893944
PATENT DESCRIBED
Empty organism
PHLORIZIN
975667
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glaucium flavum (PAPAVERACEAE)
GLAUCINE
978382
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Mansonia altissima (STERCULIACEAE)
MANSONIN
935336
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC Q-1043-B-1
1243399
PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
INSECTICIDE ACTIVITY
Sesamum indicum (PEDALIACEAE)
SESAMIN,(+):
231113
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Ascochyta species (COELOMYCETES)
ASCOCHYTA ANTIBIOTIC FE-399-P-2ASCOCHYTA ANTIBIOTIC FE-399-P-3ASCOCHYTA ANTIBIOTIC FE-399-P-1
327980
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
HYPOCHOLESTEROLEMIC ACTIVITY
Empty organism
CINNAMIC ACID ANALOGS*
742328
PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eleutherococcus senticosus (ARALIACEAE)
QUINIC ACID,1-4-DI-O-CAFFEOYL-D-(+):CHLOROGENIC ACID
981764
UV SPECTRUM GIVEN FORWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Dioscoreophyllum cumminsii (MENISPERMACEAE)
MIRACULIN
875986
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Allium sativum (LILIACEAE)
AJOENE,TRANS:
918645
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIISCHEMIC EFFECT
Salvia miltiorrhiza (LAMIACEAE)
TANSHINONE V
327335
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Cnicus benedictus (ASTERACEAE)
1032113
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
ARICINE
649369
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Empty organism
MORUSIN-4'-O-BETA-D-GLUCOSIDEKUWANON HMORUSIN
1005056
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-1902-A-3
565780
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIEDEMA ACTIVITY
Fucus vesiculosus (FUCACEAE)
75555
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Actinomadura verrucosospora (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC BBM-1675-A-1
32474
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OFANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Camptotheca acuminata (NYSSACEAE)
CAMPTOTHECIN
883099
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Empty organism
STREPTOVARICIN C
569607
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Agaricus species (AGARICACEAE)
978413
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PROTEIN KINASE C AGONIZING EFFECT
Empty organism
CERCOSPORIN
970651
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WOUND HEALING ACCELERATION
Aloe vera (LILIACEAE)
1011486
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Corynebacterium species (CORYNEFORM ACTINOMYCETE)
CORYNEBACTERIUM ANTIBIOTIC DC-5-4
1048909
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MA-144-M
319213
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
VINCANORINE
1040754
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
CHOLAGOGUE ACTIVITY
Orchis militaris (ORCHIDACEAE)
BENZYL ALCOHOL 4-O-BETA-D-GLUCOSIDE
607484
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Eutrema wasabi (BRASSICACEAE)
626537
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
894018
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Crossopteryx febrifuga (RUBIACEAE)
CHOLESTEROL
68185
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COMMON COLD RELIEF
Empty organism
PYROGLUTAMIC ACID
75408
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Agrocybe aegerita (BOLBITIACEAE)
AGROCYBE ANTIBIOTIC
666562
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
KUWANOL A
126175
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces matensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC PI-083
326307
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
PROPIONIC ACID
362009
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Desmia hornemannii (RHIZOPHYLLIDACEAE)
CYCLOHEXA-2-5-DIEN-1-ONE,4-4-DIMETHYL-2-(1-CHLORO-2-HYDROXY-ETHYL):
956138
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HAIR STIMULANT EFFECT
Empty organism
PHYTIC ACID
1015201
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CARCINOGENESIS INHIBITION
Streptococcus pyogenes (STREPTOCOCCACEAE)
STREPTOCOCCUS PYOGENES CELL SUBSTANCE N-5-1
332291
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
MARIDOMYCIN I
84864
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Azadirachta indica (MELIACEAE)
AZADIRACHTA INDICA POLYSACCHARIDE N-9-G-I
817976
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptococcus species (STREPTOCOCCACEAE)
STREPTOCOCCUS ANTIBIOTIC TD-01
672823
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Euphorbia hirta (EUPHORBIACEAE)
1215879
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Panax ginseng (ARALIACEAE)
PANAXACOL
1009144
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC AF-8
1039158
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INOTROPIC EFFECT POSITIVE
Plectranthus forskholii (LAMIACEAE)
COLEFORSIN
487416
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALDOSE REDUCTASE INHIBITION
Morus lhou (MORACEAE)
KUWANON C
1008439
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
WOUND HEALING ACCELERATION
Empty organism
ALLANTOIN
321153
PURIFICATION OFPATENT DESCRIBED
Empty organism
DOPA,L:
322696
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHEMORRHOIDAL ACTIVITY
Hamamelis species (HAMAMELIDACEAE)
332298
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces albus (STREPTOMYCETACEAE)
YEMENIMYCIN
353732
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Vitis vinifera (VITACEAE)
VITIS PROANTHOCYANDINS
476649
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
NERVE GROWTH FACTOR STIMULATION
Nicotiana tabacum (SOLANACEAE)
AESCULETINCHLOROGENIC ACIDHYDROQUINONE,2-ISO-PROPYL:BENZENE,1-2-4-TRIHYDROXY:
998059
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tyromyces species (POLYPORACEAE)
TYROMYCES SPECIES ANTIBIOTIC
605463
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIOXIDANT ACTIVITY
Sesamum indicum (PEDALIACEAE)
PINORESINOL GLYCOSIDE
50814
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Prosopis africana (FABACEAE)
PROSOPININE
610249
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Scutellaria baicalensis (LAMIACEAE)
BAICALEINBAICALIN
218982
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Scleroderma texense (SCLERODERMATACEAE)
TEXENOMYCIN A
1000828
PATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Micromonospora species (MICROMONOSPORACEAE)
KANAMYCIN B,3''-N-METHYL-4''-C-METHYL-3'-4'-DIDEOXY-6'-N-METHYL:
818624
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora echinospora (MICROMONOSPORACEAE)
HAZIMYCIN FACTOR 5HAZIMYCIN FACTOR 5,ISO:
693711
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIMUTAGENIC ACTIVITY
Empty organism
FLAVONE,4'-BROMO:
626532
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
INTERLEUKIN-II INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
319582
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
CEPHALEXIN*
228111
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Rozites caperata (CORTINARIACEAE)
530342
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Allium sativum (LILIACEAE)
ALLIIN
1021554
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
DOXORUBICIN-CIS-PLATINUM COMPLEX
447536
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SMOKING DETERRENT
Empty organism
NICOTINE
37463
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ESTROGENIC EFFECT
Butea monosperma (FABACEAE)
MIROESTROL
982855
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
329554
PHARMACOLOGY OF COMPOUND - IN VIVOCHEMICAL CONVERSION OFISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Atractylis gummifera (ASTERACEAE)
ATRACTYLOSIDE,CARBOXY:
978220
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Plakortis species (PLAKINIDAE)
PLAKORIN
490248
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Annona bullata (ANNONACEAE)
ROLLINIASTATIN 2
659771
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
BETULINIC ACID
1030321
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
DOXORUBICIN,5-IMINO:
24178
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Grifola frondosa (POLYPORACEAE)
851598
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Aconitum carmichaelii (RANUNCULACEAE)
ACONITAN A
1008931
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomyces roseochromogenes (ACTINOMYCETACEAE)
BENZODIAZEPIN-2-ONE,1-4: 3-HYDROXY-7-BROMO-5-(ORTHO-CHLORO)-PHENYL-1-2-DIHYDRO-3-(H):
187965
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Stellera chamaejasme (THYMELAEACEAE)
STELLARAMACRIN B
737371
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANALGESIC ACTIVITY
Maytenus ilicifolia (CELASTRACEAE)
QUERCITRIN,ISO:
76120
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces ambofaciens (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC PTL-448-B
533076
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIOXIDANT ACTIVITY
Chrysosporium pannorum (HYPHOMYCETES)
CHRYSOSPORIN
329064
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus cereus (BACILLACEAE)
BACILLUS ANTIBIOTIC 60-6
476703
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
HESPERIDIN,NEO: DIHYDROCHALCONE
109776
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC CI-010
987028
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aesculus hippocastanum (HIPPOCASTANACEAE)
AESCIN
67636
PATENT DESCRIBED
Empty organism
HYPERICIN
993026
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
MANILOSPORIN B-1
848753
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS
SPORE GERMINATION INHIBITOR
Empty organism
CINNAMALDEHYDE
1267005
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTITUMOR ACTIVITY
Kalopanax ricinifolius (ARALIACEAE)
1225
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
Cassia senna (FABACEAE)
SENNOSIDES A + B
143088
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Chlorella species (CHLORELLACEAE)
CHLORELLA GLYCOPROTEIN CVS-U
972905
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Ribes nigrum (SAXIFRAGACEAE)
959194
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rhus semialata (ANACARDIACEAE)
SALICYLIC ACID,6-HEPTADECA-8-11-DIENYL:
618454
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
BENZALDEHYDE
230787
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC BE-56384
978391
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
AIDS THERAPEUTIC EFFECTS
Empty organism
ALLICIN
1020963
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces endus aureus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DO-59-III
438165
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-80789
327353
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cnicus benedictus (ASTERACEAE)
81794
GEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Bacillus natto (BACILLACEAE)
BACILLUS ANTIBIOTIC AUS-1
1049863
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
MUCOPEPTIN B
841761
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces sioyaensis (STREPTOMYCETACEAE)
TRICHOSTATIN A
321247
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PREPARATION OF DERIVATIVES OF
Empty organism
PENICILLIN
970122
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPID PEROXIDE FORMATION INHIBITION
Empty organism
MORINPHELLAMURINBIOCHANIN AKAEMPFEROLRHOIFOLINWOGONINHESPERETINHESPERIDIN,NEO:CHRYSIN
321580
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Securidaca longepedunculata (POLYGALACEAE)
OLEAN-12-ENE-23-28-DIOIC ACID,2-BETA-3-BETA-27-TRIHYDROXY:
385978
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIWRINKLING ACTIVITY
Empty organism
NAHOCOL D,ISO:NAHOCOL A
996609
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Micromonospora peucetica (MICROMONOSPORACEAE)
DAUNOMYCIN,11-DEOXY:DAUNOMYCIN,11-DEOXY-DIHYDRO:DAUNOMYCIN,2-DEACETYL-11-DEOXY: 2-ETHYL:ADRIAMYCIN,11-DEOXY: 4-METHYL ETHER
948451
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
ASPARAGUSIC ACID
83168
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces griseoruber (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 859-A
610742
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cryptolepis sanguinolenta (ASCLEPIADACEAE)
QUINDOLINE
1029014
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AM-5344-A-2
657364
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIYEAST ACTIVITY
Spirastrella spinispirulifera (SPIRASTRELLIDAE)
SPONGIASTATIN 7
610037
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Rubia cordifolia (RUBIACEAE)
MOLLUGIN
318600
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
ARACHIDONIC ACIDLINOLENIC ACID,GAMMA:
13827
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
VERRUCARIN E
882458
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIFUNGAL ACTIVITY
Rosmarinus officinalis (LAMIACEAE)
662698
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Swartzia madagascariensis (FABACEAE)
SWARTZIADIONE
521284
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS
ETHYLENE BIOSYNTHESIS INHIBITION
Empty organism
THIOCYANATE,ISO: ALLYL:
323246
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Calvatia craniformis (LYCOPERDACEAE)
CALVATIC ACID
984471
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Empty organism
SITOSTEROL,BETA: FERULATE
1300787
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CELL CYCLE CYTOTOXICITY(G1 PHASE)
Cimicifuga racemosa (RANUNCULACEAE)
994573
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces griseorubiginosus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC S-551-I
686437
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Empty organism
GARCINOLGARCINOL,ISO:
76432
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
MISCELLANEOUS EFFECTS
Aspergillus alliaceus (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC I
1057975
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Saccharopolyspora hirsuta (SCHIZOMYCETACEAE)
SACCHAROPOLYSPORA ANTIBIOTIC KA-5685
483259
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Empty organism
ENMEIN
590948
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GALACTOCEREBROSIDE
332272
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Streptomyces shimizuensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC K-6-6-A
446387
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxus cuspidata (TAXACEAE)
TAXOL
1265141
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ipomoea petaloidea (CONVOLVULACEAE)
LYSERGOL
982315
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
RUTAECARPINE
670786
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
TETRACYCLINE,CHLOR:
200826
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Agaricus bisporus (AGARICACEAE)
AGARICUS GLYCOPROTEIN
490493
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
REDUCTASE,5-ALPHA: INHIBITION
Dalbergia latifolia (FABACEAE)
DALBERGIONE,4-METHOXY:
75527
PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptosporangium pseudovulgare (STREPTOSPORANGIACEAE)
STREPTOSPORANGIUM ANTIBIOTIC KUD-PC
1051585
IDENTIFICATION IN BY GLC AFTER SAPONIFICATIONPATENT DESCRIBED
Limnanthes alba (LIMNANTHACEAE)
DOCOSADIENOIC ACIDARACHIDIC ACIDDOCOSENOIC ACIDEICOSENOIC ACIDOLEIC ACID
870143
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
FOOD USE
Luffa aegyptiaca (CUCURBITACEAE)
353484
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Empty organism
NONAN-1-OL,3-7-DIMETHYL-9-(2-2-6-TRIMETHYL-1-YL-CYCLOHEXANE):
1164953
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Empty organism
IGNAVINE
924234
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RNA SYNTHESIS INHIBITION
Hormothamnion enteromorphoides (MICROCHAETACEAE)
HORMOTHAMNION
444450
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-4(30)-8-CIS-24-TRIENE-3-26-DIOIC ACID,3-4-SECO:
834618
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Magnolia denudata (MAGNOLIACEAE)
NEOLIGNAN(MAGNOLIA DENUDATA)
742077
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Costus speciosus (ZINGIBERACEAE)
GRACILLINDIOSCIN PROSAPOGENIN APROTOGRACILLINDIOSCIN
566574
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Asparagus officinalis (LILIACEAE)
136086
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Penicillium species (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC FO-608-A
883593
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTISTRESS ACTIVITY
Cistanche salsa (OROBANCHACEAE)
CISTANOSIDE H
94009
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Streptosporangium species (STREPTOSPORANGIACEAE)
STREPTOSPORANGIUM ANTIBIOTIC SF-2381-B
1063698
SYNTHESIS OF ANALOGSPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORPREPARATION OF DERIVATIVES OFANTIFERTILITY
ABORTIFACIENT EFFECT
Montanoa tomentosa (ASTERACEAE)
MONTANOL
1010267
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
KANAMYCIN B
352454
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Pseudomonas species (PSEUDOMONADACEAE)
ACATERIN
626760
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
ANTIAGGLUTININ ACTIVITY
Vaccinium macrocarpon (ERICACEAE)
426240
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
EFOMYCIN G
398803
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Mortierella exigua (MORTIERELLACEAE)
LINOLENIC ACID
558947
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Engelhardtia chrysolepis (JUGLANDACEAE)
ASTILBINASTILBIN,ISO: NEO:ASTILBIN,NEO:ASTILBIN,ISO:
183424
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Scolecobasidium arenarium (HYPHOMYCETES)
SCOLECOBASIDIUM ANTIBIOTIC WF-2015-A
704348
SYNTHESIS OF ANALOGSCHEMICAL DEGRADATION OFPATENT DESCRIBED
Empty organism
SITOSTANOL ESTERS
1015650
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Staphylococcus epidermidis (MICROCOCCACEAE)
STAPHYLOCOCCUS EPIDERMIDIS ANTIBIOTIC
972858
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Artemisia annua (ASTERACEAE)
ARTEMISININ
490012
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Senecio ambavilla (ASTERACEAE)
SENECIO LACTONE I
1035180
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Empty organism
APLASMOMYCIN CAPLASMOMYCINAPLASMOMYCIN B
1034835
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomyces species (ACTINOMYCETACEAE)
ACTINOMYCES ANTIBIOTIC BBM-928-F
129929
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES BENZANTHARACENE ANTIBIOTIC
854671
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIBACTERIAL ACTIVITY
Empty organism
OCTACOSAN-1-OL
683229
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
PARTHENOLIDE,11-13-DIHYDRO: 1(1A)-EPOXY:SANTONINPARTHENOLIDE,11-13-DIHYDRO:
526945
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eucommia ulmoides (EUCOMMIACEAE)
PINORESINOL DIGLUCOSIDEELEUTHEROSIDE D
238139
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIFUNGAL ACTIVITY
Phomopsis species (COELOMYCETES)
PHOMOPSIS ANTIBIOTIC TUF-95-F-47
976251
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Phryma leptostachya (PHRYMACEAE)
PHRYMAROLIN
665046
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Abrus precatorius (FABACEAE)
ABRUSOSIDE D
332492
PHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Arnebia euchroma (BORAGINACEAE)
SHIKONIN,DEHYDROXY:
1049868
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bacillus cereus (BACILLACEAE)
TUNICAMYCIN H
975753
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ELASTASE INHIBITION
Streptomyces viridochromogenes (STREPTOMYCETACEAE)
POSTOSTATIN
564029
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ATP-ASE(H+/K+) INHIBITION
Angelica keiskei (APIACEAE)
XANTHOANGELOL E
561448
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPOXYGENASE,5: INHIBITION
Glycyrrhiza species (FABACEAE)
GANCAONIN S
1007904
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Micromonospora olivoasterospora (MICROMONOSPORACEAE)
FORTIMICIN AL
1249252
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTITRICHOMONAL ACTIVITY
Hedera helix (ARALIACEAE)
478027
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIDEMENTIA ACTIVITY
Empty organism
DOCOSATETRANOIC ACID, 13-14-EPOXY-10-HYDROXY:DOCOSATETRAENOIC ACID,10-13-14-TRIHYDROXY:DOCOSATETRAENOIC ACID,13-14-EPOXY-12-HYDROXY:
523521
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Corynebacterium species (CORYNEFORM ACTINOMYCETE)
CANTHAXANTHIN
325896
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
MALONIC ACID
418031
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Swietenia mahagoni (MELIACEAE)
SWIETENOLIDE DIACETATE
536825
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
REDUCTASE,5-ALPHA: INHIBITION
Paullinia cupana (SAPINDACEAE)
693845
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
965235
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tephrosia species (FABACEAE)
PONGAMOL
1234075
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
CNS EFFECTS(GENERAL)
Carthamus tinctorius (ASTERACEAE)
395551
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN IMPROVEMENT EFFECT
Morus alba (MORACEAE)
126843
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MH-563-32-F-1
659721
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULONIC ACID
671669
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
GOUGEROTIN
1038362
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Corynebacterium equi (CORYNEFORM ACTINOMYCETE)
607295
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Tripterygium wilfordii (CELASTRACEAE)
TRIPCHLOROLIDE
401110
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TOPOISOMERASE II INHIBITION
Apiosordaria effusa (LASIOSPHAERIACEAE)
APIODIONEN
672523
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIMALARIAL ACTIVITY
Empty organism
FEBRIFUGINE
917142
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
VASOCONSTRICTION INHIBITION ACTIVITY
Lumbricus rubellus (LUMBRICIDAE)
FURAN-3-SULFONIC ACID,2-ETHYL-5-HEXYL:
1113578
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
PSORIASIS TREATMENT
Agrimonia eupatoria (ROSACEAE)
854013
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
FLAVORING EFFECT
Empty organism
BLUMENOL C
68286
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIECZEMA EFFECT
Cnidium monnieri (APIACEAE)
125879
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
MEMORY RETENTION IMPROVEMENT
Acanthaster planci (ACANTHASTERIDAE)
ACANTHASTER SPHINGOGLYCOLIPID
42249
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN SITUANTIFERTILITYISOLATION AND IDENTIFICATION OF
UTERINE STIMULANT EFFECT
Montanoa tomentosa (ASTERACEAE)
ZOAPATANOL
332246
PHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Streptomyces rosa (STREPTOMYCETACEAE)
NANAOMYCIN A
860414
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rhodiola rosea (CRASSULACEAE)
ROSAVIN
383987
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIAGING ACTIVITY
Coffea arabica (RUBIACEAE)
994447
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
FRAGROLIDE
742074
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Solanum lyratum (SOLANACEAE)
SOLAMARGINE
659767
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
BETULINIC ACID
327328
HPLC DATA REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
LEUROCRISTINEVINCALEUKOBLASTINE
102129
X-RAY CHRYSTALLOGRAPHIC STUDIESISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Thermomonospora species (THERMOMONOSPORACEAE)
THERMOMONOSPORA ANTIBIOTIC A-1-R-2397
970733
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
SESAMOL
686543
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus jujuba (RHAMNACEAE)
BETULINIC ACID
13835
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Myrothecium roridum (HYPHOMYCETES)
VERRUCARIN CRORIDIN ATRICHODERMOLVERRUCARIN EVERRUCARIN BVERRUCARIN D
790007
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
ACEVALTRATE
553002
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Poncirus trifoliata (RUTACEAE)
778466
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
Phellodendron amurense (RUTACEAE)
355842
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Ginkgo biloba (GINKGOACEAE)
380216
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Empty organism
RADICICOL
185088
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptosporangium carneum (STREPTOSPORANGIACEAE)
STREPTOMYCES ANTIBIOTIC A-84575-FACTOR DSTREPTOMYCES ANTIBIOTIC A-84575-FACTOR FSTREPTOMYCES ANTIBIOTIC A-84575-FACTOR HSTREPTOMYCES ANTIBIOTIC A-84575-FACTOR ESTREPTOMYCES ANTIBIOTIC A-84575-FACTOR BSTREPTOMYCES ANTIBIOTIC A-84575-FACTOR CSTREPTOMYCES ANTIBIOTIC A-84575-FACTOR ASTREPTOMYCES ANTIBIOTIC A-84575-FACTOR G
1007591
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
PRODIGIOSIN
327285
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
HESPERIDIN,NEO: DIHYDROCHALCONE
3151
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Acorus calamus (ARACEAE)
752261
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIPROLIFERATION ACTIVITY
Empty organism
RESVERATROL
601494
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Salsola collina (CHENOPODIACEAE)
GLYCINE-BETAINE
997407
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIBACTERIAL ACTIVITY
Empty organism
CORIOLIN B,5-OXO: 8-DEOXY: 8-C-BETA-METHYL:
979207
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
INTERFERON INDUCTION STIMULATION
Lentinus edodes (TRICHOLOMATACEAE)
LENTINUS EDODES ANTIBIOTIC KS-2-A
671623
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
URSOLIC ACID
617445
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
MAYTANSINE
782889
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Aplysia punctata (APLYSIIDAE)
615359
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
TOCOPHEROL,ALPHA:
1171966
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Trididemnum species (DIDEMNIDAE)
DIDEMNIN A
192975
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Amycolatopsis species (ACTINOMYCETACEAE)
AMYCOLATOPSIS ANTIBIOTIC MI-481-42-F-4-A
861007
MOULTING HORMONE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Serratula inermis (ASTERACEAE)
ECDYSONE,ALPHA:ECDYSONE,BETA:
76417
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptosporangium species (STREPTOSPORANGIACEAE)
STREPTOSPORANGIUM ANTIBIOTIC DC-87-B
327339
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cnicus benedictus (ASTERACEAE)
986957
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CEPHALOTAXYL,METHYL: FUMARATE
670667
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RADICAL SCAVENGING EFFECT
Aloe vera (LILIACEAE)
ALOERESIN D
155688
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Phoma species (COELOMYCETES)
PHOMA ANTIBIOTIC PF-1052
963003
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANALGESIC ACTIVITY
Trigonella foenum-graecum (FABACEAE)
738655
PATENT DESCRIBEDHOMEOPATHIC STUDIES
Empty organism
325127
PURIFICATION OFPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)SOLUBILITY STUDIES OF
Empty organism
CEPHALEXIN*
983349
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Echinacea purpurea (ASTERACEAE)
1008441
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Empty organism
FORPHENICINOL
587505
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TOPOISOMERASE I INHIBITION
Empty organism
CHEBULAGIC ACID
1014635
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
PYRIDINE-3-CARBOXALDEHYDE
823248
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Flammulina velutipes (TRICHOLOMATACEAE)
FLAMMULINA GLYCOPROTEIN PRF
1007672
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces tenebrarius (STREPTOMYCETACEAE)
NEBRAMYCIN II
194429
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC G-234-G
329643
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACEUTICAL FORMULATION OFPREPARATION OF DERIVATIVES OF
Empty organism
GENTAMICIN
336276
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF AN ABERRANT PRINCIPLE
Streptomyces fradiae (STREPTOMYCETACEAE)
HYBRIMYCIN B-2HYBRIMYCIN A-1HYBRIMYCIN A-2HYBRIMYCIN B-1
722192
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ALPHA-GLUCOSIDASE INHIBITION
Eucalyptus globulus (MYRTACEAE)
1035655
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Lactobacillus jugurti (LACTOBACILLACEAE)
LACTOBACILLUS JUGURTI ANTITUMOR POLYSACCHARIDE MPS-80
526084
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIATOPIC DERMATITIS ACTIVITY
Scutellaria baicalensis (LAMIACEAE)
1011764
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC MSD-803-IASPERGILLUS ANTIBIOTIC MSD-803-I FREE ACID
126496
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC YL-01896-P
836506
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN BACLACINOMYCIN A
1234074
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
CNS EFFECTS(GENERAL)
Phellodendron amurense (RUTACEAE)
1035543
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
REPELLENT ACTIVITY(ANIMAL)
Empty organism
CINNAMYL ALCOHOLCINNAMALDEHYDELEAF ALDEHYDEHEX-CIS-3-EN-1-OLKETONE,METHYL-NONYL:PHENYL-KETONE,METHYL:
998095
YIELD IS MORE THAN 100 MGMWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
REBAUDIOSIDE A
893099
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania tetrandra (MENISPERMACEAE)
FANGCHINOLIUM HYDROXIDE,1-3-4-TRIDEHYDRO:
447607
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Mirabilis jalapa (NYCTAGINACEAE)
MIRABALIS ANTIVIRAL PROTEIN
1092807
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
BITTER TASTING EFFECT
Aloe species (LILIACEAE)
84963
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 81-484
818467
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
INTERFERON INDUCTION STIMULATION
Chlorella pyrenoidosa (CHLORELLACEAE)
810116
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Jacaranda caucana (BIGNONIACEAE)
319490
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
IONONE,BETA:
870735
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aloe arborescens (LILIACEAE)
ALOCTIN A
964324
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
AVELLANIN B
1047544
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
WARBURGANAL
1289506
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aristolochia taliscana (ARISTOLOCHIACEAE)
FERULA ALDEHYDE
998353
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces vertcillus (STREPTOMYCETACEAE)
BLEOMYCIN,3-(2-(BETA-PYRIDINE)-ETHYL)-AMINO-PROPYL:
409306
COMPLEX FORMATIONPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OF
Empty organism
ALLANTOIN
852523
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Streptoverticillium species (STREPTOMYCETACEAE)
TECTORIGENIN
565711
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIOXIDANT ACTIVITY
Empty organism
UROCANIC ACID,TRANS:
47257
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
NUTRITIONAL VALUE
Catha edulis (CELASTRACEAE)
970111
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Caesalpinia sappan (FABACEAE)
CAESALPIN PBRAZILINPROTOSAPPANIN ASAPPANONE,3-DEOXY:
87185
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces sioyaensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FL-657-B
1231386
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANALGESIC ACTIVITY
Empty organism
SALICYLIC ACID METHYL ESTER
476758
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
ARBUTIN
1276545
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Hibiscus species (MALVACEAE)
HIBISCUSIDE
234769
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
SPHINGOSINE KINASE INHIBITION
Zopfiella inermis (LASIOSPHAERIACEAE)
ZOPFIELLA ANTIBIOTIC S-15183-B
322682
PATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF COMPOUND - IN HUMANSPREPARATION OF DERIVATIVES OF
PARASYMPATHOLYTIC ACTIVITY
Empty organism
CORYDALINE,(+):
1267006
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTITUMOR ACTIVITY
Thalictrum aquilegifolium (RANUNCULACEAE)
325078
SEPARATION OF ISOMERSPATENT DESCRIBED
Empty organism
DOPA,L:
819290
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOTENSIVE ACTIVITY
Streptomyces chromofuscus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-58365-B
975860
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Flavobacterium multivorum (ACHROMOBACTERIACEAE)
ZEAXANTHIN
1019720
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Saccharopolyspora hirsuta (SCHIZOMYCETACEAE)
SACCHAROPOLYSPORA ANTIBIOTIC KA-6606
560730
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Micromonospora species (MICROMONOSPORACEAE)
GLYPHOMICIN B
50836
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
DIURETIC ACTIVITY
Saponaria officinalis (CARYOPHYLLACEAE)
VITEXOSIDE
458433
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
BESTATIN
553140
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Epilobium parviflorum (ONAGRACEAE)
OENANTHIN B
841370
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces actuosus (STREPTOMYCETACEAE)
STAUROSPORINE
409831
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
XANTHOPTERIN,ISO:
931454
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eclipta alba (ASTERACEAE)
WEDELOLACTONE
667213
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
TAXOL
648021
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Annona squamosa (ANNONACEAE)
ANNORETICUIN-9-ONE
824359
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-33853
417442
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Empty organism
ALLICIN
960228
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Podocarpus macrophylla (PODOCARPACEAE)
HINOKIFLAVONE
349138
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
SUNSCREEN EFFECT
Empty organism
GALLIC ACID METHYL ESTER
1005733
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces diastaticus-amylostaticus (STREPTOMYCETACEAE)
AMYLOSTATIN E
683583
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
HAIR STIMULANT EFFECT
Astragalus species (FABACEAE)
ASTRAGALUS PEPTIDE
988387
YIELD IS MORE THAN 100 MGMWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Plectranthus forskholii (LAMIACEAE)
COLEFORSINE
131107
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Metarhizium anisopliae (HYPHOMYCETES)
METARHIZINIUM ANTIBIOTIC FR-125756
878988
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPOXYGENASE,5: INHIBITION
Artocarpus communis (MORACEAE)
CHALCONE,2-GERANYL-2'-3-4-4'-TETRAHYDROXY:
1289456
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aristolochia taliscana (ARISTOLOCHIACEAE)
ARISTOLACTAM I
84958
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPOTENSIVE ACTIVITY
Streptomyces phaeofaciens (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC WS-7739-B
418550
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
MAYTANSINE
383339
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Capsicum annuum (SOLANACEAE)
CAPSAICINCAPSANTHIN
325038
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PREPARATION OF DERIVATIVES OFANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
MITOMYCIN C
470447
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Batzella species (ESPERIOPSIDAE)
BATZELLINE A,ISO:
1073814
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
CURCUMIN
1057879
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED
Micromonospora species a (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC A-11725-N-1
600097
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Polygala tenuifolia (POLYGALACEAE)
ONJISAPONIN
413930
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
CIRSIMARITIN
1007662
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptosporangium species (STREPTOSPORANGIACEAE)
FINGAROINIC ACID
1025168
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces pactum (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC XK-218
990874
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
COFORMYCIN,ISO:
734117
PATENT DESCRIBED
Phyllanthus emblica (EUPHORBIACEAE)
1009136
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Cylindrocarpon lucidum (HYPHOMYCETES)
CYLINDROCARPON ANTIBIOTIC S-7481-F-1CYCLINDROCARPON ANTIBIOTIC S-7481-F-2
876145
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Sesbania drummondii (FABACEAE)
SESBANIMIDE BSESBANIMIDE A
1092759
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SWEETENING EFFECT
Thladiantha grosvenori (CUCURBITACEAE)
93438
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARVICIDAL ACTIVITY
Bacillus thuringiensis (BACILLACEAE)
BACILLUS ANTIBIOTIC(66000 DALTONS)BACILLUS ANTIBIOTIC(35000 DALTONS)
326175
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
Citrus species (RUTACEAE)
BIOFLAVONOIDS
928959
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Thalictrum species (RANUNCULACEAE)
CRYPTOPINE,ALLO: BETA:
978392
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIBACTERIAL ACTIVITY
Empty organism
ALLICIN
565655
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
TAXOL
1231771
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
LIPID ABSORPTION INHIBITION
Triticum aestivum (POACEAE)
WHEAT GERM BASIC PROTEIN
98917
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC SF-2457
443686
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIDEPRESSANT ACTIVITY
Empty organism
BERGAPTEN
1042958
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Phyllanthus veuminatus (EUPHORBIACEAE)
PHYLLANTHOSIDE
618581
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Glycyrrhiza glabra (FABACEAE)
GLYCYRRHIZINATE,AMMONIUM:
1014675
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
GLYCYRRHIZINSTEVIOSIDE
1281886
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIALLERGENIC ACTIVITY
Humulus lupulus (CANNABACEAE)
997717
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces murinus (STREPTOMYCETACEAE)
LYMPHOSARCIN
821950
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
NEOTHRAMYCIN ANEOTHRAMYCIN B
1009133
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces gilvotanareus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-38-B
1016666
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Panax ginseng (ARALIACEAE)
575979
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Lansium domesticum (MELIACEAE)
LANSIC ACID
971274
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMALARIAL ACTIVITY
Empty organism
TETRANDRINE,(+):
941848
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID S
1066634
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
DIURETIC ACTIVITY
Ruta graveolens (RUTACEAE)
RUTAECARPINE
1020807
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
MUCOPEPTIN C
564043
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Houttuynia cordata (SAURURACEAE)
1278340
PMR SPECTRUM REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Lactuca sativa (ASTERACEAE)
LACTUCIN
1036500
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Saccharopolyspora hirsuta (SCHIZOMYCETACEAE)
SACCHAROPOLYSPORA ANTIBIOTIC
1021011
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Lentinus edodes (TRICHOLOMATACEAE)
ADENOSINE,ISO-PENTENYL:ZEATIN,DIHYDRO:ZEATIN RIBOSIDEZEATINADENINE,ISO-PENTENYL:
323125
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
BUT-3-ENOIC ACID,L-TRANS-2-AMINO-4-(2-AMINO-ETHOXY):
824193
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 176
325859
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
DIGOXIN
231109
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC BE-54238-A
1040411
CHEMICAL DEGRADATION OFPATENT DESCRIBED
Empty organism
NARINGIN
949365
SYNTHESIS OF ANALOGSPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sandoricum indicum (MELIACEAE)
BRYONOLIC ACID
932179
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Platycodon grandiflorum (CAMPANULACEAE)
PLATYCODON INULIN-TYPE NEOPLASM INHIBITOR
478616
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Erigeron annuus (ASTERACEAE)
PYRONE,ALPHA: 5-HYDROXY:
998881
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 216
427301
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Moringa pterygosperma (MORINGACEAE)
PHENYLACETONITRILE,4-(ALPHA-L-RHAMNOSYL-OXY):
597458
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
BIOAVAILABILITY OF
Hypericum perforatum (CLUSIACEAE)
HYPERICIN
1007835
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
IONOPHORIC ACTIVITY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
NARASIN,20-DEOXY:
321472
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PREPARATION OF DERIVATIVES OF
Empty organism
AMPICILLIN*
417806
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Empty organism
ASARINOL B
976329
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIHALITOSIS EFFECT
Empty organism
CITRIC ACID
789043
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Erythroxylum pervillei (ERYTHROXYLACEAE)
PERVILLEINE DPERVILLEINE A N-OXIDEPERVILLEINE CPERVILLEINE APERVILLEINE FPERVILLEINE E
525102
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Potentilla candicans (ROSACEAE)
ELLAGIC ACID,3-3'-4-TRI-O-METHYL: 4'-SULFATE
969812
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Lentinus edodes (TRICHOLOMATACEAE)
1094345
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Streptomyces sclerotialus (STREPTOMYCETACEAE)
MAYTANSINOL ISO-VALERATE
1000409
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Micromonospora species (MICROMONOSPORACEAE)
MITOMYCIN C
1006779
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Arthrobacter species (CORYNEFORM ACTINOMYCETE)
ARTHROBACTER ANTIBIOTIC 02-8
535901
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
LEUROCRISTINE
931618
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INTERFERON INDUCTION STIMULATION
Perilla frutescens (LAMIACEAE)
PERILLA INTERFERON INDUCER
617605
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Hamamelis virginiana (HAMAMELIDACEAE)
1044414
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Secale cereale (POACEAE)
MUGINEIC ACID,3-HYDROXY:
1025288
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Aerobacillus colistinus (TO BE DETERMINED)
JOLIPEPTIN
151577
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora chersina (MICROMONOSPORACEAE)
DYNEMICIN C
201938
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Serratia liquifaciens (ENTEROBACTERIACEAE)
SERRATIA ANTIBIOTIC FR-177391
356411
PATENT DESCRIBED
Daucus carota (APIACEAE)
327329
HPLC DATA REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Catharanthus roseus (APOCYNACEAE)
VINCALEUKOBLASTINE,DE-N-METHYL:
492012
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
MELANIN FORMATION INHIBITION
Empty organism
CAFFEIC ACID 3-BETA-D-GLUCOSIDE
446078
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
RODENTICIDE ACTIVITY
Empty organism
NICOTINE
712186
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Empty organism
MORIN
676033
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIFERTILITY
LH-RELEASE INHIBITION
Belamcanda chinensis (IRIDACEAE)
417200
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
SKIN PIGMENTATION EFFECT
Empty organism
KAEMPFEROL
93647
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Aspergillus fumigatus (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC F-838
566568
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Beta vulgaris (CHENOPODIACEAE)
OLEANOLIC ACID 3-O-BETA-D-GLUCURONIDE
1231408
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
HYPOLIPEMIC ACTIVITY
Empty organism
BACTERIOHOPAN-32-OL
328581
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Micromonospora purpurea (MICROMONOSPORACEAE)
GENTAMICIN
555209
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
CINNAMIC ACID,PARA-METHOXY:
742070
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Solanum lyratum (SOLANACEAE)
SOLAMARGINE
421590
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
REVERSE TRANSCRIPTASE INHIBITION
Phyllanthus niruri (EUPHORBIACEAE)
REPANDUSINIC ACID
1048044
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Empty organism
XANTHAN GUM
985881
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces gilvotanareus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-38-B
737379
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANALGESIC ACTIVITY
Maytenus ilicifolia (CELASTRACEAE)
FRIEDELAN-3-ALPHA-OL
976013
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WOUND HEALING ACCELERATION
Mimosa tenuiflora (FABACEAE)
330867
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MICROBIAL TRANSFORMATION OF
Nocardia species (NOCARDIACEAE)
LEUCOMYCIN
1183665
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Oryza sativa (POACEAE)
321308
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
CEPHEM-4-CARBOXYLIC ACID DERIVATIVES*
67870
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTITUMOR ACTIVITY
Empty organism
TUBEIMOSIDE A
930103
PATENT DESCRIBED
Empty organism
SAIKOSAPONIN A
612515
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Yucca species (AGAVACEAE)
TIGOGENIN
441077
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tabebuia impetiginosa (BIGNONIACEAE)
FURONAPHTHOQUINONE,1-(1-HYDROXY-ETHYL):
327646
PURIFICATION OFPATENT DESCRIBED
Empty organism
SANTONIN
342156
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIVIRAL ACTIVITY
Streptomyces griseusm (STREPTOMYCETACEAE)
LEUKEMOMYCIN C,DIHYDRO:
614899
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Saccharomyces cerevisiae (SACCHAROMYCETACEAE)
BUTIROSIN B-3'-PHOSPHATE
1266770
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Allium cepa (LILIACEAE)
QUERCETIN
1231760
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Medicago sativa (FABACEAE)
1130727
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
173129
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AI-2020
154124
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Scytonema ocellatum (SCYTONEMATACEAE)
SCYTOPHYCIN E,6-HYDROXY-7-O-METHYL:
334163
PATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Mycobacterium globiforme (MYCOBACTERIACEAE)
PREGNA-1-4-DIENE-3-20-DIONE,16-ALPHA-17-ALPHA-(ISO-PROPYLIDENE-DIOXY):
1012236
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
GROWTH PROMOTER ACTIVITY
Actinoplanes species (ACTINOPLANACEAE)
PLANOTHIOCIN A
981809
PARTIAL SYNTHESIS OFPATENT DESCRIBED
Empty organism
STEVIOL
1033034
PURIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza glabra (FABACEAE)
GLYCYRRHIZIN
416883
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Limulus polyphemus (LIMULIDAE)
POLYPHEMUSIN I
917475
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHYPERCHOLESTEROLEMIC ACTIVITY
Artemisia montana (ASTERACEAE)
79340
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces majorciensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC LLCO-8078-BETA
83107
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Micromonospora species (MICROMONOSPORACEAE)
LEVUREMICIN
524786
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBED
Panax ginseng (ARALIACEAE)
827940
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Saccharomyces species (SACCHAROMYCETACEAE)
SACCHAROMYCES ANTIBIOTIC TYE-1
810966
PMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Coriolus versicolor (POLYPORACEAE)
CORIOLUS VERSICOLOR ANTIBIOTIC
965665
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Dolabella auricularia (APLYSIIDAE)
DOLASTATIN 15
409548
PHARMACOLOGY OF COMPOUND - IN VIVOYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Trametes sanguinea (POLYPORACEAE)
TRAMETES SANGUINEA ANTIBIOTIC
992656
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora sagamiensis (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC SU-1
1031668
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC 76-11
81879
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC SF-2324
183399
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomyces species (ACTINOMYCETACEAE)
ACTINOMYCES ANTIBIOTIC UO-E-6
218072
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ecteinascidia turbinata (PEROPHORIDAE)
ECTEINASCIDIN 736
1016829
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Bifidobacterium longum (ACTINOMYCETACEAE)
BIFIDIOBACTERIUM ANTIBIOTIC CW-5
1082999
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ABORTIFACIENT EFFECT
Montanoa tomentosa (ASTERACEAE)
448980
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPOXYGENASE,5: INHIBITION
Panax ginseng (ARALIACEAE)
HEPTADECA-1-8-DIENE-4-6-DIYN-10-OL-3-ONE
322695
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHEMORRHOIDAL ACTIVITY
Juniperus species (CUPRESSACEAE)
469802
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Trewia nudiflora (EUPHORBIACEAE)
TREFLORINE
981520
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
LEUROCRICTINE,5'-ACETONYL:
113404
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cytophaga species (CYTOPHAGACEAE)
KATANOSIN B
98809
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora purpureochromogenes (MICROMONOSPORACEAE)
STREPTOMYCES ANTIBIOTIC LL-D-42067-ALPHA
987318
YIELD IS MORE THAN 100 MGMWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
1032416
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-39183 FACTOR B
1002497
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
CNS DEPRESSANT ACTIVITY
Empty organism
CYCLO-9-19-LANOSTAN-3-BETA-OL,24-METHYLENE
491280
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ustilaginoidea virens (HYPHOMYCETES)
USTILOXIN A
991862
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS 50-100 MGMINFRARED SPECTRUM REPORTED FOR
Actinoplanes species (ACTINOPLANACEAE)
ACTINOPLANES ANTIBIOTIC A-10947
949754
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Camellia species (THEACEAE)
CAMELLA TRITERPENE SAPONIN 1
1007094
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
ANTICONVULSANT ACTIVITY
Marsilea species (MARSILEACEAE)
MARSILIN
84947
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 165-A
137882
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Ficus species (MORACEAE)
FICUS OLIGOPEPTIDE FLP-1
819171
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AM-6424
86215
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AM-2604-A
614784
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Papularia sphaerosperma (HYPHOMYCETES)
PAPULACANDIN B
1014670
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
24313
ISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTPATENT DESCRIBED
Calotropis gigantea (ASCLEPIADACEAE)
USCHARIDIN
662693
VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Swartzia madagascariensis (FABACEAE)
SWARTZIADIONE
1227293
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
BONE RESORPTION INHIBITION
Empty organism
FLAVONE,ISO: 7-HYDROXY:
713108
PATENT DESCRIBED
Empty organism
ERYTHRITOL
187635
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AC-44-37
355844
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WOUND HEALING ACCELERATION
Asparagus officinalis (LILIACEAE)
711634
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Goniothalamus leiocarpus (ANNONACEAE)
GONIODIOL,7-EPI:
823056
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
VIRIDOGRISEIN
764638
PATENT DESCRIBEDHOMEOPATHIC STUDIES
Empty organism
470515
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
MELANIN FORMATION INHIBITION
Empty organism
ECKOL
1040757
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Orchis militaris (ORCHIDACEAE)
BENZYL ALCOHOL,4-HYDROXY:
385964
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
GLUCOSYLTRANSFERASE INHIBITION
Empty organism
ELLAGIC ACID
28979
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Asclepias tuberosa (ASCLEPIADACEAE)
1006590
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces candidus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-35512
75552
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomadura verrucosospora (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC BBM-1675-A-1
445876
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RADICAL SCAVENGING EFFECT
Empty organism
EUGENOL,ISO: DEHYDRO:
148296
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RNA SYNTHESIS INHIBITION
Actinomadura verrucosospora (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC BU-3983-T
385970
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Kalanchoe gracilis (CRASSULACEAE)
FISETIN
731968
PATENT DESCRIBED
Empty organism
VASICINE,DEOXY:
978783
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Matricaria chamomilla (ASTERACEAE)
BISABOLOL
338608
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANESTHETIC ACTIVITY(LOCAL)
Empty organism
HYDRASTINEBERBERINE
327341
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cnicus benedictus (ASTERACEAE)
154341
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC GE-1655-CSTREPTOMYCES ANTIBIOTIC GE-1655-ASTREPTOMYCES ANTIBIOTIC GE-1655-B
183421
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC OM-4842-A
566744
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
PROP-2-ENOIC ACID,3-[4-HYDROXY-3-5-BIS-(3-METHYL-BUT-2-ENYL)-PHENYL]:
614050
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
ANTIHYPERTENSIVE ACTIVITY
Voacanga chalotiana (APOCYNACEAE)
CUANZINE
1289515
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aristolochia taliscana (ARISTOLOCHIACEAE)
CARYOPHYLLENE OXIDE
837067
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Selinum monnieri (APIACEAE)
COUMARIN,7-METHOXY-8-(2-HYDROXY-3-METHYL-BUT-3-ENYL):COUMARIN,7-METHOXY-8-(2-3-DIHYDROXY-3-METHYL-BUT-1-ENYL):
319149
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACEUTICAL FORMULATION OF
Empty organism
ERYTHROMYCIN
971987
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
PENIS ERECTILE STIMULANT
Empty organism
PAPAVERINE
1171010
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Empty organism
SANDARACOPIMARADIENE,7-HYDROXY-3-OXO:
1156009
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHEPATOTOXIC ACTIVITY
Empty organism
NOSCAPINE
618288
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIPARKINSON ACTIVITY
Orobanche (OROBANCHACEAE)
OROBANCHOSIDEVERBASCOSIDE
1158805
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Empty organism
ALANOSINE
1001543
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Corynebacterium glutamicum (CORYNEFORM ACTINOMYCETE)
LEUCINE,L:
972886
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Macleaya cordata (PAPAVERACEAE)
SANGUINARINE
978295
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Betula pubescens (BETULACEAE)
CARYOPHYLLA-4-7-DIEN-6-ONE
991877
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora sagamiensis (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC UAA-3
601345
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RADICAL SCAVENGING EFFECT
Empty organism
MANGIFERIN
1036394
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptoverticillium stramineum (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC LLBO-1208-ALPHA:STREPTOVERTICILLIUM ANTIBIOTIC LLBO-1208-BETA
322701
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIHEMORRHOIDAL ACTIVITY
Althaea species (MALVACEAE)
VITAMIN B-1AESCULETINRUTIN
337600
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Streptomyces katsunumaensis (STREPTOMYCETACEAE)
CHROMOMYCIN A-3CHROMOMYCIN A-2
447782
PATENT DESCRIBED
Empty organism
JACALIN
657284
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIYEAST ACTIVITY
Spongia species (SPONGIIDAE)
SPONGIASTATIN 1
482773
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nectria species (HYPOCREACEAE)
CYCLOSPORIN C
409829
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma tsugae (GANODERMATACEAE)
GANODERMA TSUGAE ANTIBIOTIC
1006768
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora melanogenes (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC PA-399
730691
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Polygonum cuspidatum (POLYGONACEAE)
RESVERATROL
856066
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Ephedra species (EPHEDRACEAE)
MAHUANNIN C
628024
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTIADHESION EFFECT
Vaccinium macrocarpon (ERICACEAE)
200283
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Dasyscyphus mollissimus (HYALOSCYPHACEAE)
DASYSCYPHUS ANTIBIOTIC F-10463-A
1243109
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTPATENT DESCRIBED
Polygonum tinctorium (POLYGONACEAE)
INDIGO
325569
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACEUTICAL FORMULATION OF
Empty organism
TETRACYCLINE,OXY:NEOMYCIN
2870
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTPATENT DESCRIBED
Agave lecheguilla (AGAVACEAE)
SAPONINSCHLOROPHYLL
327958
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
HEPTAN-3-ONE
327230
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rauvolfia species (APOCYNACEAE)
AJMALINE
1028565
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
DNA SYNTHESIS INHIBITION
Penicillium islandicum (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC IFO-5230-BPENICILLIUM ANTIBIOTIC IFO-5230-A
6342
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Aspergillus nidulans (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC A-22082
1077492
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Empty organism
GOSSYPOL
526906
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
INSECT ATTRACTANT ACTIVITY
Cinnamomum culilawan (LAURACEAE)
1227035
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Allium sativum (LILIACEAE)
ERUBOSIDE B
999708
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Microcyclus methanolica (SPIRILLACEAE)
COENZYME Q-10
490618
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nepeta velutina (LAMIACEAE)
IRIDAN-1-OL,3-4-DEHYDRO-4-FORMYL-8-METHYL-8-HYDROXY: 1-BETA-D-GLUCOSIDE
131847
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Xestospongia species (PETROSIIDAE)
XESTOSPONGIA STEROL YT-040
486914
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CAMPTOTHECIN,10-11-METHYLENEDIOXY: 20(RS):
854672
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
FOOD USE
Eleutherococcus senticosus (ARALIACEAE)
956099
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TUBULIN POLYMERIZATION INHIBITION
Combretum caffrum (COMBRETACEAE)
COMBRETASTATIN A-4
1251543
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
CARDIOTONIC ACTIVITY
Swertia japonica (GENTIANACEAE)
325762
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
CYMENE
1050043
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Isodon trichocarpus (LAMIACEAE)
TRICHORABDAL C
561093
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Opuntia ficus-indica (CACTACEAE)
739186
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
FUCOSIDASE INHIBITION
Anacardium occidentale (ANACARDIACEAE)
RESORCINOL,5-(PENTADECA-8-11-DIENYL):
821179
GEL PERMEATION CHROMATOGRAPHY USEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptoverticillium griseocarneum (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC SAC-IIISTREPTOVERTICILLIUM ANTIBIOTIC SAC-IISTREPTOVERTICILLIUM ANTIBIOTIC SAC-I
340298
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSISOLATION AND IDENTIFICATION OF
ANTIOBESITY ACTIVITY
Richardella dulcifica (SAPOTACEAE)
MIRACULIN
607415
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
HISTAMINE RELEASE INHIBITION
Empty organism
ERIOCITRINCOSMOSIINLUTEOLIN-7-O-RHAMNOSIDEERIODICTYOL-7-O-BETA-D-GLUCOSIDE
724735
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Casearia esculenta (FLACOURTIACEAE)
ESCULENTIN A
492357
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Panax ginseng (ARALIACEAE)
PANAXYDOL
319381
PURIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDSEPARATION OF (EXCEPT OILS, VENOM, PROTEINS, FATS)
Empty organism
SAPONINS
333076
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Actinomyces olivovariabilis (ACTINOMYCETACEAE)
CHROMOMYCINONE GLYCOSIDE
836512
GEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TM-482-B
568640
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CARCINOGENESIS INHIBITION
Empty organism
LIENSININE,O-O-DIMETHYL:NEFERINELIENSININE,ISO:
809597
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ancistrocladus korupensis (ANCISTROCLADACEAE)
KORUPENSAMINE C
995475
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Pongamia pinnata (FABACEAE)
PONGAFLAVONE
255534
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Angelica furcijuga (APIACEAE)
TEREBINTHACOSIDE ITEREBINTHACOSIDE IIFALCARINDIOL
879169
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
LEUROCRISTINE
861336
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Swertia japonica (GENTIANACEAE)
1015846
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Clitopilus pseudopinsitus (ENTOLOMATACEAE)
CLIPTOPILUS ANTIBIOTIC B-40104CLIPTOPILUS ANTIBIOTIC A-40104
1014906
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Triticum aestivum (POACEAE)
TRITICUM AESTIVUM POLYPEPTIDE SP-1TRITICUM AESTIVUM POLYPEPTIDE SP-2
552756
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHEPATOTOXIC ACTIVITY
Inula japonica (ASTERACEAE)
1057494
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Agromyces ramosus (TO BE DETERMINED)
AGROMYCES IMMUNE ACTIVATOR
425574
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bacillus megaterium (BACILLACEAE)
OXETANOCIN A
329806
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
QUININE
192147
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces bottropensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC NK-86-0279
957229
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
SLEEP(SPONTANEOUS) POTENTIATION
Eleutherococcus senticosus (ARALIACEAE)
SYRINGIN
422896
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIHEPATOTOXIC ACTIVITY
Alisma orientale (ALISMATACEAE)
ALISOL A,13-17-EPOXY:
975468
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
DENTIFRICE ACTIVITY
Astragalus hoantchy (FABACEAE)
322996
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MICROBIAL TRANSFORMATION OF
Escherichia coli (ENTEROBACTERIACEAE)
CEPHALOTHIN*
986976
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CEPHALOTAXYL-TRICHLORO-ETHYL-CARBONATE
79105
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDTOXICITY MARKER CODE
ANTITOXIC ACTIVITY
Rosmarinus officinalis (LAMIACEAE)
659781
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
BETULINIC ACID
1078896
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
Carthamus tinctorius (ASTERACEAE)
CARTHAMUS TINCTORIUS INTERFERON INDUCER
960746
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
LUTEOLIN,6-HYDROXY:
98933
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMICROBIAL ACTIVITY(UNSPECIFIED)
Streptomyces fradiae (STREPTOMYCETACEAE)
URDAMYCIN G
857436
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Aspergillus niger (HYPHOMYCETES)
ASPERGILLUS SUBSTANCE I-63913
129359
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces collinus (STREPTOMYCETACEAE)
RESORTHIOMYCIN
522489
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
DEC-2-ENOIC ACID,10-HYDROXY:
1050099
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOTENSIVE ACTIVITY
Diheterospora catemulatum (HYPHOMYCETES)
ANGIOSTATIN
432027
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Trichosanthes kirilowii (CUCURBITACEAE)
TRICHOSANTHIN,ALPHA:
601057
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Actinomadura species (THERMOMONOSPORACEAE)
HAYUMICIN
617453
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Maytenus buchananii (CELASTRACEAE)
MAYTANPRINE
128531
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC BE-16493
686538
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus jujuba (RHAMNACEAE)
BETULINIC ACID
647252
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
1112350
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Daucus carota (APIACEAE)
DAUCARIN
109899
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-282
445768
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Annona squamosa (ANNONACEAE)
SQUAMOSTATIN A
1323524
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANALGESIC ACTIVITY
Orobanche hederae (OROBANCHACEAE)
1072548
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
REBAUDIOSIDE A
949369
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Sandoricum indicum (MELIACEAE)
BRYONOLIC ACID
809424
DEPARTMENTAL MARKER CODE. NO DATA CODEDPATENT DESCRIBED
Empty organism
85482
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Sphaerotilus natans (SHEATHED BACTERIA)
90177
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
ENTEROCIN,5-DEOXY:
332248
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
TOXICITY ASSESSMENT(QUANTITATIVE)
Streptomyces rosa (STREPTOMYCETACEAE)
NANAOMYCIN A
789998
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
SLEEP TIME INCREASED
Empty organism
VALERAMIDE,ISO:
713376
PATENT DESCRIBED
Empty organism
GARCINOL#
678825
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Annona squamosa (ANNONACEAE)
MOLVIZARIN
610728
PATENT DESCRIBED
Empty organism
PILOCARPINE
672828
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Euphorbia hirta (EUPHORBIACEAE)
919198
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Lathyrus japonicus (FABACEAE)
LATHYRINE,GAMMA-L-GLUTAMYL-L:LATHYRINE
622449
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF
Larrea tridentata (ZYGOPHYLLACEAE)
GUAIARETIC ACID,NOR-DIHYDRO:
824678
GEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Bacillus subtilis (BACILLACEAE)
MANILOSPORIN B-1
1006774
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Micromonospora globosa (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC S-54832-A-I
396831
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Harungana madagascariensis (CLUSIACEAE)
HARUNGANIN
113876
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Nocardia orientalis (NOCARDIACEAE)
AMYCOLATOPSIS ANTIBIOTIC BE-7585-A
693837
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
APOPTOSIS INDUCTION
Empty organism
BETULINIC ACID
333960
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
INSECTICIDE ACTIVITY
Carica papaya (CARICACEAE)
PAPAIN
1184394
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces albus (STREPTOMYCETACEAE)
ABIERIXIN
1034829
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomyces species (ACTINOMYCETACEAE)
ACTINOMYCES ANTIBIOTIC BBM-928-C
421588
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Phyllanthus niruri (EUPHORBIACEAE)
REPANDUSINIC ACID
1002756
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Streptomyces ravidus (STREPTOMYCETACEAE)
RAVIDOMYCIN
950170
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUSSIVE ACTIVITY
Fritillaria ussuriensis (LILIACEAE)
VERTICINE
1183643
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Zea mays (POACEAE)
1019999
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces albus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AN-1
998628
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tricholoma bakamatsutake (TRICHOLOMATACEAE)
EMITANIN C
480609
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION
Sesamum indicum (PEDALIACEAE)
64550
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Pholiota nameko (STROPHARIACEAE)
332215
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIHEMORRHOIDAL ACTIVITY
Empty organism
ALLANTOINAZULENE
424683
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Circinella umbellata (MUCORACEAE)
MILBEMYCIN A-4,31-HYDROXY:
670722
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
REBAUDIOSIDE A
607499
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
817986
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces alanosinicus (STREPTOMYCETACEAE)
SPICAMYCIN
325080
PARTIAL SYNTHESIS OFPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
LEUROCRISTINE
1057353
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora species (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC Y-02077-H-ALPHA:
355863
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Mycobacterium vaccae (MYCOBACTERIACEAE)
1243389
AMINO ACID SEQUENCING OFPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Phyllanthus discoideus (EUPHORBIACEAE)
PHYLLANTHUS DISCOIDES ALKALOID(MP 136)
1323305
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
ANALGESIC ACTIVITY
Coprinus sclerotigenus (COPRINACEAE)
ANTHRANILATE,2-HYDROXY-2-CARBOXY-ETHYL-N-(7-CHLORO-4-QUINOLINYL):
747239
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Momordica charantia (CUCURBITACEAE)
PEPTIDE MC-6PEPTIDE MC6.3PEPTIDE MC6.2PEPTIDE MC6.1
771291
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
PHAGOCYTOSIS CAPACITY INCREASED
Echinacea purpurea (ASTERACEAE)
607437
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SUNSCREEN EFFECT
Lindera umbellata (LAURACEAE)
CHALCONE,2-4-6-TRIHYDROXY:
1020866
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
CYCLOHEXA-1-3-DIENE-1-CARBOXALDEHYDE,6-AMINO-5-HYDROXY
5676
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OFISOLATION AND IDENTIFICATION OF
Streptomyces griseoverticillatus (STREPTOMYCETACEAE)
TUBERACTINOMYCIN A
155528
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Sarcophaga peregrina (SARCOPHAGIDAE)
SARCOPHAGA POLYPEPTIDE A
409456
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBED
Nicotiana tabacum (SOLANACEAE)
607488
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
TYROSINASE INHIBITION
Eupatorium fortunei (ASTERACEAE)
80346
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SS-8228-B
431815
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
FORSKOLIN,1-9-DIDEOXY:*
1045831
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Claviceps purpurea (CLAVICIPITACEAE)
ERGOCRYPTINE,ALPHA:
895337
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bupleurum falcatum (APIACEAE)
POLYSACCHARIDE(BUPLEURUM FALCATUM)
854527
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Oryza sativa (POACEAE)
PHYTIN
852419
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMALARIAL ACTIVITY
Cinchona ledgeriana (RUBIACEAE)
849717
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Pseudomonas mesoacidophila (PSEUDOMONADACEAE)
PSEUDOMONAS ANTIBIOTIC F-6
362692
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
MISCELLANEOUS EFFECTS
Empty organism
CHOLESTEROL-3-(15-HYDROXY)-STEARATE
1020966
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces endus aureus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DO-59-III
815676
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CHOLERETIC ACTIVITY
Empty organism
MENTHA-1-8-DIENE,PARA:
36400
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Pueraria pseudo-hirsuta (FABACEAE)
DAIDZEINPUERARINDAIDZIN
1033045
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC M-4365-A-2
380916
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PHARMACOKINETIC ALTERATION
Empty organism
EMODIN
626533
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CELL PROLIFERATION INHIBITION
Tripterygium wilfordii (CELASTRACEAE)
568622
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Empty organism
CASTANOSPERMINE
678828
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Annona squamosa (ANNONACEAE)
MOLVIZARIN
602140
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Dysidea spinulosa (DYSIDEIDAE)
HYDROQUINONE,2-HEXAPRENYL: SULFATE
113879
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinomycete species (ACTINOMYCETES)
ACTINOMYCETE ANTIBIOTIC CL-1957-B
1052179
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Bacillus pumilus (BACILLACEAE)
STREPTOMYCES ANTIBIOTIC BN-103-C
962280
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rabdosia japonica (LAMIACEAE)
ISODONAL
228109
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Rozites caperata (CORTINARIACEAE)
962613
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Lansium domesticum (MELIACEAE)
LANSIC ACID
205302
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Curvularia pallescens (HYPHOMYCETES)
CURVULARIA ANTIBIOTIC MK-7634
339521
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
GLYCYRRHIZIN
493867
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
GLUTAMATE RECEPTOR BLOCKER
Verticillium species (HYPHOMYCETES)
VERTICILLIUM ANTIBIOTIC ES-242-7
1155524
PATENT DESCRIBED
Empty organism
CADINOL,ALPHA: (-):
352451
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
SALICYLIC ACIDHYDROQUINONE
602141
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIULCER ACTIVITY
Dysidea spinulosa (DYSIDEIDAE)
HYDROQUINONE,2-HEXAPRENYL: SULFATE
325558
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
ERYTHRODIOL DERIVATIVES*
111939
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Bacillus thuringiensis (BACILLACEAE)
BACILLUS ANTIBIOTIC(25000 DALTONS)
614719
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptoverticillium eurocidicum (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC A-16316-C
331838
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Maytenus serrata (CELASTRACEAE)
MAYTANPRINEMAYTANSINEMAYTANBUTINE
89700
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC SF-2370
1004980
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces brunneus-xanthothricini (STREPTOMYCETACEAE)
XANTHOTHRICIN
183436
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces carzinostaticus (STREPTOMYCETACEAE)
NEOCARZIRIN A
1033269
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinoplanes missouriensis (ACTINOPLANACEAE)
ACTINOPLANES ANTIBIOTIC A-4696-G
1070342
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Catharanthus roseus (APOCYNACEAE)
187687
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Aspergillus species (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC NF-00659-B-2ASPERGILLUS ANTIBIOTIC NF-00659-A-1ASPERGILLUS ANTIBIOTIC NF-00659-A-2ASPERGILLUS ANTIBIOTIC NF-00659-B-1
13241
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Fusarium anguioides (HYPHOMYCETES)
SCIRPENOL,DIACETOXY:
666550
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
MULBERROFURAN D
1032461
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Paecilomyces lilacinus (HYPHOMYCETES)
PAECILOMYCES ANTIBIOTIC 1907-VIII
93654
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptococcus pyrogenes (STREPTOCOCCACEAE)
STREPTOCOCCUS ANTIBIOTIC SPF-100-F-II
1031950
UV SPECTRUM GIVEN FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2080-D
425924
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
TOPSENTIN B,TETRANOR:
833678
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
COLLAGENASE INHIBITION
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC P-23924-E
326003
PATENT DESCRIBEDPREPARATION OF LABELLLED COMPOUND
Empty organism
THYROXINE,L:
338609
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
ANTIHYPERTENSIVE ACTIVITY
Empty organism
TYROSINE,META:
445554
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPOXYGENASE,5: INHIBITION
Epimedium koreanum (BERBERIDACEAE)
FLAVONE,4'-METHOXY-5-HYDROXY-8-(3,3-DIMETHYL-ALLY): 3-O-BETA-D-XYLOPYRANOSYL(1-3)-4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSIDE-7-O-BETA-D-GLUCOPYRANOSIDE
595555
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
PIERICIDIN B-5-N-OXIDE
1092098
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIFERTILITY
HYALURONIDASE INHIBITION
Papaver lisae (PAPAVERACEAE)
ORIDINE
37467
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ESTROGENIC EFFECT
Butea monosperma (FABACEAE)
949755
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SPORE GERMINATION INHIBITOR
Camellia species (THEACEAE)
CAMELLA TRITERPENE SAPONIN 1
569666
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Satureja hortensis (LAMIACEAE)
154217
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces graminofaciens (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FD-891
1052176
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Chromobacterium species (RHIZOBIACEAE)
CHROMOBACTERIUM ANTIBIOTIC Y-T-0678-H
170381
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
IMMUNOMODULATOR ACTIVITY
Penicillium species (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC FO-2338-A
978660
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sandoricum indicum (MELIACEAE)
BRYONOLIC ACID
489727
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tanacetum parthenium (ASTERACEAE)
PARTHENOLIDE
893951
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
SAIKOSAPONIN C
605156
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
INSULIN RELEASE INHIBITION
Empty organism
INULIN
1183476
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Pfaffia paniculata (AMARANTHACEAE)
PFAFFIC ACID
1029466
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION OFPATENT DESCRIBED
Lithospermum erythrorhizon (BORAGINACEAE)
SHIKONIN
395413
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN MOISTURIZING EFFECT
Empty organism
BETAINE
426799
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Panax ginseng (ARALIACEAE)
1002746
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AA-57
734737
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Artemisia argyi (ASTERACEAE)
ARTEMISIA SESQUITERPENE LACTONE BTANAPHILLINARTEMISIA SESQUITERPENE LACTONE C
277837
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Capsicum frutescens (SOLANACEAE)
CAPSICUM SAPONIN CAY-1
442569
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PHAGOCYTOSIS RATE INCREASED
Echinacea purpurea (ASTERACEAE)
ECHINAXANTHOL,CINNAMOYL:ECHINADIOL,CINNAMOYL:ECHINADIOL,EPOXY: CINNAMOYL:
489604
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Polygala species (POLYGALACEAE)
SINAPOYL)-GLUCOPYRANOSIDE,BETA-D-[3-O-(3-4-5-TRIMETHOXY-CINNAMOYL)]-FRUCTOFURANOSYL-ALPHA-D-(6-O:
992478
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tricholoma matsutake (TRICHOLOMATACEAE)
EMITANIN A
1251579
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Swertia japonica (GENTIANACEAE)
GENTIANINE
147729
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RNA SYNTHESIS INHIBITION
Polyangium brachysporum (POLYANGIACEAE)
GLIDOBACTIN PF-1
1011493
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Diaporthe citri (VALSACEAE)
HYDROXAMIC ACID,DIMETHYL-2-OXO-DECANOYL:
981519
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Catharanthus roseus (APOCYNACEAE)
LEUROCRISTINE
607500
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
318609
SYNTHESIS OF ANALOGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PREPARATION OF DERIVATIVES OF
Empty organism
CYCLOSERINE
992477
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tricholoma matsutake (TRICHOLOMATACEAE)
EMITANIN A
882296
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
OLIGOMYCIN E
976587
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SUNSCREEN EFFECT
Empty organism
ALLANTOIN
818790
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora species (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC M-9026-2
76125
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOPLASMAL ACTIVITY
Streptomyces thermotolerans (STREPTOMYCETACEAE)
MACROCIN,3-O-ACETYL-4''-O-ISO-VALERYL:
993022
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Bacillus subtilis (BACILLACEAE)
MANILOSPORIN A
332763
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Xanthomonas vesicatoria (PSEUDOMONADACEAE)
XANTHAN GUM
411195
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Erwinia herbicola (ENTEROBACTERIACEAE)
CATECHOL,(DL):SERINE,DL:
488624
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ADENYL CYCLASE STIMULATION
Penicillium citrinum (HYPHOMYCETES)
CITRININ
68631
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Hypericum perforatum (CLUSIACEAE)
HYPERFORINHYPERICINFLAVONES
352395
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Tripterygium wilfordii (CELASTRACEAE)
ZEYLASTERAL,DEMETHYL:
333757
PMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
ANTIBACTERIAL ACTIVITY
Actinoplanes deccanensis (ACTINOPLANACEAE)
LIPIARMYCIN
372773
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CELL DIFFERENTIATION INHIBITION
Crataegus cuneata (ROSACEAE)
521647
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Empty organism
GENISTEINFLAVONE,ISO: 3'-4-5-7-TETRAHYDROXY-8-METHOXY:
330319
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
ANTIULCER ACTIVITY
Empty organism
VITAMIN A
319489
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
ABIETIC ACID,DEHYDRO:
833673
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC P-23924-C
668193
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
NADH OXIDASE INHIBITION
Castela peninsularis (SIMAROUBACEAE)
GLAUCARUBOLONE
1192654
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
NAPHTHOMYCIN H
818783
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Micromonospora species (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC M-9026
617598
PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
ANTIHYPERTENSIVE ACTIVITY
Voacanga chalotiana (APOCYNACEAE)
CUANZINE
854675
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIBACTERIAL ACTIVITY
Eleutherococcus senticosus (ARALIACEAE)
836505
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN BACLACINOMYCIN A
672074
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
G PROTEIN RECEPTOR BINDING
Empty organism
IBOGAINE,NOR:
76436
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
MISCELLANEOUS EFFECTS
Aspergillus alliaceus (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC I
128975
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Astragalus membranaceus (FABACEAE)
ASTRAGLUCAN
1048047
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
STABILITY STUDY
Empty organism
HEXADECAPENTAENOIC ACID,TETRAMETHYL:
154339
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ACYL-CO-A:CHOLESTEROL ACYLTRANSERASE INHIBITION
Aspergillus species (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC FO-1289-A
949371
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Luffa aegyptiaca (CUCURBITACEAE)
BRYONOLIC ACID
1073555
AMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Aloe arborescens (LILIACEAE)
ALEXIN B
331559
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
ANTIPROTOZOAN ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
SEPTAMYCIN
428927
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
WOUND HEALING ACCELERATION
Empty organism
OLEANOLIC ACID
1066631
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN HUMANS
DIURETIC ACTIVITY
Empty organism
EVODIAMINE
893103
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces paulus (STREPTOMYCETACEAE)
PAULOMYCIN U
477230
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
CEPHARANTHINE,(+):
683236
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
LIPASE INHIBITION
Filipendula species (ROSACEAE)
556423
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces coerulescens (STREPTOMYCETACEAE)
THRAZARINE
606208
PATENT DESCRIBED
Cassia auriculata (FABACEAE)
978540
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Porphyra yezoensis (BANGIACEAE)
851597
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOGLYCEMIC ACTIVITY
Aconitum carmichaelii (RANUNCULACEAE)
ACONITAN A
554510
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Citrus paradisi (RUTACEAE)
917139
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Lumbricus rubellus (LUMBRICIDAE)
FURAN-3-SULFONIC ACID,2-ETHYL-5-HEXYL:
81795
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIULCER ACTIVITY
Bacillus natto (BACILLACEAE)
BACILLUS ANTIBIOTIC AUS-1
694388
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Xenorhabdus luminescens (ENTEROBACTERIACEAE)
XENORHABDIN IIXENORHABDIN I
675559
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOCHROME P450 INHIBITION
Citrus paradisi (RUTACEAE)
BERGAMOTTIN
993855
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
HEMAGGLUTININ ACTIVITY
Pseudomonas species (PSEUDOMONADACEAE)
PSEUDOMONAS HEMAGGLUTININ MHA-101
882023
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIVIRAL ACTIVITY
Lentinus edodes (TRICHOLOMATACEAE)
ZEATIN
90874
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Rhodococcus terrae (NOCARDIACEAE)
RHODOCOCCUS COMPOUND RT-1
193134
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INSECTICIDE ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC NK-154183-B
965467
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
ELLAGIC ACID
950342
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
ASPARAGUSIC ACID
610743
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Cryptolepis sanguinolenta (ASCLEPIADACEAE)
QUINDOLINE
1086266
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
CHOLERETIC ACTIVITY
Gardenia jasminoides (RUBIACEAE)
GENIPOSIDIC ACID AGLYCONE
950174
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUSSIVE ACTIVITY
Fritillaria ussuriensis (LILIACEAE)
VERTICINONE
332273
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces phaeoverticillatus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 289-FO
1055734
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Petriella guttulata (MICROASCACEAE)
PETRIELLA ANTIBIOTIC FR-900261
649368
PATENT DESCRIBED
Empty organism
MORUSIN-4'-O-BETA-D-GLUCOSIDEKUWANON HMORUSIN
1042733
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Morus bombycis (MORACEAE)
KUWANON HKUWANON G
826353
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces rishiriensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC T-23-I
1030153
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces lavendulae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FR-900201
182551
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SR-1223
781690
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
TRIPTOLIDE
329955
PATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIULCER ACTIVITY
Lactobacillus bulgaricus (LACTOBACILLACEAE)
766247
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ALDOSE REDUCTASE INHIBITION
Centella asiatica (APIACEAE)
417258
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
CARDOL,METHYL:CARDOLCARDANOLANACARDIC ACID
926993
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Azadirachta indica (MELIACEAE)
POLYSACCHARIDE MA-9
968932
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Chromobacterium violaceum (RHIZOBIACEAE)
VIOLACEIN
480379
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
REVERSE TRANSCRIPTASE INHIBITION
Rosa rugosa (ROSACEAE)
PEDUNCULAGIN
330002
PURIFICATION OFPATENT DESCRIBED
Empty organism
TRYPTOPHAN,(DL):
955612
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza glabra (FABACEAE)
GLYCYRRHIZIN,APIO:
1020314
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Panax ginseng (ARALIACEAE)
GINSENOSIDE RB-1GINSENOSIDE RG-1
701687
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Camptotheca acuminata (NYSSACEAE)
CAMPTOTHECIN
912586
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Empty organism
INDOLIZINETETRA-1-ALPHA-6-BETA-7-ALPHA-8-BETA-8(A)-BETA-OL,1-6-7-8-OCTAHYDRO: (1S): 8-O-(ALPHA-D-GLUCOSIDE)*
1093131
SYNTHESIS OF ANALOGSMARKER CODE - FERTILITY REGULATION. NO RETRIEVABLE DATAPATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
ZOAPATANOL
28983
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Asclepias syriaca (ASCLEPIADACEAE)
698750
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Empty organism
GUAIACOLVERATRYL ALCOHOLSYRINGALDEHYDE
901983
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIPROTOZOAN ACTIVITY
Empty organism
FIGAROIC ACID
536806
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
DRUG ADDICTION INHIBITION
Empty organism
NICOTINE
371823
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION
Empty organism
FORSYTHIASIDE
1029006
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces fradiae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC YT-3927
487408
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
REDUCTASE,5-ALPHA: INHIBITION
Empty organism
KUWANON H
991993
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Streptomyces clavulus (STREPTOMYCETACEAE)
STREPTOMYCES AMYLASE INHIBITOR TAI-B
1057989
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Spirulina species (OSCILLATORIACEAE)
816266
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
NEOVIRIDOGRISEIN INEOVIRIDOGRISEIN IINEOVIRIDOGRISEIN III
1035589
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces lydicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC GT-2558-A
329962
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces lavendulae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC R-4-H
236103
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces spectabilis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SNF-4435
614031
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
STREPTOMYCES ANTIBIOTIC OS-3256-B
329803
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
BERBERINE,PSEUDO:
1020433
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
MALTOSE TETRAPALMITATE
1005421
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aspergillus terreus (HYPHOMYCETES)
ITACONIC ACID
521434
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Empty organism
COUMESTROL
182192
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC S-632-C
1080420
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Montanoa tomentosa (ASTERACEAE)
ZOAPATANOL
819306
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Talaromyces species (TRICHOCOMACEAE)
FOSFONOCHLORIN
1044110
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stereospermum tetragonum (BIGNONIACEAE)
LAPACHOL
598483
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Artemisia capillaris (ASTERACEAE)
PHENYL,3-4-DIMETHOXY: 4'-O-BETA-D-GLUCOSIDE
321313
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
ERYTHROMYCIN B,4''-DEOXY-4''-OXO: DERIVATIVES*
1049852
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces tokunonensis (STREPTOMYCETACEAE)
BACTOBOLIN,ALLANYL:
1104331
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIFERTILITY
ABORTIFACIENT EFFECT
Montanoa tomentosa (ASTERACEAE)
OXEPANE,3-ACETOXY-6-(2-OXO-ETHYLIDENE)-2-METHYL-2-(4-8-DIMETHYL-5-OXO-7-NONENYL):OXEPAN-3-ONE,6-(2-HYDROXY-ETHYLIDENE)-2-METHYL-2-(4-8-DIMETHYL-5-OXO-7-NONENYL): 2(S):OXEPAN-3-ONE,6-(2-ACETOXY-ETHYL,DENE)-2-METHYL-2-(4-8-DIMETHYL-5-OXO-7-NONENYL): 2(S):OXEPAN-3-OL,6-(2-ACETOXY-ETHYLIDENE)-2-METHYL-2(4-8-DIMETHYL-5-OXO-N-NONENYL): (2S-3R):OXEPANE,3-ACETOXY-6-(2-ACETOXY-ETHYLIDENE)-2-METHYL-2-(4-8-DIMETHYL-5-OXO-7-NONENYL): (25-3R):OXEPANE,3-ACETOXY-6-(2-HYDROXY-ETHYLIDENE)-2-METHYL-2-(4-8-DIMETYL-5-OXO-7-NONENYL): 3(R):
1073762
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Caltha palustris (RANUNCULACEAE)
138645
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC RK-441-S
592024
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
AIDS THERAPEUTIC EFFECTS
Melaleuca quinquenervia (MYRTACEAE)
996143
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces coeruleorubidus (STREPTOMYCETACEAE)
BAUMYCIN C-1
1020188
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
HITACHIMYCIN,(+):
1045995
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC B-41-E
99553
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Dactylosporangium species (ACTINOPLANACEAE)
CEZOMYCIN,3-HYDROXY:
952077
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIHEPATOTOXIC ACTIVITY
Polystictus versicolor (HYMENOCHAETACEAE)
1063697
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ABORTIFACIENT EFFECT
Montanoa tomentosa (ASTERACEAE)
ZOAPATANOL
338586
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Cephalosporium acremonium (HYPHOMYCETES)
PENICILLIN NCEPHALOSPORIN C,DEACETOXY:CEPHALOSPORIN C,DEACETYL:
1005727
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces diastaticus-amylostaticus (STREPTOMYCETACEAE)
AMYLOSTATIN B
346854
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
LAXATIVE EFFECT
Plantago ovata (PLANTAGINACEAE)
187632
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces coeruleorubidus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 14-1-12
82915
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Penicillium rugosum (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC 2188
1259116
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
NARCOTIC ANTAGONIST ACTIVITY
Citrus trifoliata (RUTACEAE)
56570
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLUSCICIDAL ACTIVITY
Phytolacca dodecandra (PHYTOLACCACEAE)
330189
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
DISCRETINE
342226
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Oospora virescens (HYPHOMYCETES)
LABDA-7-14-DIEN-3-OL,5-EPI: 18-O-BETA-D-GLUCURONOSIDELABDA-7-14-DIENE,5-EPI: 3-OXO: 18-O-BETA-D-GLUCOSIDE
802933
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Humulus lupulus (CANNABACEAE)
HUMULONE
349089
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIBACTERIAL ACTIVITY
Empty organism
LIMONEN-10-OL
360496
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eucalyptus globulus (MYRTACEAE)
MACROCARPAL BMACROCARPAL CMACROCARPAL DMACROCARPAL A
1047535
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Digitalis lanata (SCROPHULARIACEAE)
DIGITOXIN
422893
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIHEPATOTOXIC ACTIVITY
Alisma orientale (ALISMATACEAE)
ALISOL A,16-KETO:
956136
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RADICAL SCAVENGING EFFECT
Empty organism
GALLIC ACIDEMODINSENNOSIDE ASENNOSIDE BSENNIDIN A
325750
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
RESORCINOL
990912
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Coriolus versicolor (POLYPORACEAE)
CORIOLUS VERSICOLOR ANTIBIOTIC
319815
CHEMICAL CONVERSION OFPATENT DESCRIBED
Empty organism
OXALIC ACID
125438
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora globosa (MICROMONOSPORACEAE)
ENDYNAMICIN A
1081955
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTHELMINTIC ACTIVITY
Hedera helix (ARALIACEAE)
HEDERASAPONIN C
79330
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces majorciensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC LLCO-8078-ALPHA-1
742305
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Peschiera australis (APOCYNACEAE)
CORONARIDINE
986336
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Mycobacterium bovis (MYCOBACTERIACEAE)
MYCOBACTERIUM ANTIBIOTIC T-0-B-1
1026066
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
MONACOLIN K LACTONE
1026466
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Lactobacillus jugurti (LACTOBACILLACEAE)
LACTOBACILLUS ANTIBIOTIC MPS-80
1023814
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
619999
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Cryptoderma pini (HYMENOCHAETACEAE)
CRYPTODERMA PINI ANTIBIOTIC
811031
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Micromonospora olivoasterospora (MICROMONOSPORACEAE)
FORTIMICIN C
986962
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CEPHALOTAXYL,METHYL: FUMARATE
566508
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Empty organism
GLABRIDIN
1036395
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Fusobacterium nucleatum (BACTERIOIDACEAE)
FUSOBACTERIUM ANTIBIOTIC TF-210
956098
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Combretum caffrum (COMBRETACEAE)
COMBRETASTATIN A-4
398953
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
WITHAFERIN A,14-ALPHA-HYDROXY:
50818
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Prosopis africana (FABACEAE)
PROSOPININE
948452
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIDANDRUFF EFFECT
Empty organism
ASPARAGUSIC ACID
321464
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
LEUROSINELEUROCRISTINEVINCALEUKOBLASTINE
818647
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC KA-7038-X
978408
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Paeonia moutan (PAEONIACEAE)
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
535379
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Kalopanax pictus (ARALIACEAE)
HEDERIN,ALPHA:
810403
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN HUMANS
BITTER TASTING EFFECT
Stevia rebaudiana (ASTERACEAE)
STEVIA REBAUDIANA COMPOUND A-6
131249
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-114-C
928015
PATENT DESCRIBED
Empty organism
GENISTEIN
325665
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza species (FABACEAE)
GLYCYRRHETINIC ACID
417812
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIALLERGENIC ACTIVITY
Empty organism
CINNAMALDEHYDE,3'-4'-5'-TRIMETHOXY:
321759
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MICROBIAL TRANSFORMATION OF
Pseudofusarium fusarioideum (HYPHOMYCETES)
PENICILLIN V
1002728
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Actinomyces longispororuber (ACTINOMYCETACEAE)
CORALLOMYCIN
984325
PHARMACOLOGY OF EXTRACT - IN VIVOIDENTIFICATION OFPATENT DESCRIBED
ANTITUMOR ACTIVITY
Symphytum officinale (BORAGINACEAE)
VITAMIN B-2VITAMIN B-12ALLANTOINPROTEIN
325117
PURIFICATION OFPATENT DESCRIBED
Empty organism
QUINOLINE
148729
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces graminofaciens (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FD-892
332020
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIPROTOZOAN ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
BUT-3-ENOIC ACID,TRANS-2-AMINO-4-(2-AMINO-ETHOXY): L:
619039
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Papaver somniferum (PAPAVERACEAE)
NARCOTOLINE
854326
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Micromonospora echinospora (MICROMONOSPORACEAE)
PSICOFURANINE
189399
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC KO-7888-BSTREPTOMYCES ANTIBIOTIC KO-7888-CSTREPTOMYCES ANTIBIOTIC KO-7888-DSTREPTOMYCES ANTIBIOTIC KO-7888
742310
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXIC EFFECT(GENERAL)
Peschiera australis (APOCYNACEAE)
VOACANGINE
220810
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS
HERBICIDAL ACTIVITY
Acremonium roseum (HYPHOMYCETES)
ACREMONIUM HERBICIDE AF-1
229544
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Cystobacter fuscus (CYSTOBACTERACEAE)
CYSTOBACTER ANTIBIOTIC YSI-40-2
950163
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
EXPECTORANT ACTIVITY
Fritillaria ussuriensis (LILIACEAE)
USSURIENINE
212403
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Vibrio species (VIBRIONACEAE)
VIBRIO ANTIBIOTIC B-4607-A
812690
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Montanoa tomentosa (ASTERACEAE)
ZOAPATANOL
1023246
UV SPECTRUM GIVEN FORISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Actinomyces tauricus (ACTINOMYCETACEAE)
TAVRIMYCIN ATAVRIMYCIN B
885264
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
WOUND HEALING ACCELERATION
Empty organism
GLYCYRRHETINIC ACID
76594
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Penicillium rugulosum (HYPHOMYCETES)
PENICILLIUM ANTIBIOTIC BP-3-I
844934
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIATHEROSCLEROTIC ACTIVITY
Phaeodactylum tricornutum (FRAGILARIACEAE)
520856
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Empty organism
THIOCYANATE,ISO: ALLYL:
1036707
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Chlorella species (CHLORELLACEAE)
CHLORELLA CHLOROPHYLL DERIVATIVE
653193
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Empty organism
CASTANOSPERMINE
979208
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Lentinus edodes (TRICHOLOMATACEAE)
LENTINUS EDODES ANTIBIOTIC KS-2-A
819212
PATENT DESCRIBED
Empty organism
STEVIOSIDE
338774
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Stachylidium bicolor (HYPHOMYCETES)
DIOSGENONE
333760
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
746074
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
MEMORY RETENTION IMPROVEMENT
Empty organism
HUPERZINE A
852412
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Platycodon grandiflorum (CAMPANULACEAE)
790002
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
VALERAMIDE,ISO:
491167
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
COT-1-ENE,6(R)-BROMO-3(S)-BROMO-METHYL-7-METHYL-2-3-7-TRICHLORO:
1058192
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Brettanomyces anomalus (HYPHOMYCETES)
COENZYME Q-10
568986
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
BENIGN PROSTATIC HYPERPLASIA IMPROVEMENT
Serenoa repens (ARECACEAE)
978401
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIRADIATION EFFECT
Iris pallasii (IRIDACEAE)
PALLASONE C
352463
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Plectranthus forskholii (LAMIACEAE)
126846
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MH-563-32-F-1
524405
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
PHARMACOKINETIC STUDY OF
Taxus baccata (TAXACEAE)
693874
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
598479
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR CONDITIONER
Macadamia ternifolia (PROTEACEAE)
1216575
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INSECTICIDE ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC B-41-D
523908
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sinularia species (ALCYONIIDAE)
SIMULAMIDE
470126
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTISTRESS ACTIVITY
Selinum monnieri (APIACEAE)
CNIDEOSIDE A
231066
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxus cuspidata (TAXACEAE)
TAXINE II,2'-HYDROXY:
84942
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 165-3
112363
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Eupenicillium parvum (TRICHOCOMACEAE)
PHTHALEXIN
1009132
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces gilvotanareus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-38-B
952189
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Agaricus blazei (AGARICACEAE)
ERGOSTA-7-22-DIEN-6-ONE,3-BETA-5-ALPHA-9-TRIHYDROXY:
218046
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ecteinascidia turbinata (PEROPHORIDAE)
ECTEINASCIDIN 729
319896
ION EXCHANGE METHODS USEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
KANAMYCIN
385968
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
HAIR INHIBITION EFFECT
Camellia sinensis (THEACEAE)
672774
PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBED
Stevia rebaudiana (ASTERACEAE)
818603
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTHELMINTIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC B-41-GSTREPTOMYCES ANTIBIOTIC B-41-E
555942
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Actinomyces species (ACTINOMYCETACEAE)
BENANOMICIN A
1047823
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces argenteolus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC PA-31088-II
996220
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces testaceus (STREPTOMYCETACEAE)
PEPSTATIN
1012234
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinoplanes species (ACTINOPLANACEAE)
PLANOTHIOCIN A
982665
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nocardia species (NOCARDIACEAE)
MAYTANSINE
560804
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Empty organism
ASTILBINASTILBIN,NEO:ASTILBIN,ISO:
1259119
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
NARCOTIC ANTAGONIST ACTIVITY
Asarum sieboldii (ARISTOLOCHIACEAE)
957210
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HAIR DYEING EFFECT
Daphniphyllum macropodium (DAPHNIPHYLLACEAE)
GENIPOSIDIC ACID
812689
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Montanoa tomentosa (ASTERACEAE)
MONTANOL
394780
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SUNSCREEN EFFECT
Empty organism
COUMARIN,ISO: 3-(4'-METHOXY-PHENYL):*
1056217
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces elizabethi (STREPTOMYCETACEAE)
ELIZABETHIN
1006788
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptoverticillium cinnamoneum (STREPTOMYCETACEAE)
STREPTOVERTICILLIUM ANTIBIOTIC SF-1908
332976
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
GALLATE,N-PROPYL:
687252
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cladosiphon okamuranus (CHORDARIACEAE)
FUCOIDAN
338607
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
PARASYMPATHOLYTIC ACTIVITY
Empty organism
HYDRASTINEBERBERINE
818621
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Aspergillus nidulans (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC IMI-238850
84964
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 81-484
610230
PATENT DESCRIBED
Empty organism
DODECAN-1-OL
964579
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stizolobium cochinchinensis (FABACEAE)
DOPA,L:
329791
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
XANTHINE
329564
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinoplanes utahensis (ACTINOPLANACEAE)
ACTINOPLANES ANTIBIOTIC A-287-AACTINOPLANES ANTIBIOTIC A-287-B
824190
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces melanosporofaciens (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SEN-128-B
406027
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
HERNANDALUINE,(DL):THALICARPINE
1051703
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces bottropensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-45-A-2
255030
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIFOULING ACTIVITY
Mytilus edulis (MYTILIDAE)
MYTILUS SESQUITERPENE I
1006593
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Pseudomonas species (PSEUDOMONADACEAE)
PSEUDOMONAS ANTIBIOTIC Y-33
876934
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptococcus zooepidemicus (STREPTOCOCCACEAE)
HYALURONIC ACID
1267355
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HYPOTENSIVE ACTIVITY
Achillea millefolium (ASTERACEAE)
955094
PATENT DESCRIBED
Empty organism
AROMOLINE,HOMO:
426796
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Platycodon grandiflorum (CAMPANULACEAE)
1066621
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CNS DEPRESSANT ACTIVITY
Montanoa tomentosa (ASTERACEAE)
MONTANOL
352649
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Pinus densiflora (PINACEAE)
BORNEOL ACETATECARYOPHYLLENE,BETA:HUMULENE,ALPHA:
328246
PHEROMONE MARKER CODEPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
STRIGOL,(DL):
352609
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INTERLEUKIN-1 FORMATION INHIBITION
Eleutherococcus koreanus (ARALIACEAE)
ACANTHOIC ACID
992305
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS 50-100 MGM
Streptomyces antibioticus (STREPTOMYCETACEAE)
1099723
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSUPPRESSANT ACTIVITY
Empty organism
RICIN MONOCLONAL ANTIBODY THY 1.2RICIN-MONOCLONAL ANTIBODY THY 1.1RICIN A CHAIN MONOCLONAL ANTIBODY THY 1.2RICIN A CHAIN MONOCLONAL ANTIBODY THY 1.1
584966
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eleutherobia albiflora (ALCYONIIDAE)
ELEUTHEROBIN
1158804
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Empty organism
ALANOSINE
347014
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Chelidonium majus (PAPAVERACEAE)
PROTOPINECHELIDONINECRYPTOPINE,ALLO:
330312
SYNTHESIS OF ANALOGSPATENT DESCRIBEDSOLUBILITY STUDIES OF
Empty organism
CAMPESTEROLERGOSTEROLSTIGMASTEROLSITOSTEROL,BETA:TOCOPHEROL,ALPHA:CHOLESTEROLVITAMIN D
362527
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIAGING ACTIVITY
Empty organism
FERULIC ACIDRUTIN,ALPHA-GLUCOSYL:
1010253
PURIFICATION OFPATENT DESCRIBED
Empty organism
MACROMOMYCIN
607496
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Benincasa hispida (CUCURBITACEAE)
194306
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
SQUALENE SYNTHASE INHIBITION
Cladosporium cladosporioides (HYPHOMYCETES)
CLADOSPORIUM ANTIBIOTIC TAN-1607-A
92877
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SS-21020-D
1028570
UV SPECTRUM GIVEN FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Veillonella alcalescens (VEILLONELLACEAE)
VEILLONELLA ANTIBIOTIC TV-134
1002745
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AA-57
559088
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces venezuelae (STREPTOMYCETACEAE)
JADOMYCIN B
426307
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Empty organism
ATROPINE
1026116
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Triticum aestivum (POACEAE)
TRITICUM AESTIVUM POLYPEPTIDE SP-1
975783
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ABSORPTION EFFECTS(CUTANEOUS)
Zingiber officinale (ZINGIBERACEAE)
978412
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
CERCOSPORIN
589932
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Bupleurum falcatum (APIACEAE)
1290251
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cryptolepis sanguinolenta (ASCLEPIADACEAE)
CRYPTOLEPINE
996608
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Micromonospora peucetica (MICROMONOSPORACEAE)
DAUNOMYCIN,11-DEOXY:DAUNOMYCIN,11-DEOXY-DIHYDRO:DAUNOMYCIN,2-DEACETYL-11-DEOXY: 2-ETHYL:ADRIAMYCIN,11-DEOXY: 4-METHYL ETHER
657348
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Spirastrella spinispirulifera (SPIRASTRELLIDAE)
SPONGIASTATIN 6
113055
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Bacillus species (BACILLACEAE)
BACILLUS ANTIBIOTIC Y-05460-M-A
598550
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
NARCOTIC ANTAGONIST ACTIVITY
Empty organism
IBOGAINE,NOR:
6506
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Phellinus igniarius (HYMENOCHAETACEAE)
PHELLINUS ANTIBIOTIC
960759
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LYMPHOCYTE STIMULATION
Ligustrum lucidum (OLEACEAE)
LIGUSTRIN
131846
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Xestospongia species (PETROSIIDAE)
XESTOSPONGIA STEROL YT-040
587532
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Topsentia species (EPIPOLASIDAE)
TOPSENTIN,4-5-DIHYDRO: 6'-DEOXY-BROMO:
547406
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Hippospongia species (SPONGIIDAE)
HIPPOSPONGIN
824681
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
MANILOSPORIN B-2
1029513
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Microellobosporia grisea (STREPTOMYCETACEAE)
MICROELLOBOSPORIA ANTIBIOTIC TC-13
691285
IDENTIFICATION IN BY GLCGC DATA REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBED
Allium sativum (LILIACEAE)
ALLICIN
1152246
MARKER CODE - FERTILITY REGULATION. NO RETRIEVABLE DATAPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
LIQUIRITIC ACID
81702
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Unidentified actinomycete (UNDETERMINED)
ACTINOMYCETE ANTIBIOTIC BBM-2478-B
1002895
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Streptomyces coelurubeorubidus (STREPTOMYCETACEAE)
PYRROMYCINONE,EPSILON:
417932
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ABSORPTION EFFECTS(CUTANEOUS)
Empty organism
MENTHONE,(-):
965722
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIARRHYTHMIC ACTIVITY
Aconitum leucostomum (RANUNCULACEAE)
LAPPACONITINE
76414
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Streptosporangium species (STREPTOSPORANGIACEAE)
STREPTOSPORANGIUM ANTIBIOTIC DC-87-A
668186
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Castela peninsularis (SIMAROUBACEAE)
GLAUCARUBOLONE
978364
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Capsicum annuum (SOLANACEAE)
CAPSIANOSIDE II
509687
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ircinia species (SPONGILLIDAE)
IRCINOLIDE A
982510
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-1942
898639
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SWEETENING EFFECT
Stevia rebaudiana (ASTERACEAE)
417517
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Phaseolus vulgaris (FABACEAE)
PHASEOLUS GLYCOPROTEIN (MW 48,000)
607418
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Pseudostellaria heterophylla (CARYOPHYLLACEAE)
PSEUDOSTELLARIN APSEUDOSTELLARIN BPSEUDOSTELLARIN EPSEUDOSTELLARIN FPSEUDOSTELLARIN DPSEUDOSTELLARIN C
952086
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
INTERFERON INDUCTION STIMULATION
Polystictus versicolor (HYMENOCHAETACEAE)
956137
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HAIR STIMULANT EFFECT
Empty organism
HINOKITIOL
325141
PATENT DESCRIBEDANTIOXIDANT PROPERTIES OF EXTRACT
Empty organism
TOCOPHEROL,ALPHA:
5691
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Micromonospora chalcea (MICROMONOSPORACEAE)
BOTTROMYCIN
870142
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
MISCELLANEOUS EFFECTS
Luffa aegyptiaca (CUCURBITACEAE)
330040
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
GUANIDINE
155687
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Phoma species (COELOMYCETES)
PHOMA ANTIBIOTIC PF-1052
731878
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sophora alopecuroides (FABACEAE)
MATRINE
998900
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIHYPERCHOLESTEROLEMIC ACTIVITY
Hordeum vulgare (POACEAE)
630327
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
NITRIC OXIDE SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
347885
PATENT DESCRIBED
Empty organism
COMBRETASTATIN A-4
327721
YIELD IS MORE THAN 100 MGMPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTUREPHARMACOLOGY OF COMPOUND - IN HUMANS
WOUND HEALING ACCELERATION
Chromolaena odorata (ASTERACEAE)
ESSENTIAL OIL(EUPATORIUM ODORATUM)
976198
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Hericium erinaceum (HERICIACEAE)
OCTADECENOIC ACID
827360
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
GROWTH PROMOTER ACTIVITY
Streptomyces virginiae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-41030-FACTOR FSTREPTOMYCES ANTIBIOTIC A-41030-FACTOR ESTREPTOMYCES ANTIBIOTIC A-41030-FACTOR ASTREPTOMYCES ANTIBIOTIC A-41030-FACTOR GSTREPTOMYCES ANTIBIOTIC A-41030-FACTOR DSTREPTOMYCES ANTIBIOTIC A-41030-FACTOR BSTREPTOMYCES ANTIBIOTIC A-41030-FACTOR C
982139
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Alcaligenes eutrophus (ACHROMOBACTERIACEAE)
TRYPTOPHAN,L:
325134
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYCOMPLEX FORMATIONPATENT DESCRIBED
Empty organism
LINOLEIC ACIDOLEIC ACID
810225
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stephania glabra (MENISPERMACEAE)
STEPHAGLABRINE
79334
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces majorciensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC LLCO-8078-ALPHA-2
410344
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
LAVANDULOL
1080925
QUANTITATIVE DATAPATENT DESCRIBEDYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Piper nigrum (PIPERACEAE)
UNDECA-TRANS-2-TRANS-4-TRANS-10-TRIENAMIDE,N-ISO-BUTYL-11-(3-4-METHYLENEDIOXY-PHENYL):
416889
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIPROTOZOAN ACTIVITY
Empty organism
PAPULACANDIN APAPULACANDIN CPAPULACANDIN DPAPULACANDIN BPAPULACANDIN E
352915
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Zopfiella curvata (LASIOSPHAERIACEAE)
ZOPFIELLIN
240233
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Pantoena agglomerans (ENTEROBACTERIACEAE)
OLIGOMYCIN SC-1
75411
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces paulus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 273-A-1-ALPHASTREPTOMYCES ANTIBIOTIC 273-A-1-BETA
893473
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITHROMBOTIC EFFECT
Picrasma quassioides (SIMAROUBACEAE)
BUTAN-1-ONE,1-(BETA-CARBOLIN-1-YL)-2-METHOXY-4-(4-8-DIMETHOXY-BETA-CARBOLIN-1-YL):
442847
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Gutenbergia cordifolia (ASTERACEAE)
GUTENBERGIN
574592
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ircinia species (SPONGILLIDAE)
SULFIRICIN
556159
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces albus (STREPTOMYCETACEAE)
PENTALENOLACTONE
410879
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Laxitextum bicolour (HERICIACEAE)
LAXITEXTUM BICOLOR ANTIBIOTIC
996147
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces coeruleorubidus (STREPTOMYCETACEAE)
BAUMYCIN C-2
470849
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Fusarium species (HYPHOMYCETES)
AGISTATIN CAGISTATIN EAGISTATIN DAGISTATIN AAGISTATIN B
1049782
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC OA-7653
1040758
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
CHOLAGOGUE ACTIVITY
Orchis militaris (ORCHIDACEAE)
BENZYL ALCOHOL,4-HYDROXY:
325088
PATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF COMPOUND - IN HUMANS
GALLSTONE SOLUBILIZING EFFECT
Empty organism
CHOLIC ACID,CHENO-DEOXY:
565689
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SUNSCREEN EFFECT
Empty organism
GALLOCATECHIN-3-O-GALLATE,EPI: (-):
1023643
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Garcinia mannii (CLUSIACEAE)
MANNIFLAVANONE
1242948
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
HYPOGLYCEMIC ACTIVITY
Mulgedium alpinum (ASTERACEAE)
857438
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS
PLANT GROWTH INHIBITOR(UNSPEC)
Aspergillus niger (HYPHOMYCETES)
ASPERGILLUS SUBSTANCE I-63913
370974
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
DERMATITIS IMPROVEMENT
Gelsemium sempervirens (LOGANIACEAE)
960785
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Trididemnum solidum (DIDEMNIDAE)
DIDEMNIN Y
1299142
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANGIOGENESIS INHIBITION
Empty organism
ADHYPERFORINHYPERFORIN
151249
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-8059
362533
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG ADDICTION INHIBITION
Salvia miltiorrhiza (LAMIACEAE)
332267
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Streptomyces lactamgenes (STREPTOMYCETACEAE)
CEPHALOSPORIN DERIVATIVE
678520
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
CARDIOTONIC ACTIVITY
Crataegus oxyacantha (ROSACEAE)
1289507
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aristolochia taliscana (ARISTOLOCHIACEAE)
VANILLIN
693844
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
659735
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
1123105
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIBACTERIAL ACTIVITY
Alpinia officinarum (ZINGIBERACEAE)
1210889
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Pinus parviflora (PINACEAE)
136941
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Lactobacillus species (LACTOBACILLACEAE)
LACTOBACILLUS POLYSACCHARIDE
348655
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
DENTIFRICE ACTIVITY
Phellodendron chinense (RUTACEAE)
1025166
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Streptomyces pactum (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC XK-218
446855
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
ADIANTIFOLINE,METHOXY:
50810
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
CAPILLARY PERMEABILITY DECREASED
Prosopis africana (FABACEAE)
PROSOPINE
843786
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF AN ABERRANT PRINCIPLE
Escherichia coli (ENTEROBACTERIACEAE)
INDIGO
870450
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Perilla frutescens (LAMIACEAE)
PERILLA PIGMENT
1050645
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aspergillus repens (HYPHOMYCETES)
REPENTIN B
187966
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Stellera chamaejasme (THYMELAEACEAE)
STELLARAMACRIN B
3133
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Viscum album (LORANTHACEAE)
334603
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ABORTIFACIENT EFFECT
Phytolacca dodecandra (PHYTOLACCACEAE)
561866
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bergenia purpurascens (SAXIFRAGACEAE)
ARBUTIN,4-6-DI-O-GALLOYL:ARBUTIN,2-4-6-TRI-O-GALLOYL:ARBUTIN,6-O-GALLOYL:ARBUTIN,2-3-4-6-TETRA-O-GALLOYL:
870408
PATENT DESCRIBED
Empty organism
BAICALEIN
1006824
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Saccharomyces species (SACCHAROMYCETACEAE)
SACCHAROMYCES ANTIBIOTIC
824066
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
STEVIOSIDE
432106
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMALARIAL ACTIVITY
Empty organism
GOSSYPOL
898510
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
LYMPHOCYTE BLASTOGENESIS INHIBITION
Empty organism
SENEGENIN
1042965
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Phyllanthus veuminatus (EUPHORBIACEAE)
PHYLLANTHOSTATIN 3
85484
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces griseoincarnatus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC C-1
1011485
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Corynebacterium species (CORYNEFORM ACTINOMYCETE)
CORYNEBACTERIUM ANTIBIOTIC DC-5-4
1324728
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Hazunta species (APOCYNACEAE)
OCHROPAMINE
960754
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cryptomeria japonica (TAXODIACEAE)
ROYLEANONE,12-DEHYDROXY-7-HYDROXY:
836504
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN BACLACINOMYCIN A
1029013
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AM-5344-A-2
568195
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
MISCELLANEOUS EFFECTS
Empty organism
GLYCYRRHETINIC ACID,BETA:
946767
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Picrasma javanica (SIMAROUBACEAE)
PICRASMA SESQUITERPENE LACTONE I
23893
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ananas comosus (BROMELIACEAE)
BROMELAIN
563166
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Plantago lanceolata (PLANTAGINACEAE)
1087443
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aloe arborescens (LILIACEAE)
ALOCTIN A
713300
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
TOXICITY ASSESSMENT(QUANTITATIVE)
Cordyceps sinensis (CLAVICIPITACEAE)
609528
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
T-CELL STIMULATION
Empty organism
PINENE,ALPHA:
411897
SYNTHESIS OF ANALOGSPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Catharanthus roseus (APOCYNACEAE)
LOGANIN
575982
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIDANDRUFF EFFECT
Swertia species (GENTIANACEAE)
961146
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPOXYGENASE,5: INHIBITION
Rehmannia glutinosa (SCROPHULARIACEAE)
VERBASCOSIDE,ISO:
611443
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Alternaria mali (HYPHOMYCETES)
TENTOXIN
552587
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxus brevifolia (TAXACEAE)
TAXOL
818614
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC BBM-2040-B
332929
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
HERNANDALINE,(+):
487283
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
XANTHINE OXIDASE INHIBITION
Hordeum vulgare (POACEAE)
VITEXIN,ISO:
992674
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDYIELD IS LESS THAN 50 MGM
Micromonospora sagamiensis (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC SUM-4
151375
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Elytrosporangium species (STREPTOMYCETACEAE)
ELYTROSPORANGIUM ANTIBIOTIC BU-3292-T-A
917473
IDENTIFICATION OFPATENT DESCRIBED
Artemisia montana (ASTERACEAE)
CAFFEIC ACIDCHLOROGENIC ACID B,ISO:CHLOROGENIC ACID METHYL ESTERCHLOROGENIC ACID A,ISO:CHLOROGENIC ACIDCHLOROGENIC ACID C,ISO:
328919
PURIFICATION OFPATENT DESCRIBED
Empty organism
COUMARIN
384436
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces species (STREPTOMYCETACEAE)
YUNNAMYCIN
657320
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Spongia species (SPONGIIDAE)
SPONGIASTATIN 3
553023
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
FATTY ACID COMPOSITION CHANGE
Empty organism
DOCOSAHEXA-4-7-10-13-16-19-ENOIC ACID
565111
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
TYROSINASE INHIBITION
Curcuma longa (ZINGIBERACEAE)
992036
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Lentinus edodes (TRICHOLOMATACEAE)
EMITANIN BEMITANIN-1A
93651
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Bifidobacterium longum (ACTINOMYCETACEAE)
BIFIDOBACTERIUM ANTIBIOTIC(15-200000 DALTONS)
975782
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ABSORPTION EFFECTS(CUTANEOUS)
Empty organism
GLYCYRRHETINIC ACID
948911
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RADIOSENSITIZING EFFECT
Iris pallasii (IRIDACEAE)
PALLASONE B
1020190
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
HITACHIMYCIN,(+):
994791
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIBACTERIAL ACTIVITY
Lentinus edodes (TRICHOLOMATACEAE)
LENTINUS ANTIBIOTIC KS-2-A
718963
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
VINCAMINE
609062
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
DAN-PHENOLIC ACID A
747179
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Hypericum perforatum (CLUSIACEAE)
XANTHONESHYPERFORIN
551557
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
CURCUMIN
1045720
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
MILBEMYCIN B-2MILBEMYCIN B-3
875953
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Rhodococcus species (NOCARDIACEAE)
CYCLOPENT-2-ENONE,4-HYDROXY: CYCLOPENT-2-EN-1-ONE,4-HYDROXY:
1094709
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Strobilanthes cusia (ACANTHACEAE)
TRYPTANTHRIN
86247
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces albolongus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TAN-528-A
1050174
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Cytophaga species (CYTOPHAGACEAE)
CYTOPHAGIN
1275258
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxus species (TAXACEAE)
BACCATIN III
151291
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-9561
490952
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Duboisia myoporoides (SOLANACEAE)
SCOPOLAMINEHYOSCYAMINE
354756
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIISCHEMIC EFFECT
Empty organism
LIQUIRITIN,ISO: APISOYL:
972475
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Artemisia capillaris (ASTERACEAE)
CAPILLONECAPILLIN
612862
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Coriolus versicolor (POLYPORACEAE)
COREOLUS VERSICOLOR PROTEOGLUCAN
1262113
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Echinacea angustifolia (ASTERACEAE)
ECHINACEA FACTOR A
76430
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
MISCELLANEOUS EFFECTS
Aspergillus alliaceus (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC I
329776
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
Citrus sinensis (RUTACEAE)
ESSENTIAL OIL
356410
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
DENTIFRICE ACTIVITY
Empty organism
CARYOPHYLLENE
565887
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Amphidinium species (GYMNODINIACEAE)
CARIBENOLIDE I
418063
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
FOOD CONSUMPTION REDUCTION
Empty organism
MENTHONE,(-):BORNEOL,ALPHA:PERILLA ALDEHYDE,(-):EUGENOLLIMONENE,(+):CAMPHOR,(DL):CINEOL,1-8:PINENE,ALPHA:CITRONELLAL
501164
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Buddleja coriacea (BUDDLEJACEAE)
BUDDLENOID A
207822
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces nobilis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC JCM-4274
327342
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Cnicus benedictus (ASTERACEAE)
598111
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN PIGMENTATION EFFECT
Empty organism
ASIATICOSIDE
617713
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDSEPARATION OF (EXCEPT OILS, VENOM, PROTEINS, FATS)
CARDIOTONIC ACTIVITY
Plectranthus forskholii (LAMIACEAE)
COELEUS FORSKOHLII SUBSTANCE(MW 410)
1007836
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ATP-ASE INHIBITION
Streptomyces aureofaciens (STREPTOMYCETACEAE)
NARASIN,20-DEOXY:
1016374
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Eucalyptus globulus (MYRTACEAE)
EUCALYPTUS GLOBULUS SUBSTANCE EK
1020802
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDTLC DATA REPORTED
Streptomyces species (STREPTOMYCETACEAE)
MUCOPEPTIN A
399433
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces fradiae (STREPTOMYCETACEAE)
TYLOSIN
917477
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WEIGHT LOSS
Artemisia princeps (ASTERACEAE)
1279582
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Aglaia leptantha (MELIACEAE)
SILVESTROLSILVESTROL,EPI:
356297
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Empty organism
EUGENOL
978865
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Gigartina ocellatus (GIGARTINACEAE)
CARRAGEENAN
1015265
PMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
ANALGESIC ACTIVITY
Chrysanthellum procumbens (ASTERACEAE)
CAULOPHYLLOGENIN ESTER
1013613
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Cytospora species (COELOMYCETES)
GRAHAMIMYCIN BCOLLETOKETOL
525542
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
CANTHARIDIN
877010
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Lathyrus japonicus (FABACEAE)
PROPIONIC ACID,DIAMINO:
362706
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
TYROSINASE STIMULATION
Paullinia cupana (SAPINDACEAE)
386154
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
COSMETIC EFFECTS
Empty organism
CAFFEOYL-3-QUINIC ACID
22518
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Viscum album (LORANTHACEAE)
PROTEIN NX1
449334
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Petasites japonicus (ASTERACEAE)
PETASIN,ISO:
958251
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR CONDITIONER
Ginkgo biloba (GINKGOACEAE)
1183640
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Papaver somniferum (PAPAVERACEAE)
1028569
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Veillonella alcalescens (VEILLONELLACEAE)
VEILLONELLA ANTIBIOTIC TV-1323
234766
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Zopfiella inermis (LASIOSPHAERIACEAE)
ZOPFIELLA ANTIBIOTIC S-15183-A
352605
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
COLLAGEN SYNTHESIS INHIBITION
Eleutherococcus koreanus (ARALIACEAE)
ACANTHOIC ACID
984982
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SWEETENING EFFECT
Stevia rebaudiana (ASTERACEAE)
14485
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
LEUROSINE
362680
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
HAIR STIMULANT EFFECT
Calendula officinalis (ASTERACEAE)
1086846
MARKER CODE - FERTILITY REGULATION. NO RETRIEVABLE DATAPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
ZOAPATANOL,(DL):
700706
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Hypericum perforatum (CLUSIACEAE)
ADHYPERFORINHYPERFORIN
1072724
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANESTHETIC ACTIVITY(LOCAL)
Aloe vera (LILIACEAE)
407796
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
EXPECTORANT ACTIVITY
Aloe arborescens (LILIACEAE)
893467
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Mentha piperita (LAMIACEAE)
1125189
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANALGESIC ACTIVITY
Prunus persica (ROSACEAE)
PROTEIN,PR-B(PRUNUS)PROTEIN,PR-A(PRUNUS)
1269881
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Marsdenia cundurango (ASCLEPIADACEAE)
CONDURANGOGLYCOSIDE D-0
148241
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-2582-A
68430
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
CARDIOVASCULAR EFFECTS(UNSPECIFIED)
Empty organism
NARINGENINNARINGIN
1130093
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Swertia japonica (GENTIANACEAE)
CYCLOHEX-2-ENE,5-(S)-ETHENYL-1-OXA-4-(S)-(2-HYDROXY-ETHYL):
329787
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
HYDROQUINONE
270160
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Juliania adstringens (JULIANIACEAE)
EUPHA-8-24-DIEN-26-OIC ACID,3-ALPHA-HYDROXY-7-11-DIOXO:
398487
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTIMUTAGENIC ACTIVITY
Aloe arborescens (LILIACEAE)
1091101
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
VINCALEUKOBLASTINE,N-DEMETHYL-N-(METHOXY-METHYL):
1065143
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ANTISPERMATOGENIC EFFECT
Ecballium elaterium (CUCURBITACEAE)
93576
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Microellobosporia grisea (STREPTOMYCETACEAE)
MICROELLOBOSPORA MANNOGLUCAN
670709
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Garcinia cambogia (CLUSIACEAE)
CITRIC ACID,ALPHA-HYDROXY: (-):
1323456
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANALGESIC ACTIVITY
Zingiber officinale (ZINGIBERACEAE)
SHOGAOL,6:GINGEROL,6:
1052181
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Bacillus pumilus (BACILLACEAE)
STREPTOMYCES ANTIBIOTIC BN-103-C
338781
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces diastatochromogenes (STREPTOMYCETACEAE)
AZDIMYCIN
841762
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces sioyaensis (STREPTOMYCETACEAE)
TRICHOSTATIN A
408382
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
EMBRYOTOXIC EFFECT(RELATED TO FERTILITY REGULATION)
Empty organism
ZOAPATANOL
236099
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIPROLIFERATION ACTIVITY
Aspergillus species (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC UCT-1072-M-1
98907
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
GROWTH PROMOTER ACTIVITY
Streptomyces noboritoensis amamiensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC WS-1627-C
326825
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION FOLLOWING BIOLOGICAL CONVERSION BYANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Streptomyces roseochromogenes (STREPTOMYCETACEAE)
DAUNORUBICINOL
693856
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
882372
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CYTOTOXIC ACTIVITY
Topsentia species (EPIPOLASIDAE)
TOPSENTIN
82934
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Actinomadura species (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC BBM-1644
997953
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
CHYMOSTATIN
955083
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Agaricus blazei (AGARICACEAE)
AGARICUS GLYCOPROTEIN
385899
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HYALURONIDASE INDUCTION
Gloiopeltis species (ENDOCLADIACEAE)
975771
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SUNSCREEN EFFECT
Empty organism
KOJIC ACID
980415
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stevia rebaudiana (ASTERACEAE)
STEVIOSIDE
470481
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aspergillus sulphureus (HYPHOMYCETES)
RADARIN CRADARIN BRADARIN D
668160
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
GLAUCARUBINONE
569664
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Carum carvi (APIACEAE)
997780
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Fuscoporia species (HYMENOCHAETACEAE)
FUSCOSPORIA SPECIES ANTIBIOTIC
417443
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
ALLICIN
1056730
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
STREPTOMYCES ANTIBIOTIC DK-7814-ASTREPTOMYCES ANTIBIOTIC DK-7814-BSTREPTOMYCES ANTIBIOTIC DK-7814-C
678829
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Annona squamosa (ANNONACEAE)
MOLVIZARIN
854668
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
FOOD USE
Empty organism
OCTACOSAN-1-OL
1050042
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Isodon trichocarpus (LAMIACEAE)
TRICHORABDAL C
417489
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIFUNGAL ACTIVITY
Empty organism
ALLICIN
668175
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
CHAPARRINONE
234544
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIPROLIFERATION ACTIVITY
Libertella species (HYPHOMYCETES)
LIBERTELLA ANTIBIOTIC MER-WF-1726
14479
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
LEUROSINE
925136
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Asteropus sarasinosum (THROMBIDAE)
SARASINOSIDE A-2
93646
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Aspergillus fumigatus (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC F-838
1287184
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Lepidium meyenii (BRASSICACEAE)
MACAMIDE AMACAMIDE BMACAMIDE CTHIOCYANATE,ISO: BENZYL:
1231388
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANALGESIC ACTIVITY
Olea europaea (OLEACEAE)
980257
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ABORTIFACIENT EFFECT
Empty organism
ZOAPATANOL
1289469
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aristolochia taliscana (ARISTOLOCHIACEAE)
MACHILIN F
112052
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Aspergillus species (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC 1656-B
589732
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
TOXIC EFFECT(GENERAL)
Empty organism
TUBEIMOSIDE I
610305
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Schumanniophyton magnificum (RUBIACEAE)
SCHUMANNIFICINE,ANHYDRO:
98739
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-102
611555
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Aleurodiscus amorphus (CORTICIACEAE)
ALOEURODISCUS AMORPHUS ANTIBIOTIC
171747
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces echinatus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC FD-991
932675
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
DEGRANULATION INHIBITION
Empty organism
ALOIN
411811
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
ANTIYEAST ACTIVITY
Psalliota xanthoderma (AGARICACEAE)
PSALLIOTA XANTHODERMA GLYCOPROTEIN
321294
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
GLUTARIC ACID,ALPHA-KETO:
566507
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Empty organism
GLABRIDINBUTYRIC ACID,GAMMA-AMINO:
853537
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Voacanga africana (APOCYNACEAE)
TABERSONINE,DIHYDRO: (-):
84913
GEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Sanguisorba officinalis (ROSACEAE)
SANGUIIN H-4
1023644
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALDOLASE INHIBITION
Garcinia mannii (CLUSIACEAE)
MANNIFLAVANONE
324509
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
JOSAMYCIN,10-ACYL-BETA:
996141
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
RHODORUBIN ARHODIRUBIN B
966534
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Empty organism
LICOCHALCONE A
331889
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Aspergillus ochraceus (HYPHOMYCETES)
TYROSINE,L: N-PHENYL-ACETYL:
693849
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
817448
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Streptomyces species (STREPTOMYCETACEAE)
STEVIOSIDE
409531
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
REPELLENT ACTIVITY(ANIMAL)
Empty organism
CYCLOHEXIMIDE
993268
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Lacunospora tetraspora (LASIOSPHAERIACEAE)
BOTRYODIPLODIN
270648
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Acremonium species (HYPHOMYCETES)
ACREMONIUM ANTIBIOTIC NF-02411-A
324906
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OFPHARMACOLOGY OF COMPOUND - IN HUMANS
BITTER TASTING EFFECT
Empty organism
BERBERINE
100082
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus pumilus (BACILLACEAE)
TREHALOSADIAMINE,3-3'-NEO:
555283
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
DEODORIZING EFFECT
Empty organism
BORNEOL
75415
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora globosa (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC S-54832-A-IMICROMONOSPORA ANTIBIOTIC S-54832-A-IIIMICROMONOSPORA ANTIBIOTIC S-54832-A-IIMICROMONOSPORA ANTIBIOTIC S-54832 A-IV
745315
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Scytalidium species (HYPHOMYCETES)
HALOVIR A
1083001
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Montanoa tomentosa (ASTERACEAE)
ZOAPATANOL
493868
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Verticillium species (HYPHOMYCETES)
VERTICILLIUM ANTIBIOTIC ES-242-8
390153
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
TOPOISOMERASE I INHIBITION
Streptomyces species (STREPTOMYCETACEAE)
ALNUMYCIN
996225
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTITUMOR ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MC-902-I'STREPTOMYCES ANTIBIOTIC MC-902
127910
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Streptomyces griseochromogenes (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC UK-86956
470448
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Batzella species (ESPERIOPSIDAE)
BATZELLINE A,ISO:
985886
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Mycobacterium tuberculosis (MYCOBACTERIACEAE)
321412
CHEMICAL CONVERSION OFPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Plexaura homomalla (PLEXAURIDAE)
PROSTAGLANDIN A-2PROSTAGLANDIN A-2,15-EPI:
552728
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Polygala senega (POLYGALACEAE)
SENEGOSE B
67059
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIVIRAL ACTIVITY
Hypericum perforatum (CLUSIACEAE)
100068
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Artocarpus communis (MORACEAE)
ARTOCARPUS CHALCONE I
193559
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces aeriouvifer (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC CL-190-Y-1
659779
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
BETULINIC ACID
419071
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Empty organism
ELLAGIC ACID
968250
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIPSORIATIC ACTIVITY
Trigonella foenum-graecum (FABACEAE)
380321
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
FLAVORING EFFECT
Empty organism
HESPERIDIN,NEO: DIHYDROCHALCONE
1010246
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
KANAMYCIN A
1128812
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEMATOCIDAL ACTIVITY
Sesamum indicum (PEDALIACEAE)
326300
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOLIPEMIC ACTIVITY
Empty organism
THEOPHYLLINE
657321
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Spongia species (SPONGIIDAE)
SPONGIASTATIN 3
355840
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
NERVE GROWTH FACTOR STIMULATION
Empty organism
JOLKINOLIDE BKANSUININ AINGENOL,TRIACETYL:
1085977
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
MAYTANSINE
1042863
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Polyporus versicolor (POLYPORACEAE)
LACCASE
1020973
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces umbrosus raffinophilus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-62
206603
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ascotricha amphitricha (XYLARIACEAE)
ASCOSTEROSIDE
1005200
YIELD IS MORE THAN 100 MGMWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SF-1293
1269890
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Marsdenia cundurango (ASCLEPIADACEAE)
CONDURANGOGLYCOSIDE D-0,20-ISO-O-METHYL:
492389
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
LAXATIVE EFFECT
Plantago ovata (PLANTAGINACEAE)
361035
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Haloferax gibbonsii (TO BE DETERMINED)
HALOCIN H-7
877911
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
VINCALEUKOBLASTINE
1000521
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bifidobacterium adolescentis (ACTINOMYCETACEAE)
BIFIDOBACTERIUM ANTIBIOTIC S-12
371131
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Quercus pedunculata (FAGACEAE)
319076
PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PREPARATION OF DERIVATIVES OF
Empty organism
CEPHALEXIN*
353486
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
MELANIN FORMATION INHIBITION
Concha blanca (TO BE DETERMINED)
318604
SEPARATION OF ISOMERSPATENT DESCRIBED
Empty organism
CHRYSANTHEMIC ACID,(DL):
525112
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Cephalodiscus gilchristi (CEPHALODISCIDAE)
CEPHALOSTATIN 1
982507
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
STREPTOMYCES ANTIBIOTIC SF-1942
14406
PATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
Cynanchum adriaticum (ASCLEPIADACEAE)
CARDIAC GLUCOSIDES(CYNANCHUM ADRIATICUM)
931455
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eclipta alba (ASTERACEAE)
WEDELOLACTONEWEDELOLACTONE,DEMETHYL:
409830
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma boninense (GANODERMATACEAE)
GANODERMA BONINENSE ANTIBIOTIC
1098925
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
LEUROCRISTINEVINCALEUKOBLASTINE
1231762
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Medicago sativa (FABACEAE)
721373
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Astilbe chinensis (SAXIFRAGACEAE)
PELTOBOYKINOLIC ACID,BETA:
1003329
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
PSORIASIS TREATMENT
Polypodium aureum (POLYPODIACEAE)
OCTONO-DELTA-LACTON-3-4-ENEDIOL,ALPHA-D-GLUCO: CALCIUM SALT
611857
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Thaumatococcus daniellii (MARANTACEAE)
THAUMATIN
964473
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Claviceps purpurea (CLAVICIPITACEAE)
ERGONOVINE
577722
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Glycyrrhiza glabra (FABACEAE)
GLYCYRRHIZIN
811962
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
NIVALENOL MONOACETATENIVALENOLNIVALENOL,DIHYDRO:
974180
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Sapindus trifoliatus (SAPINDACEAE)
SAPINDOSIDE BSAPINDOSIDE A
994987
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Empty organism
PENICILLIUM ANTIBIOTIC PS-7,BENZYL:
5879
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Streptomyces diastatochromogenes (STREPTOMYCETACEAE)
IKUTAMYCIN
554423
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF
Thuja occidentalis (CUPRESSACEAE)
PODOPHYLLOTOXIN
75558
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Actinomadura verrucosospora (THERMOMONOSPORACEAE)
ACTINOMADURA ANTIBIOTIC BBM-1675-A-4ACTINOMADURA ANTIBIOTIC BBM-1675-A-3ACTINOMADURA ANTIBIOTIC BBM-1675-A-2
565783
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTICELLULITE EFFECT
Mytilus edulis (MYTILIDAE)
321430
PHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Arthrobacter oxamiceticus (CORYNEFORM ACTINOMYCETE)
OXAMICETIN
337907
PHARMACOLOGY OF COMPOUND - IN VITROMICROBIOLOGICAL ASSAYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
LENTINANSCLEROGLUCAN
391047
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN IMPROVEMENT EFFECT
Ehretia resinosa (BORAGINACEAE)
336376
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
INSECTICIDE ACTIVITY
Empty organism
PIPERINEESSENTIAL OIL(EUCALYPTUS GLOBULUS)CHAVICINE
1036085
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Corynebacterium acetoacidophilum (CORYNEFORM ACTINOMYCETE)
CORYNEBACTERIUM ACETOACIDOPHILUM ANTITUMOR ANTIBIOTIC
964319
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
SUPEROXIDE INHIBITION
Empty organism
PROCYANIDIN B-2 3-3'-DI-O-GALLATECATECHIN-3-O-GALLATE,EPI: (-):PROCYANIDIN C-1 3-3'-3''-TRI-O-GALLATEGALLOCATECHIN-3-O-GALLATE,EPI: (-):
92228
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC PC-766-B'
318758
PURIFICATION OFPATENT DESCRIBED
Empty organism
ISOPRENE
1055567
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
CADEGUOMYCIN
895338
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
HEMOLYTIC ACTIVITY
Bupleurum falcatum (APIACEAE)
POLYSACCHARIDE(BUPLEURUM FALCATUM)
93635
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Rosmarinus officinalis (LAMIACEAE)
ROSMARIDIPHENOL
94114
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Actinomyces species (ACTINOMYCETACEAE)
ACTINOMYCES ANTIBIOTIC M-119
509717
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Curculigo latifolia (HYPOXIDACEAE)
CURCULIN
353005
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
RETICULINE,NOR:
1164892
PATENT DESCRIBED
Empty organism
CORYNANTHINE
535334
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOCHOLESTEROLEMIC ACTIVITY
Empty organism
SESAMIN
1183497
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
CHOLESTEROL,22(R)-HYDROXY:
380319
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTITUMOR ACTIVITY
Inula helianthus-aquatica (ASTERACEAE)
INULA LACTONE 1
401475
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
WEIGHT LOSS
Morus species (MORACEAE)
416882
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Limulus polyphemus (LIMULIDAE)
POLYPHEMUSIN I
1036562
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora chalcea (MICROMONOSPORACEAE)
TETROCARCIN G
941517
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INTERFERON INDUCTION STIMULATION
Staphylococcus aureus (MICROCOCCACEAE)
STAPHYLOCOCCUS LYMPHOCYTE STIMULANT MP-A
321538
STABILITY STUDIES OFPATENT DESCRIBEDPHARMACEUTICAL FORMULATION OF
Empty organism
PANTOTHENIC ACIDVITAMIN K-4VITAMIN B-1NICOTINAMIDEFOLIC ACIDVITAMIN AVITAMIN B-2VITAMIN D-3VITAMIN B-12VITAMIN B-6BENZOIC ACID,2-5-DIHYDROXY:TOCOPHEROL,ALPHA:
955093
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
TRICHOSANTHIN,ALPHA:
218047
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ecteinascidia turbinata (PEROPHORIDAE)
ECTEINASCIDIN 729
975803
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Micromonospora citrea (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC LL-19085-ETA
970705
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Cephalodiscus gilchristi (CEPHALODISCIDAE)
CEPHALOSTATIN 6
25554
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tylophora dalzellii (ASCLEPIADACEAE)
93442
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora species (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC KMR-593
127006
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIPROTOZOAN ACTIVITY
Zalerion arboricola (HYPHOMYCETES)
ZALERION ANTIBIOTIC I
1057369
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Westerdykella multispora (PHAEOTRICHACEAE)
WESTERDYKELLA ANTIBIOTIC KS-202
1021024
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
ACLACINOMYCIN S,2-HYDROXY:ACLACINOMYCIN N,2-HYDROXY:ACLACINOMYCIN M,2-HYDROXY:ACLACINOMYCIN T,2-HYDROXY:
1091326
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Phytolacca americana (PHYTOLACCACEAE)
PHYTOLACCA AMERICANA PROTEIN
1002957
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces flavogriseus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 890-A-10
997191
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Pullularia fermentans (HYPHOMYCETES)
PULLULAN
1006828
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Saccharomyces species (SACCHAROMYCETACEAE)
SACCHAROMYCES ANTIBIOTIC
555274
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Coffea arabica (RUBIACEAE)
447617
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Empty organism
COLOMINIC ACID
986967
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CEPHALOTAXYL,METHYL: ITACONATE
1029597
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Saccharomyces cerevisiae (SACCHAROMYCETACEAE)
SACCHAROMYCES ANTIBIOTIC FX-100
666565
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIBACTERIAL ACTIVITY
Empty organism
KUWANOL A
155757
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ACYL-CO-A:CHOLESTEROL ACYLTRANSERASE INHIBITION
Scedosporium species (HYPHOMYCETES)
SCEDOSPORIUM ANTIBIOTIC AS-183
418999
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMALARIAL ACTIVITY
Empty organism
ARTEMISININ
758789
PATENT DESCRIBEDHOMEOPATHIC STUDIES
Empty organism
89585
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Streptomyces cavourensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SS-7313-A
533255
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Schisandra chinensis (SCHISANDRACEAE)
GOMISIN N
948915
PATENT DESCRIBEDTOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
IRRITANT ACTIVITY
Sapindus mukorossi (SAPINDACEAE)
552307
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
FIBRINOGEN CONVERSION INHIBITION
Desmos cochinchinensis (ANNONACEAE)
FLAVANONE,8-FORMYL-2-5-7-TRIHYDROXY-6-METHYL:
490631
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBED
Vinca minor (APOCYNACEAE)
1023243
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTHELMINTIC ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC KA-3093
329151
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Claviceps purpurea (CLAVICIPITACEAE)
ERGOTAMININEERGOTAMINE
1046518
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Echinacea purpurea (ASTERACEAE)
ECHINACEA PURPUREA POLYSACCHARIDE(M.W.5000-50000)
129087
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC BU-4164-E-I
559020
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMALARIAL ACTIVITY
Empty organism
HARRINGTONINE,HOMO:
68216
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Vaccinium macrocarpon (ERICACEAE)
201940
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
LIPOPROTEIN LIPASE STIMULATION
Serratia liquifaciens (ENTEROBACTERIACEAE)
SERRATIA ANTIBIOTIC FR-177391
93448
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Nocardiopsis species (ACTINOMYCETALES)
NOCARDIOPSIS ANTIBIOTIC KT-5556
1003360
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Polyporus tuberaster (POLYPORACEAE)
POLYPORUS TUBERASTER ANTIBIOTIC
1184509
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Duboisia myoporoides (SOLANACEAE)
HYOSCYAMINE
586582
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIOXIDANT ACTIVITY
Empty organism
PHYLLODULCIN
28980
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Asclepias subulata (ASCLEPIADACEAE)
956140
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eucommia ulmoides (EUCOMMIACEAE)
ULMOIDOSIDE BULMOIDOSIDE AULMOIDOSIDE DULMOIDOSIDE C
991868
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Micromonospora matsuzakiense (MICROMONOSPORACEAE)
MICROMONOSPORA ANTIBIOTIC SF-2052
598420
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
TYROSINASE INHIBITION
Empty organism
TOCOPHEROLSESAMOL
37466
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTIFERTILITY
ESTROGENIC EFFECT
Butea monosperma (FABACEAE)
75518
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC Y-0834-HB
396143
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANESTHETIC ACTIVITY(LOCAL)
Syzygium aromaticum (MYRTACEAE)
349615
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
CEREBRAL INSUFFICIENCY IMPROVEMENT
Empty organism
DOCOSAHEXAENOIC ACID
607286
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIACNE ACTIVITY
Glycine max (FABACEAE)
713298
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTINEPHRITIC EFFECT
Cordyceps sinensis (CLAVICIPITACEAE)
939002
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Reynoutria japonica (POLYGONACEAE)
RESVERATROL
878969
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Streptomyces lavendulae (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC CA-146-A
478958
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTIOXIDANT ACTIVITY
Rosmarinus officinalis (LAMIACEAE)
723109
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Taxomyces andreanae (TO BE DETERMINED)
TAXOL
3537
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces sapporoensis (STREPTOMYCETACEAE)
BICYCLOMYCIN
678826
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Annona squamosa (ANNONACEAE)
MOLVIZARIN
657314
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIYEAST ACTIVITY
Spongia species (SPONGIIDAE)
SPONGIASTATIN 3
1104372
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTICELLULITE EFFECT
Ruscus aculeatus (LILIACEAE)
1183644
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
MITOGENIC ACTIVITY
Zea mays (POACEAE)
659786
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
BETULINIC ACID
364950
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Quercus pedunculata (FAGACEAE)
154225
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Amycolatopsis species (ACTINOMYCETACEAE)
AMYCOLATOPSIS ANTIBIOTIC MM-56597AMYCOLATOPSIS ANTIBIOTIC MM-56598
1020806
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
MUCOPEPTIN C
93711
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC YP-02908-L-A
187622
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES DEPSIPEPTIDE A
1023164
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTISTRESS ACTIVITY
Empty organism
GINSENOSIDE RB-1GINSENOSIDE RE
118239
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET ACTIVATING FACTOR INHIBITION
Phoma species (COELOMYCETES)
PHOMACTIN B
320820
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
SERINE,ISO: (R):
733434
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
IMMUNOSTIMULANT ACTIVITY
Nigella sativa (RANUNCULACEAE)
6510
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Laetiporus sulphureus (POLYPORACEAE)
LAETIPORUS ANTIBIOTIC
355864
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR CONDITIONER
Jatropha multifida (EUPHORBIACEAE)
932180
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Platycodon grandiflorum (CAMPANULACEAE)
PLATYCODON INULIN-TYPE NEOPLASM INHIBITOR
143091
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Rabdosia trichocarpa (LAMIACEAE)
LONGIKAURIN B
565496
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Curcuma aromatica (ZINGIBERACEAE)
GERMACRONE-4(S)-5(S)-EPOXIDE,(+):
963205
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIVIRAL ACTIVITY
Narcissus pseudo-narcissus (AMARYLLIDACEAE)
NARCISSUS MANNOSE-SPECIFIC LECTIN
675955
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
APOPTOSIS INDUCTION
Empty organism
NOSCAPINE
1009126
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces olivaceus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MM-4550-A
824358
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC A-33853
323776
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Digitalis purpurea (SCROPHULARIACEAE)
PURPUREA GLYCOSIDE ADIGITOXIN
1289455
VOUCHER SPECIMEN REPORTED FORPATENT DESCRIBED
Aristolochia taliscana (ARISTOLOCHIACEAE)
659800
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
BETULINIC ACID
483694
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
INSECT REPELLENT ACTIVITY
Empty organism
DAMASCONE,DELTA: TRANS-TRANS:
5677
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces griseoverticillatus (STREPTOMYCETACEAE)
TUBERACTINOMYCIN O
1113573
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
PSORIASIS TREATMENT
Arctium lappa (ASTERACEAE)
1005732
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ALPHA-AMYLASE INHIBITION
Streptomyces diastaticus-amylostaticus (STREPTOMYCETACEAE)
AMYLOSTATIN D
683582
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Astragalus species (FABACEAE)
ASTRAGALUS PEPTIDE
994713
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces thioluteus (STREPTOMYCETACEAE)
MAZETHRAMYCIN BMAZETHRAMYCIN,ANHYDRO:MAZETHRAMYCIN CMAZETHRAMYCIN A
617612
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Corydalis ochotensis (PAPAVERACEAE)
CORYTENCHINE
741572
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ilex kudincha (AQUIFOLIACEAE)
ILEKUDINOL C
489985
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Crypthecodinium cohnii (CRYPTHECODINIACEAE)
DOCOSAHEXENOIC ACID
329134
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY(PLANT PATHOGEN)
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MD-129-C-2
61040
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIULCER ACTIVITY
Senecio ambavilla (ASTERACEAE)
SENECIO ESTER I
21615
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)SEPARATION OF (EXCEPT OILS, VENOM, PROTEINS, FATS)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTIBACTERIAL ACTIVITY
Celastrus orbiculatus (CELASTRACEAE)
CELASTRUS PANICULATUS SUBSTANCE(MP 190)
155159
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC RK-1409
986960
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CEPHALOTAXYL,METHYL: FUMARATE
999709
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Hyphomicrobium variabilii (BUDDING BACTERIA)
COENZYME Q-9
326298
SYNTHESIS OF ANALOGSPATENT DESCRIBED
ANTIEMETIC ACTIVITY
Empty organism
BENZAMIDE
986973
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CEPHALOTAXYL-L-MANDELATE-TRICHLORO-ETHYL-CARBONATE
994489
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Penicillium stipitatum (HYPHOMYCETES)
DUCLAUXIN
409891
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
PAPAVERINE,DI:*
722190
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ALPHA-GLUCOSIDASE INHIBITION
Apocynum venetum (APOCYNACEAE)
883587
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Ephedra species (EPHEDRACEAE)
EPHEDRANNIN A
1125180
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Plantago lanceolata (PLANTAGINACEAE)
151554
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Saccharothrix species (TO BE DETERMINED)
SACCHAROTHRIX ANTIBIOTIC CF-24
710994
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
446742
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Alpinia galanga (ZINGIBERACEAE)
GALANAL A
337612
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN HUMANS
SWEETENING EFFECT
Empty organism
HESPERETIN DIHYDROCHALCONE-4'-O-BETA-D-XYLOSIDE
964572
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Epilobium angustifolium (ONAGRACEAE)
MYRICETIN-3-O-BETA-D-GLUCURONIDE
79341
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
GROWTH PROMOTER ACTIVITY
Streptomyces majorciensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC LLCO-8078-BETA
460184
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
DNA POLYMERASE INHIBITION
Empty organism
QUERCETIN
41958
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Beta vulgaris (CHENOPODIACEAE)
PROTEIN(BETA VULGA$IS)
555425
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
MYOSIN LIGHT CHAIN KINASE INHIBITION
Empty organism
WORTMANNIN
1231422
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Stachybotrys bisbyi (HYPHOMYCETES)
COCHLIOQUINONE A,EPI:
709396
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Salacia prinoides (HIPPOCRATEACEAE)
LUP-20(29)-EN-2-ONE,3-BETA-30-DIHYDROXY:
802951
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Panus rudis (POLYPORACEAE)
HEXACYCLINOL
328630
SYNTHESIS OF ANALOGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Empty organism
GARAMINE,1-3-3-TRI-ACETYL:*
836511
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC TM-482-A
1185887
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Streptomyces species (STREPTOMYCETACEAE)
MAYTANSINE
584850
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Cassia senna (FABACEAE)
SENNOSIDE ASENNOSIDE B
1323519
UV SPECTRUM GIVEN FORPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Orobanche hederae (OROBANCHACEAE)
OROBANCHOSIDEVERBASCOSIDE
525438
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
DEPIGMENTATION EFFECT
Empty organism
ELLAGIC ACID
992480
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Tricholoma matsutake (TRICHOLOMATACEAE)
EMITANIN B
417204
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
PENIS ERECTILE STIMULANT
Empty organism
PAPAVERINE
447878
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Streptomyces hygroscopicus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC MBA-028-24-B
977794
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Actinomadura atramentaria (THERMOMONOSPORACEAE)
MATLYSTATIN A-1
693873
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULINIC ACID
976244
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Caesalpinia sappan (FABACEAE)
SAPPANCHALCONE
1005177
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Aspergillus melleus (HYPHOMYCETES)
MELLEDINE
866745
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Claviceps purpurea (CLAVICIPITACEAE)
ELYMOCLAVINE
174580
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces griseus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 446-53-1
1000827
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Micromonospora species (MICROMONOSPORACEAE)
KANAMYCIN B
822919
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOCHOLESTEROLEMIC ACTIVITY
Aspergillus terreus (HYPHOMYCETES)
ASPERGILLUS ANTIBIOTIC MF-4833
417421
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIMIGRAINE EFFECT
Empty organism
TRIGONELLINETRIGONELLIC ACID
883126
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces arginensis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 10381-B
323570
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
FLAVORING EFFECT
Hydrangea serrata (SAXIFRAGACEAE)
933963
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus pumilus (BACILLACEAE)
BACILLUS ANTIBIOTIC OM-001
1077498
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIFERTILITY
SPERMICIDAL EFFECT
Empty organism
GOSSYPOL
975894
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Petasites japonicus (ASTERACEAE)
PETASIN,ISO:
1020829
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Arthrobacter species (CORYNEFORM ACTINOMYCETE)
ARTHROBACTER ANTIBIOTIC 02-8-II
1081182
PATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
Aloe arborescens (LILIACEAE)
ALOE ARBORESCENS GLYCOPROTEIN P-2
1051578
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCPATENT DESCRIBEDQUANTITATIVE DATA REPORTED
Gynostemma pentaphyllum (CUCURBITACEAE)
GYPENOSIDE I
668182
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
PENINSULARINONE,(-):
1014694
PURIFICATION OFPATENT DESCRIBED
Empty organism
STEVIOSIDE
1047457
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces anandii (STREPTOMYCETACEAE)
ANANDIMYCIN
1289501
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aristolochia taliscana (ARISTOLOCHIACEAE)
CONIFERYL ALCOHOL
610298
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORTLC DATA REPORTEDISOLATION AND IDENTIFICATION OF
Schumanniophyton magnificum (RUBIACEAE)
ROHITUKINE
659775
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Ziziphus mauritiana (RHAMNACEAE)
BETULINIC ACID
356600
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ancistrocladus korupensis (ANCISTROCLADACEAE)
MICHELLAMINE B
524155
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
CHOLEST-4-EN-3-ONESITOST-4-EN-3-ONE,BETA:STIGMAST-4-EN-3-ONECAMPEST-4-EN-3-ONE
230236
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC BE-51068
319862
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
CORYNANTHINE DERIVATIVES*
1034828
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Actinomyces species (ACTINOMYCETACEAE)
ACTINOMYCES ANTIBIOTIC BBM-928-B
1013609
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
BETA-LACTAMASE INHIBITION
Chaetomella raphigera (COELOMYCETES)
CHAETOMELLA ANTIBIOTIC M-4854-I
821381
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERCHOLESTEROLEMIC ACTIVITY
Empty organism
CYCLOARTENOL
90970
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC 82-85-8-A
489575
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Bugula neritina (BUGULIDAE)
NERISTATIN 1
985882
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces gilvotanareus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC DC-38-B
426677
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Momordica charantia (CUCURBITACEAE)
MOMORDICA PROTEIN MAP-30
569667
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Nigella sativa (RANUNCULACEAE)
235168
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces griseus (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC B-2289-AN
206805
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Actinoplanes species (ACTINOPLANACEAE)
ACTINOPLANES ANTIBIOTIC BE-40644
978389
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTILEPROTIC ACTIVITY
Empty organism
ALLICIN
1122753
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
VINCALEUKOBLASTINE
178596
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Halichondria okadai (AXINELLIDAE)
HALICHONDRIN B
353397
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Empty organism
BRUCEANTIN
83103
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Nocardiopsis species (ACTINOMYCETALES)
NOCARDIOPSIS ANTIBIOTIC SP/K-252
328926
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
CAMPTOTHECIN
251650
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTITUMOR ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC BE-69785-A
1054276
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Dictyophora species (PHALLACEAE)
DICTYOPHORA ANTIBIOTIC
68220
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Ajuga turkestanica (LAMIACEAE)
215520
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
BONE RESORPTION INHIBITION
Nardostachys jatamansi (VALERIANACEAE)
NARDOSTACHYS COMPOUND BR-606
417704
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
RADICAL SCAVENGING EFFECT
Empty organism
GALLIC ACIDSENNOSIDE ASENNOSIDE BSENNIDIN A
111974
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces phaeoviridis (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC AF-030
48182
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ficus carica (MORACEAE)
659729
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULIN
361021
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
WOUND HEALING ACCELERATION
Cymbopogon citratus (POACEAE)
141306
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC RK-1441-B
815892
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE
ANTIULCER ACTIVITY
Allium sativum (LILIACEAE)
ALLIUM SATIVUM PROTEASE INHIBITOR AS-1
1251472
PURIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBED
Swertia japonica (GENTIANACEAE)
SWERTIAMARIN
815675
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
HAIR STIMULANT EFFECT
Empty organism
COENZYME Q-10
68445
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
GASTROINTESTINAL DISORDERS(UNSPECIFIED)
Empty organism
LIMONENE,(+):
329970
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Bacillus sphaericus (BACILLACEAE)
BUTYRIC ACID,2-KETO:
1032112
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Empty organism
ARICINE
963658
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Panax pseudoginseng (ARALIACEAE)
25904
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
TOBACCO SUBSTITUTE
Gnaphalium polycephalum (ASTERACEAE)
1021028
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Scenedesmus species (SCENEDESMACEAE)
318652
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Inonotus culicularis (HYMENOCHAETACEAE)
1274247
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Bulbophyllum kwangtungense (ORCHIDACEAE)
BULBOPHYLOL A
996152
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Streptomyces galilaeus (STREPTOMYCETACEAE)
ACLACINOMYCIN BACLACINOMYCIN A
693884
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Empty organism
BETULONIC ACID
185094
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Streptomyces roseoflavus (STREPTOMYCETACEAE)
ZHIJIANGJUNSU
857057
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIASTHMATIC ACTIVITY
Empty organism
SIDERITOFLAVONE
329798
PURIFICATION OFPATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Empty organism
DOPA,L:
80345
GEL PERMEATION CHROMATOGRAPHY USEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC SS-8228-B
233161
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYTOTOXIC ACTIVITY
Metarhizium species (HYPHOMYCETES)
METARRHIZIUM ANTIBIOTIC MER-F-3
351020
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIOXIDANT ACTIVITY
Empty organism
DOPA,L:METHIONINETOCOPHEROLSALICYLIC ACIDCITRIC ACIDMALIC ACIDCAROTENETYROSINEGUAIAZULENERUTINPAPAINHISTIDINEBENZOIC ACIDHINOKITIOLTRYPTOPHANCYSTEINE
142780
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Streptomyces species (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC NK-155141
50807
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
HYPOTENSIVE ACTIVITY
Prosopis africana (FABACEAE)
PROSOPINE
257389
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CHITIN SYNTHASE INHIBITION
Diploospora longispora (HYPHOMYCETES)
DIPLOSPORA ANTIBIOTIC WSS-1061
358180
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITION
Empty organism
BERBERINE
1035923
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ceratostigma plumbaginoides (PLUMBAGINACEAE)
PLUMBAGIN
1244284
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Trillium tschonoskii (LILIACEAE)
TRILLENOSIDE
986956
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
CEPHALOTAXYL,ETHYL: OXALATE
605767
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
DERMATITIS IMPROVEMENT
Empty organism
PULEGONE
610750
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN IMPROVEMENT EFFECT
Malva verticillata (MALVACEAE)
419332
PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Empty organism
OXETANOCIN G
1021738
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Lentinus edodes (TRICHOLOMATACEAE)
LENTINUS ANTIBIOTIC KS-2-D
978241
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Eleutherococcus senticosus (ARALIACEAE)
SYRINGIN
1086648
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Marsdenia cundurango (ASCLEPIADACEAE)
3199
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Streptomyces irabensis (STREPTOMYCETACEAE)
BICYCLOMYCIN
Show SPARQL Queries (1)